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Toxicity Evaluations of Nanoclays and an Associated Nanocomposite 
throughout their Life Cycle 
Alixandra Wagner 
Nanoclays are layered mineral silicates that originate from the clay fraction of soil and 
carry a platelet thickness of about 1 nm and lengths and widths of up to several microns. Due to 
their nanoscale dimensions, they have been used for numerous applications ranging from media 
for oil well drilling to sorbents in treatment of waste-water. Additionally, upon functionalization 
with organic modifiers, nanoclays have been incorporated into polymers to form nanocomposites 
with increased mechanical strength, barrier properties, UV dispersion, and fire resistance to be 
implemented in food packaging or medical devices related applications. Such increased 
implementation into industrial and commercial products has brought scrutiny onto nanoclays and 
associated nanocomposites toxicity. Previous studies have shown for instance that nanoclays 
induce cytotoxic and genotoxic effects upon cellular or model animal exposure, however little 
investigations were performed to identify how nanoclay functionalization may influence such 
toxicological profiles. Moreover, most of the studies related to nanoclays and nanocomposites 
toxicity only refer to their consumption/usage exposure and fail to assess manufacturing or 
disposal exposures.   
 Herein, we aimed to understand how the physical and chemical properties of nanoclay 
systems (i.e. pristine and organically modified, along with a nanoclay-enforced nanocomposite) in 
both their as-received (mimicking manufacturing) and thermally degraded (mimicking end of life 
cycle incineration) forms influence lung cells, used to model inhalation toxicity. Physical and 
chemical properties of the materials were investigated via microscopical and spectroscopical 
approaches, while toxicity profiles were assessed both in real-time or at disparate time points via 
in vitro cellular and molecular assays, cell imaging, and electric cell-substrate impedance sensing. 
Our analyses showed that nanoclays and nanocomposites properties (both physical and chemical) 
influence the materials’ degradation profile and ultimately their induced toxicity in model cellular 
systems. The toxic effects were displayed either by reductions in cell proliferation and viability, 
changes in cell morphology, and/or alterations in the cell cytoskeleton. Overall, our results provide 
unique insights into how materials properties, both physical and chemical dictate materials’ 
toxicological profiles throughout their life cycle (from manufacturing to disposal) with such 
information to be possibly aiding in safe-by-design strategies as well as safety protocols 











































First and foremost, I would like to express my sincere gratitude to my advisor Dr. Cerasela 
Zoica Dinu for all her guidance, advice, and support throughout my graduate studies. Without her 
encouragement, I would not have entered the Ph.D. program and been given the opportunities I 
have now. Further, her continuous assistance on all aspects of these studies have made such 
research a possibility and helped me learn and grow as a researcher.  
In addition, I would like to thank Dr. Todd A. Stueckle for all his advice and assistance on 
the projects performed throughout my studies. I would also like to thank my committee members 
Dr. Rakesh K. Gupta, Dr. Konstantinos A. Sierros, and Dr. Charter Stinespring for all their 
assistance on these projects, as well as for serving on my committee. In addition, I would like to 
thank Dr. Yon Rojanasakul and Dr. Sushant A. Agarwal for their advice and assistance in 
laboratory space and materials that helped support this research.  
I would like to thank the staff of the WVU Shared Research Facilities for all their help on 
equipment used for the material characterization studies in this research, with special thanks to Dr. 
Marcela Redigolo, Dr. Weiqiang Ding, and Dr. Qiang Wang. I would also like to thank Gabriela 
Perhinschi for her help with the TGA and the members of Dr. Sierros’s lab for help with the DLS.  
I would also like to express my gratitude for the current and former members of Dr. Dinu’s 
and Dr. Rojanasakul’s lab with whom I have worked with over the years and have helped greatly 
with numerous aspects of my graduate studies. I would also like to give a special thanks to the 
former and current faculty, staff, and students of the Chemical and Biomedical Engineering 
Department for all their help and support over the years.  
Finally, I would like to thank my family and friends for all their continuous support over 













Table of Contents………………………………………………………………………………….v 
List of Figures…………………………………………………………………………………….vi 
List of Tables……………………………………………………………………………………..xi 
List of Symbols/Nomenclature………………………………………………………………….xvi 
Introduction………………………………………………………………………………………1 
Chapter 1: Nanoclays: A Review of their Toxicological Reports and Risk Assessment 
Implementation Strategies………………………………………………………………………...4 
Chapter 2: Toxicity Evaluations of Nanoclays and Thermally Degraded Byproducts through 
Spectroscopical and Microscopical Approaches……………………………………………...…33 
 Supporting Information………………………………………………………………...53 
Chapter 3: Early Assessment and Correlations of Nanoclay’s Toxicity to their Physical and 
Chemical Properties……………………………………………………………………………...67 
 Supporting Information…………………………………………………………………93 
Chapter 4: Toxicity Assessment of Byproducts Resulted from Nanoclay Composite Disposal by 
Incineration……………………………………………………………………………………..114 












LIST OF FIGURES 
 
Chapter 1: Nanoclays: A Review of their Toxicological Reports and Risk Assessment 
Implementation Strategies 
 
Figure 1: Cellular uptake of nanoclays by A549 cells. A549 cells grown onto 8-well 
chamber slides were (a) fixed (control) or (b) incubated with rhodamine (red) labeled Cloisite Na+ 
(25 µg/ mL) for 4 h, (c) or 24 h. Cells were also counterstained with Alexa Fluor 488 phalloidin 
(green) for their cytoskeletal organization identification and Hoechst (blue) for their nuclear 
localization. Intracellular accumulation of the nanoclays was detected by confocal microscopy; the 
representative images show the nanoclays localization mostly concurrent with the nuclear regions. 
(Copyright after Verma et al. 2012). HepG2 cells uptake (d) 0-62.5 µg/ml Cloisite Na+ labeled 
with Neutral red uptake (NR) or (e) 0-500 µg/ml Cloisite 30B labeled with NR. All values are 
expressed as mean ± SD. *Significantly different from control (p≤0.05). (Copyright after 
Maisanaba et al. 2013). Comet assay results of: (f) Caco-2 cells after 24 and 48 h of exposure to 
8.5, 17, or 34 µg/ml Clay 2; (g) HepG2 cells after 24 and 48 h of exposure to 22, 44, and 88 µg/ml 
Clay 2. Results from 3 independent experiments with 2 replicates/experiment. All values are 
expressed as mean ± s.d. *Significantly different from control (p < 0.05). **Significantly different 
from control (p ≤ 0.01). (Copyright after Houtman et al. 2014)…………………………………..15 
Figure 2: (a) Comet assay performed on Wistar rats (n = 6) exposed to Cloisite30B 
suspended in water (being administered at 250, 500 and 1000 mg/kg body weight of rat) or cell-
culture medium (being administered at 1000 mg/kg body weight of rat). Ethylmethane sulfonate 
(EMS) suspended in water was the positive control. For the experiments, six rats were exposed to 
250 mg/kg body weight. Data from liver, kidney and colon cells of the EMS-exposed group were 
statistically significantly different (p < 0.001, p < 0.001: *** and p < 0.05: *), respectively, from 
the values in the corresponding control group (two-tailed, unpaired t-test). Internal standards: 
positive controls (Caco-2 cells exposed to 0.05% ethylmethane sulfonate):16 slides, % tail DNA, 
mean ± S.D., 21.6 ± 6.6; negative controls (untreated Caco-2 cells): 16 slides, % tail DNA, mean 
± S.D., 1.8 ± 0.6. (Copyright after Sharma et al. 2014). (b) Catalase (CAT) and (c) superoxide 
dismutase (SOD) activities (nKat/mg protein) in kidney of rat exposed to Clay 1. The values are 
vii 
expressed as mean ± SD (n=10). The levels observed are significant at *p<0.05 in comparison to 
control group values. (Copyright after Maisanaba et al. 2014)…………………………………..20 
Figure 3: Histopathological evaluations of liver of Wistar rats exposed to a PLA-Clay1 
extract as beverage for 90 days. (a) He-stained liver section and (b) He-stained kidney sections. 
Bars, 100 μm. (a,b) Control rats. (a) Liver parenchyma with hepatocytes with normal morphology, 
central nuclei and light cytoplasm (He), organized in hepatic cords (circle). (b) Normal structure 
of kidney parenchyma with glomerulus (circle), proximal convoluted tubules (Pct), and distal 
convoluted tubules (Dct). (c,d) Exposed rats (c) Liver parenchyma with hepatocytes with normal 
morphology, central nuclei, and light cytoplasm (He), organized in hepatic cords (circle). (d) 
Normal structure of kidney parenchyma with glomerulus (circle), proximal convoluted tubules 





















Chapter 2: Toxicity Evaluations of Nanoclays and Thermally Degraded Byproducts 
through Spectroscopical and Microscopical Approaches 
 
Figure 1: (a) Thermal degradation profile of UC and CC (n=2). (b) FTIR spectrum for UC 
and CC along with their thermally degraded byproducts (n=2)…………………………………..41 
Figure 2: Surface morphology of (a) UC, (b) CC, and thermally degraded (c) UC900, and 
(d) CC900 as determined by SEM. (e) Elemental composition of as-received nanoclay and their 
thermally degraded byproducts as determined by EDX at 1 µm (n=5). The symbols * and ~ indicate 
significant differences between UC and CC and between as-received nanoclay and its thermally 
degraded byproduct, respectively………………………………………………………………...43 
Figure 3: Average particle diameter size distribution of UC, CC, UC900, and CC900 in 
solutions of (a and b) media or (c and d) PBS…………………………………………………….45 
Figure 4: (a) Representative real-time measurements of normalized resistance for BEAS-
2B cells before (Region A), during (Region B), and after treatment (Region C) with as-received 
and thermally degraded nanoclays. (b) Real-time measurements of normalized alpha (α) parameter 
for BEAS-2B cells before (Region A), during (Region B), and after treatment (Region C) with as- 
received and thermally degraded nanoclays……………………………………………………...47 
Figure 5: Toxicity of as-received and thermally degraded nanoclays determined by (a) live 
cell count and (b) cellular viability via WST assay, for unsterilized nanoclay (n=6). The symbols 
* and ~ indicate significant differences between the control and nanoclay treatments and between 
as-received nanoclay and thermally degraded byproducts, respectively…………………………49 
Figure 6: Fluorescent images of the cell membrane (red) and nucleus (blue) for (a) control 
cells and cells treated with (b) UC, (c) CC, (d) UC900, and (e) CC900 after 24 h. (f) Cell area (µm) 








Chapter 3: Early Assessment and Correlations of Nanoclay’s Toxicity to their Physical and 
Chemical Properties 
 
Figure 1: (a) Chemical structures of the organic modifiers present in I.31PS, I.34TCN, and 
I.44P (b) Thermal degradation profile of PGV and the 3 organically modified nanoclays (n=2). 
FTIR spectrum for (c) I.31PS, (d) I.34TCN, and (e) I.44P along with their thermally degraded 
byproducts, all relative to PGV and PGV900 (n=2).……………………………………………..78 
Figure 2: Surface morphology of (a) PGV, (b) I.31PS, (c) I.34TCN, and (d) I.44P and 
thermally degraded (e) PGV900, (f) I.31PS900, (g) I.34TCN900, and (h) I.44P900 as determined 
by SEM…………………………………………………………………………………………...80 
Figure 3: Elemental composition of (a) as-received nanoclay and (b) their thermally 
degraded byproducts as determined by EDX at 1 µm (n=10). The symbol * indicates significant 
differences between the unmodified clay (PGV/PGV900) and the organically modified clays. 
Average size of <90% of (c) the as-received nanoclays in solutions of PBS, DMEM, SAGM, or 
Survanta (d) as well as their byproducts (n=3).…………………………………………………...83 
Figure 4: (a) IC50 values (µg/cm
2) for BEAS-2B cells and SAECs treated with as-received 
nanoclays and byproducts. The symbol * and ~ indicate significant differences between the 
unmodified nanoclay (PGV/PGV900) and the organically modified nanoclays and between the as-
received nanoclay and its thermally degraded byproduct, respectively (n≥4 for each treatment). (b) 
Representative optical images of BEAS-2B cells and SAECs treated with as-received nanoclays 
and byproducts at their respective IC50 dose after 24 h of exposure. (c) Extracellular ROS 
production by BEAS-2B cells after treatment with as-received nanoclays and byproducts at their 









Chapter 4: Toxicity Assessment of Byproducts Resulted from Nanoclay Composite 
Disposal by Incineration 
 
Figure 1: (a) Thermal degradation profile of PLA and PLACC as determined by TGA 
(n=2). Chemical characteristics analysis. (b) Elemental composition of PLA, PLACC, and 
PLACC900 as determined by EDX (n=5). The symbol * and ~ indicate significant differences 
between PLA and PLACC and between PLACC and its incinerated byproduct, PLACC900, 
respectively. (c) FTIR spectra for PLA, PLACC, and PLACC900 (n=2)……………………….124 
Figure 2: Surface morphology of (a) PLA, (b) PLACC, and (c), (d) the two morphologies 
displayed by PLACC900 as determined by SEM……………………………………………….128 
Figure 3: (a) Dose response curve (based on live cell counts) for BEAS-2B cells exposed 
to PLACC900 from 0-750 µg/ml (n=5). (b) Cellular viability (based on WST assay) for cells 
exposed to PLACC900 (n=6). The symbol * indicates a significant difference between the control 
cells and exposed cells. The values are normalized relative to the controls. (c) Extracellular ROS 
of cells exposed to varying doses of PLACC900 (n=4). The symbol * indicates a significant 
difference between the control cells and exposed cells………………………………………….130 
Figure 4: Fluorescent images of the cell membrane (red) and nucleus (blue) for (a) control 
cells and cells exposed to PLACC900 at (b) 100 µg/ml, (c) 300 µg/ml, and (d) 500 µg/ml after 24 
h…………………………………………………………………………………………………132 
Figure 5: (a) Representative real-time measurements of normalized resistance for BEAS-
2B cells before and during exposure to PLACC900 from 100-500 µg/ml. Representative real-time 
measurements of normalized resistance for the recovery of BEAS-2B cells over 72 h after exposure 
to PLACC900 for (b) 24 h, (c) 48 h, and (d) 72 h. (e) Percentage of cells in the G1, G2, or S phase 









LIST OF TABLES 
 
Chapter 1: Nanoclays: A Review of their Toxicological Reports and Risk Assessment 
Implementation Strategies 
 
Table 1: Examples of nanoclays researched along with their organic modifiers, 
























Chapter 2: Toxicity Evaluations of Nanoclays and Thermally Degraded Byproducts 
through Spectroscopical and Microscopical Approaches 
 
Table 1: Amount of moisture, volatile, ash, and fixed carbon present in UC and CC as 
determined by TGA. The symbol * indicates a significant difference between UC and CC……40 
Table 2: Average particle diameter distribution sizes (µm) in solutions of media relative 
to the number of particles………………………………………………………………………...45 
Table 3: Average particle diameter distribution sizes (µm) in solutions of PBS relative to 























Chapter 3: Early Assessment and Correlations of Nanoclay’s Toxicity to their Physical and 
Chemical Properties 
 
Table 1: The percent amount of moisture, high temperature volatiles, ash, and fixed carbon 
present in the Nanomer nanoclays as determined by TGA. The symbol * indicates a significant 



























LIST OF SYMBOLS / NOMENCLATURE 
 ANOVA: analysis of variance 
 BEAS-2B: immortalized human lung epithelial cells 
 CC: as-received Cloisite 30B 
 CC900: thermally degraded Cloisite 30B 
 DLS: dynamic light scattering 
 DMEM: Dulbecco’s Modified Eagle’s Medium (cellular media for BEAS-2B cells) 
 ECIS: electric cell-substrate impedance sensing 
 EDX: Energy dispersive X-ray spectroscopy 
 FACS: fluorescence activated cell sorting 
 FBS: fetal bovine serum 
 FTIR: Fourier Transform Infrared Spectroscopy 
 I.31PS: as-received Nanomer I.31PS 
 I.31PS900: thermally degraded Nanomer I.31PS 
 I.34TCN: as-received Nanomer I.34TCN 
 I.34TCN900: thermally degraded Nanomer I.34TCN 
 I.44P: as-received Nanomer I.44P 
 I.44P900: thermally degraded Nanomer I.44P 
 MMT: montmorillonite 
 PBS: phosphate buffered saline 
 PGV: as-received Nanomer PGV 
 PGV900: thermally degraded Nanomer PGV 
 PLA: polylactic acid 
 PLACC: polylactic acid-Cloisite 30B nanocomposite 
 PLACC900: thermally degraded polylactic acid-Cloisite 30B nanocomposite 
 ROS: reactive oxygen species 
 SAECs: small airway epithelial cells 
 SAGM: small Airway Growth Medium (cellular media for SAECs) 
 SEM: scanning electron microscopy 
xv 
 TGA: thermogravimetric analysis 
 UC: as-received Cloisite Na+ 
 UC900: thermally degraded Cloisite Na+ 
 WST: tetrazolium salt (cellular viability assay) 





























Montmorillonite (MMT) is the most common type of phyllosilicate nanoclay, which 
consist of 2 silicate-oxygen tetrahedral sheets and an aluminum octahedral sheet. However, MMT 
has a negative charge due to the substitution of aluminum for silicon in its tetrahedral sheets and 
magnesium for aluminum in its octahedral sheets, respectively. Positively charged ions, such as 
sodium and calcium, are attracted to the inner galleries of such a negative nanoclay, allowing for 
its functionalization with organic modifiers through ion exchange reactions. The organic modifier 
increases nanoclay’s basal spacing and leads to a more hydrophobic material with substantially 
improved ease of implementation into polymer mixtures for nanocomposites formation.  
Nanoclays high aspect ratio along with their abundance in soil and low cost have made 
nanoclays applicable to numerous areas from sorbents for the treatment of waste water or 
hazardous spills, to rheological modifiers for oil well drilling fluids, paints, and cosmetics. 
Additionally, their functionalization with organic modifiers and incorporation into polymers to 
form a nanocomposite with increased mechanical strength, barrier properties, UV dispersion, and 
fire resistance, extended their usages to areas such as food packaging, medical devices, or 
automotive industry. However, with larger consumer implementation, nanoclays and 
nanocomposites have the extended potential for human exposure throughout their life cycle, i.e., 
from manufacturing, consumption/usage, to disposal. Impactful assessment strategies are needed 
to evaluate their possible toxicity profiles in order to establish consumer and worker exposure 
limits or design strategies that minimize their possible deleterious effects.  
 This thesis looks at identifying the toxicological profiles of nanoclays or nanoclay-enforced 
composites (nanocomposites) during their life-cycle, i.e. from manufacturing to disposal. 
Specifically:  
Chapter one introduces structural and functional characteristics of nanoclays that have led 
to their increased ability for processing and applicability in numerous areas from sorbents in 
pollution prevention, to environmental remediation, paints, and cosmetics. Additionally, the 
chapter highlights the properties and applications of nanocomposites in the food packaging 
industry. Further, a comprehensive summary of the current studies differentiating toxicity and 
toxicity-related mechanisms resulted from cellular exposures to commercially available nanoclays 
(e.g., with different physico-chemical characteristics as provided by the organic modifier or the 
size of the nanoclay itself etc.) currently in use is presented. Lastly, this chapter highlights the gaps 
2 
in knowledge related to the toxicological profiles of the nanoclays and proposes that the logistical 
burden associated with their toxicological risk assessment could be circumvented through 
implementation of tailored strategies that ensure a greener route for nanoclay functionalization and 
implementation. (Book Chapter: Wagner, A., Gupta, R., Dinu, C.Z. Nanoclays: A Review of their 
Toxicological Profiles and Risk Assessment Implementation Strategies, in Nanotechnology 
Commercialization: Manufacturing Processes and Products. 2017. John Wiley & Sons, Inc., 
Hoboken, NJ, USA.) 
Chapter two details the specific investigation as related to the potential inhalation toxicity 
of a pristine nanoclay, Cloisite Na+, and an organically modified nanoclay, Cloisite 30B, as well 
as their thermally degraded byproducts, thus uniquely accounting for exposure in both 
manufacturing and disposal environments. With studies showing that nanoclays have the potential 
to come into contact with humans during manufacturing and handling, and considering that their 
disposal potentially leads to increased reactivity at interfaces with biological systems, this chapter 
highlights why it is important to understand nanoclays’ life cycle and induced interactions with 
cellular systems. Through material characterization and toxicity analyses, the chapter demonstrates 
that the greatest degree of toxicity occurs for the organically modified nanoclay. Further, different 
toxicological profiles were obtained for the thermally degraded nanoclays relative to their as-
received counterparts. The results show that both manufacturing and disposal exposures need to 
be considered when evaluating materials’ toxicity profiles; further, the chapter emphasizes that 
viable safety protocols need to be implemented when nanoclays are being considered for consumer 
products. (Publication: Wagner, A., Eldawud, R., White, A., Agarwal, S., Stueckle, T.A., Sierros, 
K.A., Rojanasakul, Y., Gupta, R.K., Dinu, C.Z. Toxicity Evaluations of Nanoclays and Thermally 
Degraded Byproducts through Spectroscopical and Microscopical Approaches. Biochimica et 
Biophysica Acta. 2017, 1861 (1 Pt A), 3406-3415.) 
Chapter three extends the existing literature and provides a comprehensive analysis of the 
physical and chemical characteristics of four types of nanoclays used in food packaging 
applications as well as differentiates their toxicity-related mechanisms based on their different 
physico-chemical characteristics. A variety of microscopical and spectroscopical materials 
characterization techniques, as well as two in vitro model lung cell lines, an immortalized and a 
primary line (to provide a more realistic view of nanoclay-related toxicity and a verification of 
results in pertinent human-related exposure models), were used. Additionally, the toxicity of the 
3 
nanoclays was investigated at levels of exposure that mimic a manufacturing and a disposal 
environment to thus establish valid toxicity pathways during the life cycle of the nanoclays. 
(Publication: Wagner, A., White, A.P., Stueckle, T.A., Banerjee. D., Sierros, K.A., Rojanasakul, 
Y., Agarwal, S., Gupta, R.K., Dinu, C.Z. Early Assessment and Correlations of Nanoclay’s 
Toxicity to their Physical and Chemical Properties. ACS Applied Materials & Interfaces. 2017, 9 
(37), 32323-32335.)  
Chapter four establishes that toxicity studies do not only need to account for nanoclays 
themselves or for their exposure at both manufacturing and disposal areas, but further, have to 
account for nanoclays implementation.  As such, this chapter establishes correlations between the 
consumption/usage and disposal stages of a nanocomposite while also allowing the individual 
toxicological impacts of the components themselves, i.e. polymer (model polymer considered is 
polylactic acid) and nanoclay, as well as their associated byproducts (i.e. products resulted from 
incineration), to be explored. The results of this chapter show that the byproduct of such a 
nanocomposite does induce changes to human lung cellular systems with effects being associated 
with the multiple stages of the nanocomposite life cycle. (Publication: Wagner, A., White, A.P., 
Tang, M.C., Agarwal, S., Stueckle, T.A., Rojanasakul, Y., Gupta, R.K., Dinu, C.Z. Incineration of 
Nanoclay Composites Leads to Byproducts with Reduced Cellular Reactivity. Scientific Reports. 

















Nanoscale properties and increased ability for processing, along with abundance in soil 
and low cost, make nanoclays applicable to numerous areas from sorbents in pollution prevention 
to environmental remediation, paints, and cosmetics. Further, reinforcement of polymer films with 
nanoclays has led to implementation of nanoclays in the next generation of nanocomposites with 
increased mechanical strength, barrier properties, UV dispersions, and fire resistance capabilities, 
to be applied in the food packaging industry. 
The first part of this review describes the characteristics of nanoclays and how they can 
be exploited for synthetic applications, especially food packaging applications, while the second 
part of the review focuses on the challenges associated with nanoclay integration in consumer 
products and their potential to induce deleterious effects that could affect humans at the exposure 
levels of manufacturing, consumption, and disposal. Lastly, the review highlights the potential 
mechanisms of toxicity resulted upon cellular exposure to nanoclays and proposes that logistical 
burden associated with risk assessment resulted from such exposures could be circumvented 
through implementation of tailored strategies to ensure a greener route for nanoclay 








Nanoclay structure and resulting applications 
Nanoclays are layered, mineral silicates that originate from the clay fraction of the soil.1,2  
Carrying platelet thickness of around 1 nm and lengths and widths of up to several microns,3,4 the 
smectite group of nanoclays are largely made up of 2:1 phyllosilicates, a silicate-oxygen 
tetrahedral and an aluminum octahedral sheet.1,5 Such features differentiate them from chlorite and 
kaolinite nanoclays which consist of two tetrahedral and two octahedral sheets and one tetrahedral 
and one octahedral sheet, respectively.1,6 Montmorillonite, the most common type of phyllosilicate 
clay,1 has a negative charge due to the substitution of aluminum for silicon in its tetrahedral sheets 
and magnesium for aluminum in its octahedral sheets.7 Bentonite, a source of montmorillonite, 
also contains crystalline quartz, cristobalite, and feldspar,8  and due to the presence of inorganic 
cations in its galleries is hydrophilic in nature.7,5  
Positively charged ions, such as, sodium, potassium, and calcium, are attracted to the inner 
galleries of negative nanoclays,7 allowing for cations exchange and organic modification via an 
ion exchange reaction9. The addition of the organic modifier increases basal spacing to allow for 
a relatively larger distance between nanoclay platelets further allowing for the naturally 
hydrophilic clay to become more hydrophobic.7,8,10 Smectite clays for instance have a cation 
exchange capacity (CEC) of 70-130 meq/100g,6 where CEC is a measure of the number of 
positively charged ions that are able to be held by the negatively charged surface of the clay 
platelets.8  
Due to their nanoscale thickness and longer relative lengths and widths, nanoclays have a 
high aspect- and surface area-to-volume ratios that lead to an increase of their reactivity.1,9 This, 
along with their abundance in soil1 and low cost,1 have made nanoclays applicable to numerous 
areas from sorbents in pollution prevention,7 to environmental remediation,7 waste water 
treatment,11,12 as well as rheological modifiers for oil well drilling fluids,11,13 paints,11 and 
cosmetics,11 food packaging,14,15 automotive,16,17 medical devices,18,19 and coatings-related 
industry.20,21 A comprehensive list of the numerous organically modified nanoclays currently in 





Table 1: Examples of nanoclays researched along with their organic modifiers, applications, and 
associated references. 








Adsorbents in water and 
wastewater treatment, 
drilling fluid, paints, 
cosmetics, coatings, drug 
delivery  
Pluta et al.33 Mondal 
et al.24 Meera et al.20 
Introzzi et al.21 Baek 
et al.63 Rawat et al.64 
Li et al.65 Liu et al.66 
Murphy et al.70 
Octadecyl amine 
 
Food packaging Barua et al.19 
Manikantan et al.40 
Trimethyl stearyl ammonium  Coatings Meera et al.20 
Halloysite None Coatings, drug delivery, 
implants, food packaging, 
composites 
Alipoormazandarant 
et al.26  Sadegh-
Hassani and Nafchi38  
Verma et al.58 




Drilling mud, absorbent, 
groundwater barrier, 
cosmetics, pharmaceutical 
Barua et al.19 Meibian 
et al.44 Murphy et 
al.70 Meibian et al.75 
Yuwen et al.83  
3-5 wt.% Na2CO3  Geh et al.48  
HCl  Geh et al.48 
Distearyl-dimethylamonium-
chloride 
 Geh et al.48 
H2SO4   Meibian et al.44 
Meibian et al.75 
Quartz None Drilling, glass making, 
foundry sand, electronics, 
abrasives 
Gao et al.59  
Kaolin None Coatings, cosmetics, paints, 
adsorbents in water and 
wastewater treatment, 
medical 










Amine groups  Yoshida et al.46  




None  Adsorbents in water and 
wastewater treatment, 
drilling fluid, paints, 
cosmetics, coatings, drug 
delivery 
Janer et al. 45 
Cloisite Na+ 
(MMT) 
None Adsorbents in water and 
wastewater treatment, 
drilling fluid, paints, 
cosmetics, coatings, drug 
delivery 
Shojaee-Aliabadi et 
al.35 Rhim et al.25 
Houtman et al.49 
Maisanaba et al.50 
Maisanaba et al.52 
Lordan et al.53 Verma 
et al.58 Maisanaba et 
al.62 Sharma et al.47  
Cloisite 10A Dimethyl, benzyl, hydrogenated 
tallow, quaternary ammonium 
Composites, food 
packaging, paints, coatings 
Molinero et al.31 








tallow, quaternary ammonium 
Composites, drilling fluid, 
food packaging, medical, 
automotive 
Agarwal et al.13 
Krikorian et al.28 
Pereira de Abreu et 
al.14 Plackett et al.22 




tallow quaternary ammonium 
chloride 
Composites, drilling fluid, 
food packaging, paints, 
coatings 
Agarwal et al.13 
Molinero et al.31 




Vergnes37  Choi et 
al.15 Houtman et al.49  
Cloisite 25A 
(MMT) 
Dimethyl, hydrogenated tallow, 
2-ethylhexyl quaternary 
ammonium methyl sulfate 
Composites, drilling fluid, 
medical, food packaging 
Agarwal et al.13 
Krikorian et al.28 






Composites, drilling fluid, 
food packaging, medical, 
automotive, paints, coatings  
Agarwal et al.13 
Krikorian et al.28 
Molinero et al.31 
Plackett et al.22 Rhim 
et al.25  Beltrán et 
al.39 Dalir et al.17 
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Abreu et al.41  
Maisanaba et al.50  
Maisanaba et al.52 
Sharma et al.47 
Sharma et al.80   
Cloisite 93A 
(MMT) 
Methyl dehydrogenated tallow 
ammonium 
Composites, paints, 
coatings, food packaging 
Molinero et al.31 










Composites, drilling fluids, 
medical, food packaging 





Dimethyl benzyl hydrogenated 
tallow ammonium 
Composites, drilling fluids, 
medical, food packaging 
Janer et al.45  
PSAN-MMT Oligo(styrene-co-acrylonitrile) Drug delivery Liu et al.66  
Halloysite MP1 None Coatings, drug delivery, 
implants, food packaging, 
composites 
Verma et al.58  
 
Delilite LVF  
 
(Bentonite) 




None Composites, rheological 
modifier 
Verma et al.58  





Houtman et al.49 
Maisanaba et al.51 
Jorda-Beneyto et al.54 
Maisanaba et al.81 
Maisanaba et al.82  




Houtman et al.49 
Maisanaba et al.51 




Carbonate Composites, catalyst, 
pharmaceuticals, filters  
Chung et al.60  
Chloride Composites, catalyst, 
pharmaceuticals, filters  
Chung et al.60  
Bentone MA 
(hectorite clay) 
None Cosmetics, adhesives, 
paints, cleaners, coatings 





None Composites Verma et al.58  
 
 
Nanoclays in food packaging applications 
Polymers such as polylactic acid (PLA),22,23 polycaprolactone (PCL),23 methylcellulose, 
starch, lignin, and poly(vinyl alcohol) have been of interest to replace the petroleum-based, non-
biodegradable packaging materials.22,24,23 However, such polymers do not always have the thermal 
stability,25 strength,24 or barrier properties25 of conventional, synthetic polymers thus making their 
implementation as effective food packaging materials challenging. Further, gases, such as oxygen, 
carbon dioxide, water vapor, or ethylene, can penetrate the polymer matrix and diffuse throughout 
it14 in the process decreasing matrix quality.14,26  
The addition of nanoclays into a polymer matrix at a low silicate content3,27 allows for 
better reinforcement within the polymer plane,28,29 as well as an increase in its mechanical 
strength,30,28 barrier properties,3,31,14 UV dispersions,31 and fire resistance, 32,33 and makes it 
applicable to food packaging industry.14,15 As such, nanoclay-enforced polymers were shown to 
maintain their transparency,14,26 with further research showing that nanoclay addition into a 
polymer matrix creates a tortuous path in which the nanoclays are acting as physical barriers to 
slow down the movement of gases14 and create a greener route for production and disposal of 
packaging.14,26,25,34 For instance, Plackett et al. found that nanoclays only caused a slight reduction 
in light transparency when incorporated into PLA-PCL films,22 with Shojaee-Aliabadi et al. 
showing that the addition of up to 10% weight of nanoclays into polymers can still lead to 
translucent films when kappa-carrageenan/Cloisite Na+ (a pristine montmorillonite with Na+ 
between the platelets) were used for instance.35 However, Rhim et al. found that nanoclays 
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significantly reduced the light transmittance when introduced in PLA alone, with a better 
exfoliation within PLA being observed for Cloisite 20A (a hydrophobic dimethyl dihydrogenated 
tallow quaternary ammonium chloride nanoclay).25  
The degree of exfoliation14 was shown to depend on the organic modifiers being used, as 
well as the temperature,36 processing time,22 and processing conditions.37 For example, Pereira de 
Abreu et al. showed that longer processing mixing times generally have a positive influence on the 
dispersion of nanoclays.14 Studies also found that between 180° and 200°C, better exfoliation of 
Cloisite 20A in polypropylene (PP) was obtained at 180°C presumably as a result of the polymer 
stress in this domain of temperature.36 Further, Lertwimolnun and Vergnes showed that exfoliation 
of Cloisite 20A in PP films increased with decreasing feeding rate from 29 to 4.5 kg/h and 
increasing the screw speed from 100 to 300 rpm.37  
Other studies showed that the addition of a low percent weight of nanoclays can increase 
mechanical properties of polymers.14, 24 The displayed increases in mechanical strength was shown 
to help nanocomposite packaging materials withstand the stresses encountered during handling 
and transportation of food products.38 Pereira de Abreu et al. for instance showed that the addition 
of Cloisite 15A (nanoclay organically modified with dimethyl, dihydrogenated tallow, quaternary 
ammonium) into PP increased the Young’s modulus of the material by 692 MPa relative to the 
control PP14 while the addition of halloysite (a 1:1 aluminosilicate) nanoclay to soluble soybean 
polysaccharide (SSPS) films increased their tensile strength by 4.1 MPa relative to SSPS with no 
halloysite.26 Shojaee-Aliabadi et al. showed increases in tensile strength of 8.38 MPa when 
montmorillonite (MMT) was exfoliated in kappa-carrageenan (KC) films relative to KC films 
without MMT.35 Sadegh-Hassani and Nafchi showed that tensile strength increased 2.49 MPa for 
potato starch films containing halloysite nanoclay38 while Beltrán et al. showed that the addition 
of Cloisite 30B (nanoclay organically modified with methyl, tallow, bis-2-hydroxyethyl, 
quaternary ammonium) increased elongation at break for PCL.39  
Studies also revealed that addition of nanoclays to polymers such as PLA reduced water 
vapor permeability (WVP) by 6-33% when compared to control PLA alone.25 Sadegh-Hassani and 
Nafchi also showed a decrease in oxygen permeability upon addition of halloysite nanoclay,38 
while Alipoormazandarani et al. showed that halloysite nanoclay reduced water vapor and oxygen 
permeability by 56% and 58%, respectively, when incorporated into soluble soybean 
polysaccharide (SSPS).26 Complementarily, Manikantan et al. found that nanoclays added into 
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polypropylene (PP) also decreased the WVP with banana chips packaged in 2% nanoclay/ PP films 
showing 22% lower moisture content and banana chips packaged in 4% nanoclay/PP films having 
24% lower moisture content respectively all relative to the control,40 while Shojaee-Aliabadi et al. 
showed a decrease in WVP by around 78% upon addition of MMT into kappa-carrageenan (KC) 
films.35 Numerous other studies have shown similar results with different nanoclays and polymer 
matrices, 26,35,24,38,39,40 with further analysis of PLA reinforced with Cloisite 30B also displaying 
antimicrobial activity against L. monocytogenes25 while starch films containing Cloisite 30B 
decreased microbial growth for S. aureus and  E. Coli.41  
Possible toxicity upon implementation of nanoclay in consumer applications 
The large consumer implementation of nanoclays, especially in food packaging 
applications as indicated above, has the potential to affect humans at the exposure levels of 
manufacturing, consumption/usage, and disposal.42,43 As such, studies aimed to differentiate 
toxicity and toxicity-induced mechanisms based on the organic modifier or the size of the 
nanoclays. For the organic modifier for instance, Meibian et al. found that activated bentonite 
particles had a greater cytotoxic response relative to untreated counterparts, indicating that surface 
characteristics may be playing a large role in mechanisms of toxicity, such as the adsorption 
capacity, cation exchange, charge interactions, and surface area.44 Janer et al. also observed 
differences in toxicity based on the organic modifier being used, with the modifier dimethyl benzyl 
hydrogenated tallow ammonium displaying greater toxic effects relative to the modifier dimethyl 
dehydrogenated tallow ammonium for instance.45 However, Yoshinda et al. found that the 
organically modified silica particles coated with amine or carboxyl groups were less toxic than the 
unmodified silica particle, as the modified particles reduced the amount of reactive oxygen 
generated in a human keratinocyte cell line (HaCat) and a murine hepatocyte cell line (TLR-1) and 
the amount of DNA damage in HaCaT cells.46   
For the size, Sharma et al. showed that samples of Cloisite 30B that had been filtered 
through a 0.2 µm filter, thus eliminating particles in the micro range, were less cytotoxic than their 
unfiltered counterparts.47 However, Janer et al. did not observe any differences in cytotoxicity 
between the small (100-822 nm) and large (100-3230 nm) sized pristine MMT particles.45 Size 
played a role in the uptake of bentonite particles, with a maximum uptake for particles in the size 
range of 0.4-1.6 µm for the activated bentonite particles, and a less selective size range for the 
unactivated particles.48 Other in vitro studies evaluated the toxicity of nanoclays (both pristine and 
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organically modified nanoclays) and differentiated the observed nanoclay-induced effects based 
on the exposure levels or the cell type being used, with the majority of studies focusing on 
understanding toxicity at the consumption level of exposure (i.e. around 48%, 24%, and 28% for 
consumption exposure, inhalation exposure, and other, respectively) and assuming that nanoclays 
will eventually migrate out of the polymer matrix into food stocks when used for food packaging 
applications.49,50,51,52,53,54 Detailed below are several investigations that mean to identify the 
deleterious effects that nanoclays can have and possibly propose means to reduce the logistical 
burden associated with developing meaningful risk assessment strategies for evaluating their 
potential and feasibility for implementation in food packaging industry.  
In vitro studies reveal the potential of nanoclay to induce changes in cellular viability  
Studies proposed that the small size and platelet morphology of nanoclays have the 
potential to allow for their inhalation and deposition in the bronchial or alveolar regions of the 
lung.42,55,56,57 In support of this hypothesis, Verma et al. investigated the inhalation toxicity of both 
platelet and tubular shaped nanoclays using in vitro models, i.e., human alveolar epithelial cells 
(A549), and a dosage ranging from 1 to 250 µg/ml.58 Analyses showed that tubular nanoclays did 
not induce toxicity until doses of 250 µg/ml, which was in contrast with the platelet nanoclays that 
induced toxicity at only 25 µg/ml and 24 h exposure.58 Further studies by the same authors showed 
that the pristine nanoclay, i.e., Cloisite Na+ was internalized by the exposed cells and accumulated 
in their perinuclear region (Figure 1b,c; nanoclays were labeled in red using rhodamine dyes and 
their localization is indicated with white arrowheads).58 Figure 1a displays the control cells; all 
cells were also counterstained with Alexa Fluor 488 phalloidin (green) for cellular cytoskeleton 
and Hoechst (blue) for nucleus identification. Analysis showed that the uptake was time dependent 
with increases in the amount of Cloisite Na+ occurring accumulatively over the 24 h exposure time. 
Geh et al. also observed uptake of bentonite particles into human lung fibroblasts (IMR90 cells) 
over 24 h exposure at a dose of 10 µg/cm2, with uptake increasing when the bentonite particles 
were activated with quartz (5-6%).48 Such nanoclays were also more cytotoxic when compared to 
non-activated or lower quartz content particles with the observed cytotoxicity being attributed to 
the lysis of the cell membrane upon translocation of the activated nanoclays.48 
Complementarily, Janer et al. found that organically modified nanoclays induced a greater 
toxicity than the pristine nanoclays.45 For instance, when A549 cells were treated with pristine clay 
or nanoclays modified with dimethyl dihyrdrogenated tallow ammonium or dimethyl benzyl 
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hydrogenated tallow ammonium respectively (doses <500 µg/ml), a greater loss in cellular 
viability was experienced even though both the nanoclays were taken up by the cell during the 72 
h window of incubation, with the internalization being more prevalent for the pristine clay.45 Other 
studies showed that quartz and kaolin dust decreased pulmonary alveolar macrophage viability 
within 1 day of exposure at doses of 40 µg/cm2 and 20 µg/cm
2 respectively,59 however quartz and 
kaolin treated with the surfactant dipalmitoyl phosphatidylcholine (DPPC) did not induce 
significant decreases in viability even after 3 or 5 days of treatment.59 Lastly, Chung et al. 
examined both the short- and long-term toxicity of anionic nanoclays (carbonate and chloride 
forms) on A549 cells and found no toxic effects at high exposure doses of 1000 µg/ml,60 however 
the anionic nanoclay seemed to have inhibited colony formation after 10 days of exposure to doses 
ranging from 250 to 500 µg/ml.60 
However, due to the nanoclay incorporation into nanocomposites for food packaging 
applications,14,15,61 it is likely that nanoclays will not only come into contact with humans through 
the route of inhalation but also through the route of ingestion. Studies aimed to examine the toxicity 
of nanoclays upon exposure to cell lines isolated or belonging to the ingestion track have shown 
toxic effects induced by Cloisite 30B on human hepatocellular carcinoma epithelial cell line 
(HepG2) for instance, with significant decreases in both cellular growing rate and viability (Figure 
1d,e).50 In particular, analyses showed that significant decreases in uptake occurred starting at the 
dose of 62.5 µg/ml to 500 µg/ml upon both 24 and 48 h cellular exposure to Cloisite 30B (Figure 
1e). However, analyses on pristine nanoclay Cloisite Na+ did not reveal any cytotoxic effects on 
the HepG2 cells up to a dose of 62.5 µg/ml upon the same time of exposure (Figure 1d).50 Further, 
Cloisite Na+ again did not show any cytotoxicity after 24 h of exposure to cells in doses up to 62.5 
µg/ml.62 Similarly, Sharma et al. found that Cloisite 30B showed increased toxicity relative to 
Cloisite Na+ (40% toxicity in human colon carcinoma cells-Caco-2) after 24 h exposure to a dose 
of 226 µg/ml,47 with Cloisite 30B inducing greater toxicity than Cloisite Na+ and also causing both 
time and dose-dependent decreases in protein content (PC), 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) reduction,52 all standards for 
the in vitro evaluation of cytotoxicity. A significant toxic effect for Cloisite Na+ was only obtained 
using the MTS assay after 48 h of exposure to doses of 31.25 µg/ml, all relative to control cells.52  
Janer et al. complemented the above studies showing that the organically modified 
nanoclays were more toxic than the pristine ones when a colorectal carcinoma cell line (HCT116) 
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and HepG2 cells were assessed, with all organoclays displaying IC50’s at doses below 25 µg/ml 
whereas the IC50 of pristine clays were above 100 µg/ml.
45 Houtman et al. treated HepG2 and 
Caco-2 cells with 3 other types of clays used in packaging namely Cloisite 20A, Clay 1 (modified 
with quaternary ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA)), and Clay 2 
(modified with HDTA and acetylcholine chloride (ACO)) respectively.49 Analyses showed that 
Clay 2 caused significant decreases in viability in both HepG2 cells and Caco-2 cells, with more 
prevalent effects being observed in Caco-2 cells.49 In another study, Clay 1 was shown to cause 
significant reductions for HepG2 cells at the same dosage.54 Both Cloisite Na+ and Cloisite 93A 
(modified with methyl dehydrogenated tallow ammonium) caused significant dose-dependent 
decreases in HepG2 cell viability after 24 h starting from a dose of 1 µg/ml.53 Similarly, MMT 
caused significant decreases in the viability of human normal intestinal cells (INT-407) in a dose 
and time-dependent manner at doses of 100 µg/ml or above, all over 24-72 h.63 For instance, Rawat 
et al. found that MMT induced 50% cytotoxicity in the human embryonic kidney cell line at a dose 
as low as 0.005 µg/ml.64 When examining the effects on HepG2 or Caco-2 cells after 24 and 48 h 
of exposure to extracts of PLA-Clay 1 and PLA-Clay 2 nanocomposites for instance, Maisanaba 
et al. did not observe any cytotoxic effects up to 2.5-100% extracts.51 Li et al. showed that 
nanosilicate platelets (NSP) originated from MMT produced significant decreases in viability of 
Chinese Hamster Ovary (CHO) cells after 24 h of treatment with doses from 62.5 to 1000 µg/ml,65 
while Meibian et al. treated a human B lymphocyte cell line (HMy2.CIR) with active and native 
bentonite particles and showed that both the active (treated with 10-15% H2SO4) and native 
bentonite particles resulted in dramatic decreases in cellular viability within only 4 h of exposure, 
with 1000 µg/ml exposure dose causing almost complete loss of cellular viability.44 Mouse 
embryonic fibroblast (NIH 3T3) and Human Embryonic Kidney 293 (HEK) cells however did not 
show a loss in cellular viability when treated with MMT or MMT modified with oligo(styrene-co-
acrylonitrile) (PSAN-MMT) until exposure doses of 1 g/L, with MMT showing a greater loss in 
viability relative to PSAN-MMT.66 Complementarily, human breast cancer cell line (MCF-7) and 
human cervical cancer cell line (HeLa) displayed decreases in viability after concentrations of 75 
µg/ml of the tubular nanoclay, halloysite,67 and halloysite coated with amino-propyl-





Figure 1: Cellular uptake of nanoclays by A549 cells. A549 cells grown onto 8-well chamber 
slides were  (a) fixed (control) or (b) incubated with rhodamine (red) labeled Cloisite Na+ (25 
µg/mL) for 4 h, (c) or 24 h. Cells were also counterstained with Alexa Fluor 488 phalloidin (green) 
for their cytoskeletal organization identification and Hoechst (blue) for their nuclear localization. 
Intracellular accumulation of the nanoclays was detected by confocal microscopy; the 
representative images show the nanoclays localization mostly concurrent with the nuclear regions. 
(Copyright after Verma et al. 2012). HepG2 cells uptake (d) 0-62.5 µg/ml Cloisite Na+ labeled 
b a c 
d e 
Comet Assay Caco-2 Comet Assay HepG2 f g 
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with Neutral red uptake (NR) or (e) 0-500 µg/ml Cloisite 30B labeled with NR. All values are 
expressed as mean ± SD. *Significantly different from control (p≤0.05). (Copyright after 
Maisanaba et al. 2013). Comet assay results of: (f) Caco-2 cells after 24 and 48 h of exposure to 
8.5, 17, or 34 µg/ml Clay 2; (g) HepG2 cells after 24 and 48 h of exposure to 22, 44, and 88 µg/ml 
Clay 2. Results from 3 independent experiments with 2 replicates/experiment. All values are 
expressed as mean ± s.d. *Significantly different from control (p < 0.05). **Significantly different 
from control (p ≤ 0.01). (Copyright after Houtman et al. 2014). 
 
Proposed mechanisms of toxicity for the in vitro cellular studies  
Due to the observed changes in cellular viability upon exposure to different types of 
nanoclays, studies aimed to determine the nanoclay-induced mechanisms of toxicity. For this, the 
strategies have considered the effects of nanoclays exposure to cell morphology, structure, cell 
signaling, cell-cell and cell-substrate interactions, as well as cell progression through cell cycle 
and appropriate cellular proliferation since all these aspects are known to be influencing cell 
viability and ultimately determine cellular fate.68,69 Further, the evaluations of such changes were 
meant to provide the means for assessing  and differentiating the nanoclay-induced cyto and/or 
genotoxic mechanisms in a clay type-dependent manner.  
Analyses showed that HepG2 cells had dilated endo-membranes after treatment with 
Cloisite 30B,50 while Caco-2 cells treated with 20 and 40 µg/ml of the same nanoclay displayed 
changes in cell morphology, intense vacuolization and euchromatic irregular nuclei.52  
Nanoclays exposure led to membrane damage and changes in cellular structure, likely due 
to their induced charge interactions with the membrane and resulting membrane lysing ability.70 
For instance, Murphy et al. determined that primary murine spinal cord neurons were lysed after 
60 min of incubation with 0.1 mg/ml bentonite or MMT, whereas differentiated N1E-115 cells did 
not appear to be lysed or undergo any morphological damage.70 Studies by Meibian et al. found 
that both active and native bentonite particles induced significant lactate dehydrogenase (LDH) 
leakage in human B lymphocyte cells after 4 h of exposure to doses of 60 and 120 µg/ml, 
respectively.44 Li et al. also observed significant membrane damage in CHO cells after cell 
treatment with NSP particles in 62.5-1000 µg/ml doses.65 Both Cloisite Na+ and Cloisite 93A 
caused significant increases in LDH release in HepG2 cells, with the organically modified clay 
inducing the greater response.53 However, Baek et al. only observed significant LDH release in 
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INT-407 cells at the top dose of 1000 µg/ml MMT after 48 and 72 h.63 The organically modified 
MMT, i.e., PSAN-MMT, showed lower LDH release relative to MMT.66  
Combined with effects on cellular morphology and structure, changes in mitochondrial 
function were proposed as another viable mean to explain nanoclay-induced toxicity since it is 
known that the mitochondria regulates redox signaling to cellular cytosol and nucleus.71,72 Studies 
by Maisanaba et al. have showed that mitochondria of cells treated with nanoclays exhibited both 
matrix and inner membrane degradation.52 However, when reactive oxygen species (ROS) were 
assessed in the HepG2 cell line treated with Cloisite Na+ or Cloisite 30B up to a dose of 88 µg/ml 
for instance, no significant increases were recorded.50 Further both the HepG2 and Caco-2 cells 
showed no ROS generation when treated with Clay 2 up to a dose of 88 µg/ml for 48 h.49 However, 
Lordan et al. found that both Cloisite Na+ and Cloisite 93A produced ROS in HepG2 cells, with 
Cloisite Na+ inducing more ROS than the organically modified counterpart and with the significant 
increases being recorded for smaller doses of 50 µg/ml over 24 h of exposure.53 This is in contrast 
with studies performed with both active and native bentonite which showed significant ROS levels 
upon only 30 min of exposure to human B lymphocyte cells.44 ROS was also generated in Caco-2 
cells upon treatment with 40 µg/ml of Cloisite 30B,52 while MMT generated ROS in INT-407 cells 
at concentrations above 50 µg/ml after 48-72 h.63 One possible explanation for the observed dose 
and nanoclay-dependent ROS generation was that the toxic effects of nanoclays could be 
potentially circumvented by changes in the endogenous antioxidant glutathione (GSH), a known 
regulator of the intracellular redox balance.73 Maisanaba et al. for instance found that Cloisite 30B 
caused significant decreases in GSH cellular concentration for both HepG2 cells and Caco-2 
cells,50,52 with the GSH concentration being dependent on both the type of clay used (e.g., Clay 2 
did not affect the GSH content of Caco-2 cells) and the dose of nanoclay.49 
With changes in cellular structure and energetic activity being known to influence cell 
cycle and overall fate,69,74 the role of nanoclays to induce genotoxicity was also investigated.  
Studies of NIH 3T3 cells exposed to 1 g/L MMT for 24 h identified nuclei fragmentation and 
condensed chromatin, however the changes were minimal for cells exposed to organically 
modified PSAN-MMT.66 Maisanaba et al. also showed that Cloisite 30B caused significant time 
dependent DNA breaks in HepG2 cell,50 while Houtman et al. showed that Clay 2 induced DNA 
changes in both HepG2 and Caco-2 cells respectively, with Clay 2 having a slightly greater effect 
on Caco-2 cells (Figure 11.1f,g).49 However, exposures to Cloisite 20A and Clay 1 did not induce 
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DNA strand breaks in either Caco-2 or HepG2 cells after 48 h and concentrations up to 62.5 and 
8 µg/ml, respectively.49 Additionally, neither of the extracts of the PLA-Clay 1 or PLA-Clay 2 
nanocomposites induced any genotoxicity after 24 or 48 h of exposure.51 Studies by Sharma et al. 
also complemented previous findings and showed DNA damage in a nanoclay dose-dependent 
manner when Caco-2 cells were treated with Cloisite 30B, with the 2 highest doses of 113 and 170 
µg/ml respectively being significantly different from the control (not exposed cells) after 24 h of 
exposure.47 However, no change was recorded for the Caco-2 cells treated with Cloisite Na+,47 or 
Cloisite 30B.52 However, Cloisite Na+ caused an increase in micronuclei frequency in HepG2 cells 
after 24 h at exposure levels of 62.5 µg/ml.62 Similarly, when CHO cells were treated with 
nanosilicate platelets from MMT, DNA dose-dependent damage was observed within the exposure 
dose range of 62.5 to 1000 µg/ml.65 An increase in DNA damage was observed when human B 
lymphoblast cells were treated with active or native bentonite particles from doses of 120 µg/ml 
for 24 h, 60 µg/ml for 48 h, or 30 µg/ml over 72 h, with active bentonites showing a greater effect, 
and with both particles causing significant increases in micronucleus frequency.75 Untreated quartz 
particles induced significant DNA damage in rat pulmonary alveolar macrophages within 1 day of 
exposure at a dose of 20 µg/cm2, whereas quartz/DPPC induced damage after 3 days at double that 
dose.59 Additionally, untreated kaolin induced DNA damage after 1 day at an exposure dose of 40 
µg/cm2 and kaolin/DPPC inducing DNA damage after 5 days at a dose of 40 µg/cm2.59 Lastly, 
Janer et al. observed a slight increase in caspase 3/7 for HepG2 cells exposed to 100 µg/ml 
nanoclay.45 Caspases 3 and 7 are cysteine asparate proteases with similar structures76,77 that control 
apoptotic pathways. Briefly, intrinsic apoptosis is mediated by mitochondrial outer membrane 
permeabilization with cytosol release of pro-apoptotic proteins such as cytochrome c activating 
caspase-9.78,79 The resulting activated caspase-9 then cleaves and actives caspase-3 and 7 
respectively to initiate the degradation of cellular structures and cell detachment, eventually 
leading to cell death.78 
Maisanaba et al. proposed to further investigate genotoxicity of nanoclays by investigating 
the effect of Cloisite Na+ on the regulation of genes in HepG2 cells.62 Cloisite Na+ was found to 
deregulate genes associated with cellular metabolism, immediate-early response/signaling, DNA 
damage response, oxidative stress, and apoptosis/survival.62 Specifically, 4 out of the 5 genes 
studied for metabolism and 2 DNA damage responsive genes were found to be upregulated at the 
tested concentrations of 6.25 µg/ml or 62.5 µg/ml of Cloisite Na+ after 24 h of exposure. Catalase, 
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an oxidative stress responsive gene, was down regulated however at both concentrations used. 
Complementarily, both apoptosis responsive genes and early response/signaling genes were also 
affected after 24 h, with early response/signaling also having a gene (JUNB) affected at 4 h at the 
dose of 62.5 µg/ml.62  
In vivo evaluation of nanoclay toxicity 
While the mechanism of toxicity is still not completely understood, the deleterious effects 
observed upon exposure to both pristine and organically modified nanoclays from the in vitro 
studies have prompted increased interest for their in vivo evaluations at a consumer level of 
exposure. Herein the consumer level of exposure is defined as exposures to nanoclays when in use 
by the public who buys the product embedding nanoclay. Analyses by Sharma et al. found that 
Wistar rats orally exposed for two times to Cloisite 30B ranging from 250-1000 mg/kg of their 
body weight, with 24 h apart the exposures, did not induce changes in their organs nor DNA strand 
breaks in the cells isolated from the colon, liver, or kidney (Figure 2a).80 Specifically, analyses 
showed that the Wistar rats treated with Cloisite 30B suspended in water or cell culture media had 
no significant differences in % tail DNA relative to the controls, even up to a dose of 1000 mg/kg 
body weight for the liver, kidney, or colon. However, the tracer element aluminum was found in 
the rat’s feces thus indicating there was no absorption of the clay from the gastrointestinal tract. 
Complementarily, results by Maisanaba et al. administering Clay 1 over 90 days at 40 mg/kg/d 
showed that rats underwent an adaptive response in result of an increased oxidative stress.81 
Specifically, significant increases in catalase (CAT; responsible in maintaining ROS levels) 
activity in the kidney (Figure 2b) as well as changes in proteins expressions level of CAT in the 
kidney of the rat were observed, which was in contrary to no significant effects on the antioxidant 
enzymes, superoxide dismutase (SOD), glutathione peroxidase (GPx), and gluthatione S-
transferase (GST) responsible for maintaining ROS levels respectively (Figure 2c).81  
Maisanaba et al. also tested the migrant extract of a PLA-Clay 1 (4%) nanocomposite on 
the same animal models over an exposure of 90 days and showed no significant effects on their 
biomarkers, which included the oxidative stress biomarkers of enzymes gluthatione S-transferase 
(GSH)/ glutathione disulfide (GSSG) ratios, lipid peroxidation via thiobarbituric acid (TBA), and 
antioxidant enzyme activities (CAT, SOD, GPx, and GST).82 Further, unlike the previous study 
dealing with Clay 1, the migrant extract did not cause any changes in CAT activity or in genetic 





Figure 2: (a) Comet assay performed on Wistar rats (n = 6) exposed to Cloisite 30B suspended in 
water (being administered at 250, 500 and 1000 mg/kg body weight of rat) or cell-culture medium 
(being administered at 1000 mg/kg body weight of rat). Ethylmethane sulfonate (EMS) suspended 
in water was the positive control. For the experiments, six rats were exposed to 250 mg/kg body 
weight. Data from liver, kidney and colon cells of the EMS-exposed group were statistically 
significantly different (p < 0.001, p < 0.001: *** and p < 0.05: *), respectively, from the values in 
the corresponding control group (two-tailed, unpaired t-test). Internal standards: positive controls 
(Caco-2 cells exposed to 0.05% ethylmethane sulfonate):16 slides, % tail DNA, mean ± S.D., 21.6 
± 6.6; negative controls (untreated Caco-2 cells): 16 slides, % tail DNA, mean ± S.D., 1.8 ± 0.6. 
(Copyright after Sharma et al. 2014). (b) Catalase (CAT) and (c) superoxide dismutase (SOD) 
activities (nKat/mg protein) in kidney of rat exposed to Clay 1. The values are expressed as mean 
± SD (n=10). The levels observed are significant at *p<0.05 in comparison to control group values. 
(Copyright after Maisanaba et al. 2014). 
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There were also no major differences being observed in the histopathology of the control 
versus the exposed groups to the migrant extract of PLA-Clay 1 (Figure 3). Specifically, Figure 3a 
and 3b display the unexposed rat liver and kidney tissues, respectively, stained with hematoxylin 
and eosin (HE).82 Figure 3c and 3d displays the exposed rat liver and kidney tissues, with analyses 
showing that the liver tissue displayed hepatocytes similar to that of the control and with the kidney 
tissue displaying a normal parenchyma and normal proximal convoluted tubules (Pct) and distal 
convoluted tubules (Dct) relative to the control group.82 Li et al. also evaluated the LD50 of NSP 
particles being fed to Sprague-Dawley rats at doses of 1500, 3000, and 5700 mg/kg over 14 days 
and showed no acute oral toxicity of these nanoclays,65 while results by Baek et al. obtained in 
ICR mice exposed to MMT particles orally in single administered doses in between 5-1000 mg/kg 
showed that after 14 days there was no significant accumulation of nanoclay in any specific organs 




Figure 3: Histopathological evaluations of liver of Wistar rats exposed to a PLA-Clay1 extract as 
beverage for 90 days. (a) He-stained liver section and (b) He-stained kidney sections. Bars, 100 
μm. (a,b)  Control rats. (a) Liver parenchyma with hepatocytes with normal morphology, central 
nuclei and light cytoplasm (He), organized in hepatic cords (circle). (b) Normal structure of kidney 
parenchyma with glomerulus (circle), proximal convoluted tubules (Pct), and distal convoluted 
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tubules (Dct). (c,d) Exposed rats (c) Liver parenchyma with hepatocytes with normal morphology, 
central nuclei, and light cytoplasm (He), organized in hepatic cords (circle). (d) Normal structure 
of kidney parenchyma with glomerulus (circle), proximal convoluted tubules (Pct), and distal 
convoluted tubules (Dct). (Copyright after Maisanaba et al. 2014). 
 
Conclusions and Outlook  
In the past decades, research has been trying to answer critical questions related to the 
properties and characteristics of nanoclays that could allow for enhancing their consumer-related 
utility at minimum toxicological risks. However, even though extensive body of evidence from in 
vitro studies supports that nanoclay could be toxic at the exposure level of consumption and 
inhalation, it is still unclear as to what extent they could potentially affect humans. The isolated 
study performed by Yuwen et al. for instance showed that organic bentonite particles could affect 
workers in two different factories producing such nanoclays. Specifically, group I was exposed to 
high concentration (around 13 mg/m3), while group II was exposed to moderate concentration 
(around 8 mg/m3) of bentonites.83 Preliminary analyses performed in the study identified that 
group I had a higher frequency of micronuclei, nucleus buds, micronucleated cells, nucleoplasmic 
bridges, apoptotic cell rate, and necrotic cell rate relative to group II and the control (unexposed 
individuals) in all the isolated human lymphocytes. Further, group II had higher frequencies of all 
the above parameters relative to the control group, indicating that genetic damage can occur. 
Further, both groups showed an increase in lipid peroxidation, responsible for cell damage due to 
oxidation of lipids in cell membranes, all relative to the control groups, with the age factor further 
accentuating such correlations. 
We propose that circumventing strategies to limit toxicological risks of nanoclays should 
consider that their toxicity is a combination of both cyto and genotoxic effects (Scheme 1), where 
effect differentiation is based on the cell and nanoclay type being studied, as well as on the 
nanoclay physical and chemical characteristics (size, organic modifier etc.). For risk prevention 
for instance, one could envision controlling the synergistically induced toxicological effects by 
reducing the nanoclay-induced generation of ROS through direct activation of nanoclay 
degradation upon their cellular uptake. As such, if the potential of nanoclays implementation in 
user-directed applications is to be fully reached at the minimum human and environmental 
logistical burden, both the development of functionalization strategies that allow for such 
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activation strategy to occur, as well as the confirmative body of evidence to demonstrate the 
feasibility of the activation need to be established. A technical approach in which the addition of 
user-tailored copolymers to the surface of the nanoclay would facilitate both their cellular uptake 
as well as their cellular-based autophagy, i.e., the lysosome-based degradation, could be 
implemented prior to consumer integration. With degradative pathways being activated at 
minimum changes of the lysosome-encapsulated enzymes, the continuous cellular degradation of 
any uptaken nanoclays will then take place to maintain cellular homeostasis and reduce any cellular 
toxicity. The underlying functionalization techniques that would ensure such a greener route to 
nanoclay degradation as well as the lysosome-based degradative pathways will still need to be 
elucidated. However, until such means are achieved, the “no harm” policy for the worker 
implementing nanoclays in food packaging or derived products can only account for a proper 
system of safety measures to be implemented. They could impose limiting the amount of any 
airborne particles in workplaces or developing personal protective equipment such as respirators 
capable of removing nanoclays in a reliable and timely fashion, and with a high efficiency. Lastly, 
high-throughput screening tests to quickly gain an idea of the toxicity of the numerous types of 
nanoclays in a time efficient manner could be developed and implemented to allow for realistic 
human and environmentally relevant concentrations rather than excessively high concentrations to 




Scheme 1: Schematic representation of the proposed mechanisms of toxicity induced by cellular 
exposure to nanoclays. In vitro exposure of cells to nanoclays with different physico-chemical 
properties undergo changes in their structure and functions, with such changes being directly 
correlated with cellular morphology or proliferation rates controlled at the genetic level. 
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Toxicity Evaluations of Nanoclays and Thermally Degraded Byproducts 
through Spectroscopical and Microscopical Approaches 
 
Abstract 
Montmorillonite is a type of nanoclay that originates from the clay fraction of the soil and 
is incorporated into polymers to form nanocomposites with enhanced mechanical strength, barrier 
and flammability properties used for food packaging, automotive, and medical devices. However, 
with implementation in such consumer applications, the interaction of montmorillonite-based 
composites or derived byproducts with biological systems needs to be investigated. Herein we 
examined the potential of Cloisite Na+ (pristine) and Cloisite 30B (organically modified 
montmorillonite nanoclay) and their thermally degraded byproducts’ to induce toxicity in model 
human lung epithelial cells. The experimental set-up mimicked biological exposure in 
manufacturing and disposal areas and employed cellular treatments with occupationally relevant 
doses of nanoclays previously characterized using spectroscopical and microscopical approaches. 
For nanoclay-cellular interactions and for cellular analyses respectively, biosensorial-based 
analytical platforms were used, with induced cellular changes being confirmed via live cell counts, 
viability assays, and cell imaging. Our analysis of nanoclays’ or byproducts’ chemical and physical 
properties revealed both structural and functional changes. Real-time high throughput analyses of 
exposed cellular systems confirmed that nanoclay induced significant toxic effects, with Cloisite 
30B showing time-dependent decreases in live cell count and cellular viability relative to control 
and pristine nanoclay respectively. Thermally degraded byproducts produced less toxic effects; all 
treatments caused alterations in the cell morphology upon exposure. Our morphological, 
behavioral, and viability cellular changes show that nanoclays have the potential to produce toxic 
effects when used both in manufacturing or disposal environments. The reported toxicological 
mechanisms prove the extensibility of a biosensorial-based platform for cellular behavior analysis 





Nanotechnology is quickly establishing itself as the next revolution in commercial and 
industrial products, with about one third of all produced engineered nanomaterials to occur within 
the U.S..1,2 Naturally occurring montmorillonite nanoclays3,4 are readily available, negatively 
charged,5 low cost,6 and consist of aluminum or magnesium octahedral sheets sandwiched between 
two silica-oxygen tetrahedral sheets. Isolated from the clay fraction of the soil,7 nanoclays are 
currently used as sorbents in the treatment of waste water or hazardous spills8 or as media for oil 
well drilling,9 paints,10 and cosmetics.11 Functionalization with organic modifiers via an ion 
exchange reaction confers montmorillonite increased basal spacing and separation between its 
platelets4,12 as well as better mixing ability, and facilitates its interactions with hydrophobic 
polymers.3,4,13 Complementary, its high aspect ratio5 ensures better reinforcement within the 
polymeric plane itself14 by enhancing polymer’s properties at a fairly low silicate content13 and 
leading to the formation of nanoclay-polymer-based composites with increased mechanical 
strength,3,14 barrier properties,3,15 UV dispersion,15 and fire resistance capabilities,3,16 to be used 
for food packaging,17,18 automotive,19,20 medical devices,21,22 and for coatings-related 
applications.23,24 
 With nanoclay or nanoclay-plastic composites wide implementation,25 analyses of 
potential risks of these nanomaterials to exposed workers’ lung health have started to emerge. As 
such, recent studies aiming to unravel the nanoclay toxicological profiles showed that its high 
aspect ratio resulted from its platelet thickness of about 1 nm and length and width of up to several 
microns,5 has led to increased cellular uptake and interactions.26 While such in vitro analyses 
allowed for elimination of animal subjects, lower processing time, and cost effectiveness,27,28 they 
rely on usage of synthetic compounds such as tetrazolium salts (MTT) to measure mitochondrial 
reduction/cellular viability for instance.28 Specific results based on such analyses revealed that 
cellular exposure to nanoclays lead to mitochondrial damage,29,30 decreased cellular 
proliferation,31 reactive oxygen species (ROS) generation,29,30 as well as membrane29,32 and DNA 
damage,33,34,35 with the type and range of toxicity being dependent on the cell model being used, 
the dosage, and the organic modifier functionalizing the nanoclay, respectively.5 However, based 
on our knowledge no analyses are currently available to report the toxicological profiles of 
nanoclays upon the end of composite life cycle.26,36 High temperatures, oxidation, reduction, and 
potential chemical reactions occurring during the incineration process normally used for 
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composites disposal37 could induce physical and chemical changes38 and lead to increased 
reactivities of the resulting nanoclay-resulting byproducts. Further, previous analyses on other 
types of nanomaterials have showed that single-walled carbon nanotubes (SWCNTs), carbon black 
nanoparticles, fullerenes, and silica for instance, all interact with indicator dyes such as the MTT 
by binding to the formazan crystals and making them insoluble and thus creating false 
positives.27,39,40 Additionally, the high adsorptive capacities of nanomaterials due to their large 
surface per unit mass have shown interferences with annexin V/PI binding, ELISA and ROS 
assays.27,28 Finally, Casey et al. found considerable variation in the toxicity of carbon 
nanomaterials on human alveolar carcinoma cells (A549) from MTT, Commassie Blue, Neutral 
Red, and WST-1 assays, all of which help indicate cellular viability. 41 
Given the complex effects of nanoclays on increased cellular instability, previous research 
showing possible interference between nanomaterials in general and the assays being used, and 
lastly, given that smaller particles resulting from incineration are more likely to escape filters37 
and travel greater distances through the air by Brownian diffusion26 thus leading to deeper 
inhalation, larger sedimentation and diffusion rates into the lungs26,42 it is important that we 
perform a systemic analyses to assess how parallel exposures to nanoclay or byproducts resulted 
during their manipulation, handling, and disposal affects cellular systems’ fate. Such tests should 
be cheap, not time intensive43 or invasive,43 and provide results in real-time in contrast with 
discrete time points currently achieved through the standard assays named above.44,45 Further, such 
assays should be high throughput and should have the ability to provide accurate results that avoid 
the artifacts known to result from the interaction of nanomaterials with dyes or chemical 
compounds normally found in such standard assays.39,41 
Herein we propose to assess toxicological profiles of nanoclays, both during the duration 
as well as at the end of their life cycle. Further, to eliminate the concern associated with using 
standardized single point assays and chemical compounds interference with nanoclays or their 
byproducts, we propose to use an electrical cell-substrate impedance sensing (ECIS) previously 
applied to monitor changes in cell adherence, proliferation, motility, and morphology. Our analysis 
will allow quantitative measurements, at a nanoscale resolution, and in a noninvasive, real-time 
manner44,46 to establish whether nanoclays and their thermally degraded byproducts are leading to 
cellular changes when exposed to model target inhalation systems at an occupationally relevant 
dose for particles otherwise not regulated.47,48 Exploitation of our findings can further advance 
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implementation of nanoclays or nanoclay-polymer-based composites in “safe-by-design” 
consumer-based applications, as well as confirm that ECIS has the potential to be a powerful tool 
for quickly, efficiently and non-invasively determining toxicity of a large variety of nanomaterials.  
 
Materials and Methods 
Nanoclay Preparation 
Raw (as-received) Cloisite Na+ (UC) and Cloisite 30B (CC) were obtained from Southern 
Clay  Products (Gonzales, TX, USA). Cloisite Na+ is an unmodified montmorillonite while Cloisite 
30B is organically modified via an ion-exchange reaction (per the manufacturer specifications) 
with methyl, tallow, bis-2-hydroxyethyl, quaternary ammonium at a concentration of 90 meq/100 
g clay.4,5  
Thermal Degradation 
UC and CC samples were thermally degraded using a TGA701 Thermogravimetric 
Analyzer from LECO to mimic the end of life cycle of the nanoclay. In order to determine the 
moisture content of the samples, around 0.5 g of each of the samples was heated in nitrogen at a 
rate of 6 °C/min and in a range of temperatures from 25 °C to 105 °C. To determine the volatile 
content, the samples were heated from 105 °C to 950 °C in nitrogen at a rate of 43 °C/min. Finally, 
to determine the ash content, the samples were heated from 550 °C to 900 °C in oxygen at a rate 
of 15 °C/min. The resulted ash was collected to serve as a model of the byproducts resulted from 
incineration i.e., thermally degraded Cloisite Na+ (UC900) and thermally degraded Cloisite 30B 
(CC900) respectively.  
Materials Characterization 
Chemical composition of the samples (i.e., unsterile and sterilized clays, and their 
thermally degraded byproducts) was determined using Fourier Transform Infrared Spectroscopy 
(FTIR, Digilab FTS 7000) equipped with diamond Attenuated Total Reflection (ATR). Unsterile 
and samples sterilized under UV for 30 min were investigated to compare whether the sterilization, 
otherwise necessary for further biological-based studies, changes the physical and chemical 
properties of the nanoclays. Scans were collected in the range of 4000-400 cm-1 at a resolution of 
4 cm-1; a total of 100 scans were co-added to form the final spectrum for each of the samples.  
Surface morphology and elemental composition of the samples were investigated using a 
Hitachi S-4700 Field Emission Scanning Electron Microscope (SEM, Hitachi High-Technologies 
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Corporation) equipped with an energy dispersive X-ray spectroscopy (EDX). Surface morphology 
was examined at 5.0 kV while elemental composition was determined at 20.0 kV. For the analyses, 
dry powder samples were mounted onto a carbon tape and then sputter coated for 10 s in vacuum 
injected with argon using a gold/palladium target. The argon atoms were ionized and collided with 
the gold/palladium target, causing the metal ions to deposit on the sample in a thin conductive 
layer of about 3 nm as calculated using the equation d=KIVt, where d is thickness, k is a constant 
value of 0.17, I is plasma current, V is voltage, and t is the time.  
The size distribution of the samples was determined by dynamic light scattering (DLS) via 
the Mastersizer 2000 with a Hydro 2000S accessory (Malvern Instruments). For this, solutions of 
UC, CC, UC900, or CC900 dispersed and bath sonicated in cell culture media (Dulbecco’s 
Modified Eagle Medium: DMEM) containing 5% fetal bovine serum (FBS) or in phosphate 
buffered saline (PBS) were dropped into the Hydro 2000S until laser obscuration was within 10-
20%. The size analysis was performed 3 consecutive times with a stirrer speed of 1750 rpm and 
under continuous sonication.  
Samples’ sedimentation studies were performed by tracking changes in absorbance upon 
different incubation time when using an Evolution 300 UV-VIS spectrophotometer (Thermo 
Scientific). Briefly, concentrations of 100 µg/ml of UC, CC, UC900, and CC900 were prepared in 
media as described above. The maximum absorbance of each sample was obtained by scanning 
the absorbance in the 400-1100 nm range. Sedimentation was determined by measuring the 
changes in absorbance of each solution at the obtained maximum absorbance of 560 nm after 0, 
0.5, 1, 2, 3, 4, 5, and 6 h incubation in media respectively, with media serving as the blank at each 
time point.  
Cell Culture 
Immortalized human bronchial epithelial cells (BEAS-2B) were cultured in media 
containing 1 % L-glutamine, and 1 % penicillin-streptomycin (all reagents were purchased from 
Life Technologies, USA). The cells were passaged regularly using 0.25 % trypsin (Invitrogen, 
USA) and incubated at 37 ⁰C, 5 % CO2 and 80 % relative humidity. Before each experiment cells 
were grown to a confluent monolayer.  
Electrical Cell-substrate Impedance Testing 
Real-time measurements of cellular resistance and attachment were performed using an 
electrical cell-substrate impedance sensing instrument (ECIS-ZΘ, Applied Biophysics, NY). For 
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the cellular studies, a 96 well plate (96W10idf) that contained inter-digitated finger connection 
electrodes covering an area of 3.985 mm2 of the each well were used. Before addition of the cells, 
the electrodes were stabilized for 2 h with 200 µl media to minimize electrode drift during the 
experiment. After stabilization the cells were added at a density of 1.50E+05 cells/ml in a volume 
of 150 µl/well. The cells were allowed to grow for 24 h until they reached a confluent monolayer, 
as indicated by a constant level resistance.49  After 24 h, 100 µg/ml of UC, CC, UC900, or CC900 
(unsterilized) dispersed in media was added to their respective wells; cells in media served as the 
control. Subsequently, 24 h after treatment, the media was removed and the cells were washed 2 
times with PBS. Fresh media was added to all of the wells, and the recovery of the cells was 
monitored for 48 h. 
Live Cell Count 
BEAS-2B cells were seeded in a 12 well plate (Thermo Scientific, USA) at a density of 
2.0E+05 cells/ml. After 24 h, the cells were treated with UC, CC, or thermally degraded 
byproducts at a dose of 100 µg/ml. Before addition to the respective wells, each of the samples 
was sonicated for 8-10 min in media in a bath sonicator (2510 Branson); cells in only media served 
as controls. Twenty-four, 48, and 72 h post exposure to UC, CC, or thermally degraded byproducts, 
the cells were trypsinized and stained with 0.4% trypan blue solution (Invitrogen, USA). 
Subsequently, 10 µl of the sample containing the stained cells was added to a hemocytometer, and 
the number of cells in the 4 outer grids was counted through the use of the Leica DM IL optical 
microscope (Leica Microsystems) using a 10X objective. Analyses of cellular proliferation after 
exposure to UC, CC, UC900, and CC900, along with their sterilized counterparts, respectively 
were performed through direct live cell counts to eliminate concerns associated with false positive 
as resulted from the similar sizes of the cells and clay suspensions.  
Cellular Viability 
BEAS-2B cells were seeded in a 96 well plate (Thermo Scientific, USA); 2.0E+05 cells/ml 
were used. After 24 h, 100 µg/ml of UC, CC, UC900, or CC900 (unsterilized and sterilized) 
dispersed in media was added to their respective wells while cells in media served as control 
samples. The 4-[3-(4-Idophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate 
known as WST-1 assay (Roche, USA) was used to determine cellular viability as a change in color 
produced when cellular dehydrogenases reduced WST-1 to formazan.50 The color change is known 
to be directly correlated with the number of metabolically active cells.50 Briefly, after 24, 48, and 
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72 h of exposure, 10 µl of WST was added to the wells. Cells (exposed and control) were incubated 
for 2.5 h and changes in their absorbances were evaluated using a FLUOstar OPTIMA plate reader 
(BMG LABTECH) and 485 nm absorbance. Media, UC+media, CC+media, UC900+media, and 
CC900+media (unsterilized and sterilized) served as blanks and resulted absorbance values were 
subtracted from the cellular measurements counterparts.  
Cell Imaging 
BEAS-2B cells were seeded on glass coverslips in a 12 well plate at a density of 1.5E+05 
cells/ml overnight. The cells were subsequently exposed to 100 µg/ml of UC, CC, UC900, or 
CC900 (unsterilized) dispersed in media. After 24 h, the media was removed and the cells were 
washed two times with Hank’s Balanced Salt Solution (HBSS) (Corning, USA), fixed with 4% 
formaldehyde (Sigma-Aldrich, USA) for 15 min at 37 ⁰C, and subsequently washed 3x with HBSS 
to remove any remaining formaldehyde. The cells plasma membrane and nuclei were then stained 
with 3 µg/ml Alexa Fluor 594 wheat germ agglutinin (WGA) and 2 µM Hoechst 33342 (Image-iT 
LIVE Plasma Membrane and Nuclear Labeling Kit, Life Technologies) in HBSS for 10 min at 4 
⁰C. After incubation, cells were washed 2x with HBSS, mounted on glass coverslips, and imaged 
under a Nikon Inverted Microscope Eclipse Ti Series using a 40x objective. The NIS-Elements 
BR 3.1 software was used to define and analyze the size and morphology of cells. Around 75 cells 
per treatment were considered to allow for 375 cell measurements per replicate; a total of 3 
replicates were used.  
Statistical Analyses 
All cellular experiments were repeated at least 6 times for all samples, with the exception of 
cell imaging which was repeated 3 times for unsterilized clay samples and ECIS which was repeated 
4 times for unsterilized clay samples. All tables are presented as the average value with (+/-) SD 
values. All graphs are presented as the mean value of the number of indicated replicates with (+/-) 
SE bars. Significance was determined by one- or two-way analysis of variance ANOVA with 
p<0.05* indicating significance; a post-hoc test was also run to identify which groups were different 
from each other if statistical differences were recorded.  
 
Results and Discussion 
We aimed to investigate the toxicological profiles of as-received pristine and organically 
modified nanoclays and their thermally degraded, end of life cycle byproducts using non-
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destructive and high throughput real-time electroanalytical approaches.44,51,46 Cloisite Na+ (UC), a 
pristine montmorillonite, and Cloisite 30B (CC), an organically modified montmorillonite 
frequently used in food packaging17,18 and medical industry,21 were used as testing materials to 
mimic potential human inhalation exposure during nanocomposites manufacturing and usage, 
while thermally degraded forms of these nanoclays, i.e., Cloisite Na+ (UC900) and Cloisite 30B 
(CC900), were used to mimic the municipal solid waste incineration disposal environment 
generated at the product-based nanoclay end of life cycle.  
Nanoclays and Their Thermally Degraded Byproducts Characterization 
First, to mimic the incineration conditions of pristine (UC) or organically modified 
nanoclay (CC) and thus generate end of life cycle nanoclay byproducts, thermogravimetric 
analysis (TGA) was used. Briefly, samples degraded under temperatures ranging from 25 to 950 
⁰C allowed moisture, volatile, fixed carbon content, and ash content identifications (Table 1). If 
initially UC had a greater weight loss, with about 20 % weight loss by 105 °C and 5 % more in the 
105 to 800 °C temperature range, CC experienced the vast majority of its weight loss (about 30 
%) in the 105 to 800 °C temperature range (Figure 1a).33  Further, a significant higher volatile and 
ash content were observed for CC relative to the pristine sample, presumably resulted from the 
functionalization of CC with methyl, tallow, bis-2-hydroxyethyl, quaternary ammonium (per the 
manufacturer specifications).  
 
 
Table 1: Amount of moisture, volatile, ash, and fixed carbon present in UC and CC as determined 










UC 17.76 +/- 0.12 6.31 +/- 0.04 75.72 +/- 0.13 0.22 +/- 0.03 







Figure 1: (a) Thermal degradation profile of UC and CC (n=2). (b) FTIR spectrum for UC and 








Differences in chemical composition between UC, CC, and their thermally degraded 
byproducts were confirmed using Fourier transform infrared spectroscopy (FTIR) and are shown 
in Figure 1b. Both clays revealed the characteristic peaks indicative of the Si-O-Si stretching 
vibration of silicate29,52 at 1000 cm-1 and of the Al-OH-Al deformation of aluminates29,53 at 900 
cm-1 respectively, while peak shifting was observed after their thermal degradation. The peak 
around 840 cm-1 was a result of the deformation of the OH linked to Al3- and Mg2- 53 while the 
peak around 630 cm-1 was associated with the out of plane vibration of the Al-O group.54,55 
Complementarily, UC900 had an additional peak around 640 cm-1 presumably due to Si-O-Si 
bending53 while CC900 no longer retained the peaks normally present in its CC form at 2920, 
2850, and 720 cm-1 respectively, thus confirming the degradation of the organic modifier.56 Such 
peaks were likely resulted from the asymmetric or symmetric stretching of the C-H groups 
included in methylene groups or alkane rock of CH2 for alkanes with 7 or more carbons, 
respectively29,53 as resulted from the incorporation of the methyl, tallow, bis-2-hydroxyethyl, 
quaternary ammonium organic modifier during the nanoclay processing.29,53 Molecular 
composition of UC, CC, and their thermally degraded counterparts was not changed after UV 
sterilization (Figure S1). 
Scanning Electron Microscopy (SEM) allowed surface morphologies analyses of the as- 
received and end of life cycle samples (Figure 2). Generally, UC appeared to have less layering 
and smoother edges relative to CC (Figure 2a,b); similarly, UC900 and CC900 existed in 
agglomerated forms however, they displayed a fairly uniform surface with smooth edges for 
UC900 (Figure 2c) and a more fragmented surface with platelets jutting out for CC900 (Figure 
2d). The observed changes in morphology from pristine nanoclay to thermally degraded nanoclay 
could be due to both the dehydroxylation of the crystal lattice structure of montmorillonite that 
occurs around 700 °C 56 as well as from the presence of the organic modifier which causes an 
increase in the nanoclay’s basal spacing57 and thus possible differences in the platelet structure 
breakdown during thermal degradation. UV sterilization did not produce significant changes in the 





   
   
 
Figure 2: Surface morphology of (a) UC, (b) CC, and thermally degraded (c) UC900, and (d) 
CC900 as determined by SEM. (e) Elemental composition of as-received nanoclay and their 
thermally degraded byproducts as determined by EDX at 1 µm (n=5). The symbols * and ~ indicate 
significant differences between UC and CC and between as received nanoclay and its thermally 





UC and CC differed significantly in their elemental composition as determined by energy 
dispersive X-ray (EDX) spectroscopy (Figure 2e). Specifically, CC showed a higher weight 
percent of carbon and a lower weight percent of sodium, both relative to UC, thus confirming the 
modification with the organic modifier.58 After thermal degradation however, the weight percent 
of carbon decreased significantly for CC900, while the weight percent of magnesium, aluminum, 
and silicon increased; further, no sodium was observed. Complementarily, no significant 
differences were observed between the elemental composition of UC and its thermally degraded 
byproduct, UC900. The lower amount of carbon present in CC900 versus CC, as well as the fact 
that there was no longer a carbon difference between the two forms of thermally degraded clay is 
consistent with the previous studies and confirms the loss of the organic modifier after thermal 
degradation56 Analyses also showed that the elemental composition of UC, CC, and their thermally 
degraded counterparts was not affected by UV sterilization (Figure S2e).  
All of the samples displayed size distributions in the micrometer range upon sonication in 
either cellular media (Table 2) or phosphate buffer saline (PBS; Table 3), indicating that samples 
formed agglomerates. Agglomerate’s size distribution was a function of the sample’s chemical 
signature (Figure 3), with cell culture media with 5% serum containing appropriate cell growth 
proteins favoring larger agglomerates formation than PBS alone, likely due to the interactions of 
the clays with the proteins in the media forming coronas.59,60 Interestingly, analyses showed that 
CC displayed smaller diameter sizes in both media and PBS relative to the other three samples, 
likely due to the presence of the organic modifier (Figure 3a,c). Contrary, thermally degraded 
samples of CC900 formed larger conglomerates relative to their non-degraded counterparts 
presumably due to their reduction of OH contents, with a 35 % and 36 % increase in size for CC900 
in media and PBS, respectively, relative CC (Figure 3b,d). Table S1 and S2 and Figure S3a-d (both 
in Supplementary Information) display particle diameter sizes based upon % volume, with results 
confirming that while there were a greater number of small sized particles, the larger sized particles 
were taking up more volume. Sedimentation analysis showed that all of the samples had around 
85% or more particles settled by 6 h ((Supplementary Information Figure S4), with the samples 




Table 2: Average particle diameter distribution sizes (µm) in solutions of media relative to the 
number of particles. 
  UC CC UC900 CC900 
<10% 4.66 +/- 0.25 2.63 +/- 0.06 3.58 +/- 0.08 3.75 +/- 0.13 
<50% 7.70 +/- 0.40 3.85 +/- 0.17 5.50 +/- 0.18 5.89 +/- 0.23 
<90% 13.91 +/- 0.48 7.23 +/- 0.36 10.86 +/- 0.24 11.22 +/- 0.29 
 
 
Table 3: Average particle diameter distribution sizes (µm) in solutions of PBS relative to the 
number of particles. 
  UC CC UC900 CC900 
<10% 3.88 +/- 0.16 2.66 +/- 0.06 3.32 +/- 0.01 3.75 +/- 0.01 
<50% 6.16 +/- 0.26 3.99 +/- 0.12 5.41 +/- 0.02 6.23 +/- 0.00 




Figure 3: Average particle diameter size distribution of UC, CC, UC900, and CC900 in solutions 
of (a and b) media or (c and d) PBS.  
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The measured clay or thermally degraded byproducts sizes were similar to those found in 
manufacturing and disposal environments.61 Specifically, manufacturing workplaces showed 
particle sizes from around 2.3 nm to 50 µm.62,63 Further, the fly ash from incinerators was shown 
to display particles of size distributions ranging from 1 nm to 1000 µm, with a large fraction of 
such particles being under 100 µm.37,64,65 This is in contrast with bottom ash64,65 which was 
generally shown to contain larger particles normally ranging from around 250 µm to more than 8 
mm, though the majority of the bottom ash was around 2-8 mm.65  
Evaluate Cellular Behavior upon Exposure to Nanoclays or Thermally Degraded Byproducts 
Changes in cell-induced impedance signals’ were used to evaluate the characteristics of 
epithelial lung cells before and after exposure to as-received pristine, organically modified and 
end of life cycle nanoclay byproducts, as well as cellular ability to recover from any potential 
deleterious effects. Specifically, electric cell-substrate impedance sensing (ECIS) quantified 
changes in cell-substrate interactions and cell morphology, in real-time and non-invasively, all 
after exposure of human bronchial epithelial cells (BEAS-2B) to 100 µg/ml doses of the above-
characterized samples. ECIS was previously used to monitor the morphology, attachment, and 
movement of cells,51,46 while BEAS-2B’s were previously used as model systems66 to mimic 
inhalation toxicity. Previous studies have showed that the size of particles greatly influences their 
translocation in biological systems, with particles below 2.5 µm reaching the alveoli42 and larger 
ones likely affecting cells in the upper airways.42 Another study showed that the platelet-shaped 
particle with a projected area diameter up to 25 µm and thickness up to 0.1 µm is able to be respired 
and deposited in the lungs.67 BEAS-2B epithelial cells were shown to serve as the first line of 
defense when a material is introduced into the human lung by respiration. The dose was chosen to 
represent a 6-year working lifetime, based on 8 h/day and 50 weeks/year as derived from particle 
deposition studies in rat lungs or computer modeling involving variables related to particle 
characteristics and lung characteristics of humans respectively.48,68  
For analysis, the BEAS-2B cells were seeded onto the ECIS electrodes and exposed to 
clays or end of life cycle clay-based byproducts for 24 h (Figure 4, Region A and Region B 
respectively). To assess cellular recovery after clay or byproduct-based treatment, the clays and 
byproducts were removed and cellular behavior was recorded in real-time for another 48 h, using 
4000 Hz, (Figure 4, Region C). The chosen frequency allows for resistance evaluation without 
effects on cell’s plasma membrane.69 Further, at this frequency, previous analyses have showed 
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that the impedance is dependent on the cell bodies, whereas at the lower or higher frequencies, 
parameters such as impedance of the electrode/electrolyte interface or the medium, and the 
constriction resistance of the working electrode dominate the impedance measurements.70  
Our results showed that the resistance of cells treated with the clay or byproduct dropped 
when compared to the control (Figure 4a); in particular, CC showed the greatest drop in resistance, 
with an almost complete loss after 6 h of treatment (Region B). Upon 24 h of treatment and removal 
of the clays or end of life cycle byproducts, cells treated with UC, UC900, and CC900 were able 
to regain/maintain their resistance values (Region C). Further, the trends in resistance were similar 
for both UC and UC900, and slightly lower for CC900; no regain in resistance was however 
recorded for cells exposed to CC.  
 
 
Figure 4: (a) Representative real-time measurements of normalized resistance for BEAS-2B cells 




thermally degraded nanoclays. (b) Real-time measurements of normalized alpha (α) parameter for 
BEAS-2B cells before (Region A), during (Region B), and after treatment (Region C) with as- 
received and thermally degraded nanoclays. 
 
Mechanisms Responsible for Nanoclays or Thermally Degraded Byproducts Cellular Changes 
Previous analysis have showed that a drop in resistance could be associated with changes 
in cell-substrate interactions,71 in cell viability and proliferation,72 or in cell shape as resulted from 
cell death, since flatter, more spread cells are responsible for higher resistance than rounder or 
apoptotic cells.51,46 Complementary, complete loss in resistance was shown to be due to cell death 
and detachment from the electrode.71  
To evaluate the first, namely whether cells exposed to nanoclays show changes in cell-
substrate interactions, we used the α parameter which details the current through the ventral 
surfaces of the cells and electrodes73 (Figure 4b). Indeed, while CC showed a complete loss in cell-
substrate interaction within the course of the study time, cells treated with UC showed a decrease 
in α relative to the control cells within Region B, however, after clay removal, they maintained 
their cell-substrate interaction (Region C). Complementary, UC900 and CC900 had similar α 
values relative to the control, thus indicating that interactions between the cells and the substrate 
were maintained; however, resistance was lower for both relative to the control, possibly indicating 
that changes to the cell morphology had occurred. CC900 also showed an increase in the α 
parameter within the 48 h post treatment removal (Region C) confirming cell recovery.  
To evaluate the second, namely whether changes in resistance are due to decreases in 
cellular viability and proliferation, we used cellular assays. Indeed, analyses showed that UC and 
CC displayed significant decreases, with CC causing a time-dependent decrease in cellular 
proliferation and viability over 72 h of exposure, relative to the control, UC, and the thermally 
degraded byproducts. Similar results were obtained by Maisanaba et al. who showed decreases in 
cellular viability in a time dependent manner at doses above 3.91 µg/ml upon treatment with CC 
of the human colon cell line, Caco-2.30 UC900 and CC900 showed a more varied response in both 
live cell counts and cellular viability relative to their non-degraded counterparts. In particular, 
UC900 had a significant decrease in live cell count (Figure 5a), while no significant decreases in 
cellular viability were obtained for the thermally degraded clays, both relative to the control 
(Figure 5b). CC900 displayed an increase in cellular proliferation at 72 h relative to 48 h and 
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further confirmed the observed Region C changes in the α parameter. The ability of CC900 to 
display increased proliferation, may hint at its potential to produce effects similar to carcinogen 
carbon black; complementary study noted for instance that carbon black caused an increase in 
epithelial cell proliferation, as well as increases in mutation frequency in these cells, therefore 
hinting at an increased prevalence of cancer incidence upon such exposures.74 No significant 
differences were obtained between UC and UC900 and overall there were no major differences 
between sterilized and unsterilized nanoclays (Figure S5a,b). Verma et al. complement our results 
on as-received nanoclays by showing differences in toxicity in A549 cells based on the clay 
morphology, with platelet type nanoclays showing lower cell numbers relative to the tubular type, 
as well as varying toxicity between the platelet types.31 
 
          
     
Figure 5: Toxicity of as-received and thermally degraded nanoclays determined by (a) live cell 
count and (b) cellular viability via WST assay, for unsterilized nanoclay (n=6). The symbols * and 
~ indicate significant differences between the control and nanoclay treatments and between as-




To evaluate the last, namely whether changes in cell shape were correlated with the ECIS 
results, cellular imaging was used. Indeed, analysis showed that all of the clays and thermally 
degraded byproducts altered cellular shape and size, as well as cells confluence (Figure 6a-e). For 
instance, the treated cells displayed abnormal cell shapes with a more stretched and altered profile 
away from the more oval shape of the control cells. Further, the membranes of the cells exposed 
to UC900 and CC900 did not appear as distinct as those of the control cells and further, the 
integrity of the exposed cell monolayer seemed compromised. Moreover, treatment with UC and 
CC caused significant decreases in the area of the cells relative to the control therefore further 
confirming the ECIS results (Figure 6f); i.e., smaller cells would be taking up less room on the 
electrode, causing for more current to pass through and thus a lower resistance as shown by ECIS. 
Further, the dramatic loss of resistance and α shown for cells treated with CC along with the 
circular shape observed in cell imaging, show that alterations are likely occurring in these cells 
morphology as a first step towards cell transformation.  
The larger effect observed for CC is presumably due to the presence of its organic modifier 
known to induce toxicity33,30,35 through decrease in cellular proliferation,31 as well as membrane 
changes29,32 and DNA damage.33,34,35 It is our hypothesis that the route of the displayed toxicity of 
cells treated with CC could be through alteration of the cytoskeleton, causing for the observed 
decreases in resistance and α. Specifically, previous analysis for instance have shown that circular 
cells have lost their ability to attach to the substrate (electrode), as well as to other cells eventually 
leading to and/or serving as a signal of cell death.75,76 Such changes in morphology are known to 
be occurring due to cytoskeleton reorganization76 with alteration in cytoskeleton44 leading to 
changes in cell mechanics,77 migration,78 differentiation,79 and organization.80 Further, it is likely 
that cells exposed to UC are also experiencing alterations of their cytoskeleton. While UC900 and 
CC900 did not experience as much a loss in the α parameter relative to the as-received clays, they 
still showed decreases in resistance, possibly associated with reduced membrane integrity as 
observed in cellular imaging. Such changes in cell morphology, structure, and cell-substrate 
interactions may eventually lead to loss of cell-cell signaling.76,81  
Similar to our results, the presence of the organic modifier in clays was associated to greater 
toxicity.29,30,35,82 Janer et al. for instance tested dose-response (<500 µg/ml) of 5 cell lines and 1 
primary cell line and found that clays organically modified with dimethyl dihydrogenated tallow 
ammonium and dimethyl benzyl hydrogenated tallow ammonium respectively had higher 
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cytotoxicity relative to pristine clays.82 When testing the modifier, quaternary ammonium 
compound (QAC), Sharma et al. found that the QAC had the same effect as the coated clay on the 
genotoxicity of Caco-2 cells, suggesting that the toxic effects were due to QAC.35 Further, one 
study by Yoshida et al. found that organically modified silica particles coated with amine or 
carboxyl groups reduced the amount of reactive oxygen generation in HaCaT and TLR-1 cells. 
They also observed reduced DNA damage in HaCaT cells all relative to the unmodified silica 




Figure 6: Fluorescent images of the cell membrane (red) and nucleus (blue) for (a) control cells 
and cells treated with (b) UC, (c) CC, (d) UC900, and (e) CC900 after 24 h. (f) Cell area (µm) 
after 24 h of treatment with nanoclays (n=3). 
 
While the full picture of the mechanistic toxicity of the nanoclays or end of life byproducts 
is still undergoing, to our knowledge, these are the first studies to identify toxicological profiles 
associated with cellular exposure to thermally degraded byproducts using a non-invasive and real-
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time cellular based platform. Further, while in our study we evaluated 4 different samples, one 
could envision creating a combinatorial assay to allow for profiles identification based on both 
sample as well as cellular characteristics thus extending the flexibility of this experimental set-up 




The ECIS provided new means to identify the toxicity profiles of the clays or byproducts, 
in a non-invasive, high-throughput, and real-time manner. Specifically, the morphological, 
behavioral, and viability changes observed in BEAS-2B cells after treatment with as-received clay 
or thermally degraded byproducts show that such samples have the potential to produce toxic 
effects when used both in manufacturing or disposal environments. Organically modified 
nanoclay, CC, had the greatest toxic effects, with large losses in cell-substrate and cell-cell 
interactions and near maximal cell population loss by 72 h. Contrary, its thermally degraded 
byproduct, CC900, induced cell proliferation possibly hinting to similar toxic profiles to known 
carcinogen carbon black. UC, and its thermally degraded counterpart, UC900, displayed less 
significant toxic effects.  
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Chapter 2: Toxicity Evaluations of Nanoclays and Thermally Degraded Byproducts 
through Spectroscopical and Microscopical Approaches 
 
Materials and Methods 
Material Characterization  
In order to determine if UV sterilization caused changes in molecular composition, samples 
of UC, CC, UC900, and CC900 were sterilized for 30 min under UV light and examined via 
Fourier Transform Infrared Spectroscopy (FTIR, Digilab FTS 7000) equipped with diamond 
Attenuated Total Reflection (ATR). Scans were collected in the range of 4000-400 cm-1 at a 
resolution of 4 cm-1; a total of 100 scans were co-added to form the final spectrum of each one of 
the samples being analyzed. Samples were used as dry powders. 
 In order to determine if UV sterilization caused changes in surface morphology and 
chemical composition, samples of UC, CC, UC900, and CC900 were sterilized for 30 min under 
UV light and examined using a Hitachi S-4700 Field Emission Scanning Electron Microscope 
(SEM, Hitachi High-Technologies Corporation) equipped with an energy dispersive X-ray 
spectrographic detector (EDX). Surface morphology was examined at 5.0 kV while elemental 
composition was determined at 20.0 kV. For the analyses, the samples (dry powder forms) were 
mounted onto a carbon tape and then sputter coated for 10 s in vacuum injected with argon using 
a gold/palladium target.  
Sedimentation over 6 h of the clays was performed by measuring absorbance via the   
spectrophotometer. Briefly, a concentration of 100 µg/ml of the two clays and their thermally 
degraded byproducts was prepared in media. The maximum absorbance of each clay was obtained 
by scanning the absorbance of each solution from 400-1100 nm. Sedimentation was determined 
by measuring the absorbance of each solution at the obtained maximum absorbance of 560 nm for 
0, 0.5, 1, 2, 3, 4, 5, and 6 h with media serving as the blank at each time point.  
Toxicity Analyses 
 UC, CC, and their thermally degraded byproducts were sterilized under UV light for 30 min 
in order to verify that the toxic effects obtained from the clay were due to the clay and not due to 
contaminants on the clay before sterilization. Therefore, live cell counts and cellular viability via 
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the WST assay were also performed with UV sterilized clay samples. Live cell counts were 
performed by seeding BEAS-2B cells in a 12 well plate (Thermo Scientific, USA) at a density of 
2.0E+05 cells/ml. After 24 h, the cells were treated with UC(UV), CC(UV), or UV sterilized 
thermally degraded byproducts at a dose of 100 µg/ml. Before addition to the respective wells, the 
samples were sonicated for 8-10 min in media. Cells in only media served as controls. After 24, 
48, and 72 h post exposure to UC(UV), CC(UV), UC900(UV) or CC900(UV), the cells were 
trypsinized and stained with 0.4% trypan blue solution (Invitrogen, USA). Subsequently, 10 µl of 
the sample containing the stained cells was added to a hemocytometer, and the number of cells in 
the four outer grids was counted through the use of the Leica DM IL optical microscope (Leica 
Microsystems) at 100X magnification. Cellular viability of cells treated with UV sterilized clays 
was performed by seeding BEAS-2B cells in a 96 well plate (Thermo Scientific, USA) at a density 
of 2.0E+05 cells/ml. After 24 h, 100 µg/ml of UC(UV), CC(UV), UC900(UV), or CC900(UV) 
dispersed in media was added to their respective wells; cells in media served as control samples. 
After 24, 48, and 72 h of exposure, 10 µl of WST was added to the wells. The cells were incubated 
for 2.5 h and then read by a FLUOstar OPTIMA plate reader (BMG LABTECH) at 485 nm 
absorbance. Media, UC(UV)+media, CC(UV)+media, UC900(UV)+media, and 
CC900(UV)+media served as blanks and their obtained absorbance values were subtracted from 

















Table S1: Average particle diameter distribution sizes (µm) in solutions of media relative to % 
volume. 
 UC CC UC900 CC900 
<10% 7.93 +/- 0.27 4.25 +/- 0.16 6.25 +/- 0.01 6.36 +/- 0.20 
<50% 14.41 +/- 0.46 9.76 +/- 0.08 13.53 +/- 0.21 12.71 +/- 0.30 
<90% 24.21 +/-1.08 21.73 +/- 1.32 25.81 +/-0.76 23.05 +/- 1.11 
 
 
Table S2: Average particle diameter distribution sizes (µm) in solutions of PBS relative to % 
volume. 
 UC CC UC900 CC900 
<10% 6.29 +/- 0.16 4.68 +/- 0.12 6.69 +/- 0.03 6.79 +/- 0.01 
<50% 11.68 +/- 0.12 11.12 +/- 0.12 14.64 +/- 0.05 13.16 +/- 0.03 




Figure S1: FTIR spectrum of as-received and thermally degraded nanoclay sterilized by UV light 
for 30 min (n=2). 
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Figure S2: Surface morphology of sterilized (a) UC(UV), (b) CC(UV), and thermally degraded 
(c) UC900(UV), and (d) CC900(UV) as determined by SEM. (e) Elemental composition of as-
received and thermally degraded nanoclay sterilized by UV light for 30 min determined by EDX 
at 1µm (n=5). The symbols * and ~ indicate significant differences between UC and CC and 







Figure S3: Average particle diameter size distribution of UC, CC, UC900, and CC900 in solutions 




Figure S4: Sedimentation of as-received and thermally degraded nanoclays over 6 h as determined 





Figure S5: Toxicity of as-received and thermally degraded nanoclays sterilized by UV light for 
30 min determined by (a) live cell count and (b) cellular viability via WST assay. The symbols * 
and ~ indicate significant differences between the control and nanoclay treatments and between 
as-received nanoclay and thermally degraded byproducts, respectively. The symbol ¤ indicates 









1.  Roco, M. C., The long view of nanotechnology development: The National 
Nanotechnology Initiative at 10 years. Journal of Nanoparticle Research 2011, 13, 427-445. 
2.  Sargent Jr., J. F., The National Nanotechnology Initiative: Overview, Reauthorization, and 
Appropriations Issues. Congressional Research Service 2014. 
3.  Paul, D. R.; Robeson, L. M., Polymer nanotechnology: Nanocomposites. Polymer 2008, 
49, 3187-3204. 
4.  Singla, P.; Mehta, R.; Upadhyay, S. N., Clay modification by the use of organic cations. 
Green and Sustainable Chemistry 2012, 2, 21-25. 
5.  Ray, S. S.; Okamoto, M., Polymer/layered silicate nanocomposites: a review from 
preparation to processing. Progress in Polymer Science 2003, 28, 1539-1641. 
6.  Ultracki, L. A.; Sepehr, M.; Boccaleri, E., Synthetic, layered nanoparticles for polymeric 
nanocomposites (PNCs). Polymers for Advanced Technologies 2007, 18 (1), 1-37. 
7.  Floody, M. C.; Theng, B. K. G.; Reyes, P.; Mora, M. L., Natural nanoclays: applications 
and future trends-a Chilean perspective. Clay Minerals 2009, 44, 161-176. 
8.  Beall, G. W., The use of organo-clays in water treatment. Applied Clay Science 2003, 24, 
11-20. 
9.  Agarwal, S.; Tran, P.; Soong, Y.; Martello, D.; Gupta, R. K., Flow behavior of 
nanoparticles stabilized drilling fluids and effect of high temperature aging. Journal of Petroleum 
Science and Engineering 2014, 117, 15-27. 
10.  Jones, T. R., The Properties and Uses of Clays Which Swell in Organic Solvents. Clay 
Minerals 1983, 18, 399-410. 
11.  Elmore, A. R. Final Report on the Safety Assessment of Aluminum Silicate, Calcium 
Silicate, Magnesium Aluminum Silicate, Magnesium Silicate, Magnesium Trisilicate, Sodium 
Magnesium Silicate, Zirconium Silicate, Attapulgite, Bentonite, Fuller's Earth, Hectorite, Kaolin, 
Lithium Magnesium Silicate, Lithium Magnesium Sodium Silicate, Montmorillonite, Pyrophyllite, 
and Zeolite; International Journal of Toxicology, 2003; pp 37-102. 
12.  Tiwari, R. R.; Khilar, K. C.; Natarajan, U., Synthesis and characterization of novel organo-
montmorillonites. Applied Clay Science 2008, 38, 203-208. 
13.  Lebaron, P. C.; Wang, Z.; Pinnavaia, T. J., Polymer-layered silicate nanocomposites: an 
overview. Applied Clay Science 1999, 15, 11-29. 
60 
14.  Krikorian, V.; Pochan, D. J., Poly (L-Lactic Acid)/Layered silicate nanocomposite: 
fabrication, characterization, and properties. Chemistry of Materials 2003, 15, 4317-4324. 
15.  Molinaro, S.; Romero, M. C.; Boaro, M.; Sensidoni, A.; Lagazio, C.; Morris, M.; Kerry, 
J., Effect of nanoclay-type and PLA optical purity on the characteristics of PLA-based 
nanocomposite films. Journal of Food Engineering 2013, 117, 113-123. 
16.  Zheng, X.; Wilkie, C. A., Flame retardancy of polystyrene nanocomposites based on an 
oligomeric organically-modified clay containing phosphate. . Polymer Degradation and Stability 
2003, 81, 539-550. 
17.  Choi, R.; Cheigh, C.; Lee, S.; Chung, M., Preparation and Properties of 
Polypropylene/Clay Nanocomposites for Food Packaging. Journal of Food Science 2011, 76, 62-
67. 
18.  Laufer, G.; Kirkland, C.; Cain, A. A.; Grunlan, J. C., Oxygen barrier of multilayer thin 
films comprised of polysaccharides and clay. Carbohydrate Polymers 2013, 95, 299-302. 
19.  Dalir, H.; Farahani, R. D.; Nhim, V.; Samson, B.; Lévesque, M.; Therriault, D., Preparation 
of Highly Exfoliated Polyester-Clay Nanocomposites: Process-Property Correlations. Langmuir 
2012, 28, 791-803. 
20.  Okada, A.; Usuki, A., The chemistry of polymer-clay hybrids. Material Science and 
Engineering: C 1995, 3, 109-115. 
21.  Barua, S.; Dutta, N.; Karmakar, S.; Chattopadhyay, P.; Aidew, L.; Buragohain, A. K.; 
Karak, N., Biocompatible high performance hyperbranched epoxy/clay nanocomposite as an 
implantable material. Biomedical Materials 2014, 9. 
22.  Kevadiya, B. D.; Thumbar, R. P.; Rajput, M. M.; Rajkumar, S.; Brambhatt, H.; Joshi, G. 
V.; Dangi, G. P.; Mody, H. M.; Gadhia, P. K.; Bajaj, H. C., Montmorillonite/poly-(e-caprolactone) 
composites as versatile layered material: Reservoirs for anticancer drug and controlled release 
property. European Journal of Pharmaceutical Science 2012, 47, 265-272. 
23.  Fogelström, L.; Malmström, E.; Johansson, M.; Hult, A., Hard and Flexible 
Nanocomposite Coatings using Nanoclay-Filled Hyperbranched Polymers. Applied Materials & 
Interfaces 2010, 2, 1679-1684. 
24.  Meera, K. M. S.; Sankar, R. M.; Murali, A.; Jaisankar, S. N.; Mandal, A. B., Sol–gel 
network silica/modified montmorillonite clay hybrid nanocomposites for hydrophobic surface 
coatings. Colloids and Surfaces B: Biointerfaces 2012, 90, 204-210. 
61 
25.  Mitrano, D. M.; Motellier, S.; Clavaguera, S.; Nowack, B., Review of nanomaterial aging 
and transformations through the life cycle of nano-enhanced products. Environmental 
International 2015, 77, 132-147. 
26.  Stern, S. T.; McNeil, S. E., Nanotechnology Safety Concerns Revisited. Toxicological 
Sciences 2008, 101 (1), 4-21. 
27.  Dhawan, A.; Sharma, V., Toxicity assessment of nanomaterials: methods and challenges. 
Analytical and Bioanalytical Chemistry 2010, 398, 589-605. 
28.  Kroll, A.; Pillukat, M. H.; Hahn, D.; Schnekenburger, J., Current in vitro methods in 
nanoparticle risk assessment: Limitations and challenges. European Journal of Pharmaceutics and 
Biopharmaceutics 2009, 72, 370-377. 
29.  Lordan, S.; Kennedy, J. E.; Higginbotham, C. L., Cytotoxic effects induced by unmodified 
and organically modified nanoclays in human hepatic HepG2 cell line. Journal of Applied 
Toxicology 2011, 31, 27-35. 
30.  Maisanaba, S.; Gutièrrez-Praena, D.; Pichardo, S.; Moreno, F. J.; Jordá, M.; A.M., C.; 
Aucejo, S.; Jos, A., Toxic effects of a modified montmorillonite clay on the human intestinal cell 
line Caco-2. Journal of Applied Toxicology 2013, 34, 714-725. 
31.  Verma, N. K.; Moore, E.; Blau, W.; Volkov, Y.; Babu, P. R., Cytotoxicity evaluation of 
nanoclays in human epithelial cell line A549 using high content screening and real-time impedance 
analysis. Journal of Nanoparticle Research 2012, 14, 1-11. 
32.  Baek, M.; Lee, J.; Choi, S., Toxicological effects of cationic clay, montmorillonite in vitro 
and in vivo. Molecular and Cellular Toxicology 2012, 8, 95-101. 
33.  Maisanaba, S.; Puerto, M.; Pichardo, S.; Jorda, M.; Moreno, F. J.; Aucejo, S.; Jos, A., In 
vitro toxicological assessment of clays for their use in food packaging application. Food and 
Chemical Toxicology 2013, 57, 266-275. 
34.  Houtman, J.; Maisanaba, S.; Puerto, M.; Gutièrrez-Praena, D.; Jordá, M.; Aucejo, S.; Jos, 
A., Toxicity assessment or organomodified clays used in food contact materials on human target 
cell lines. Applied Clay Science 2014, 90, 150-158. 
35.  Sharma, A. K.; Schmidt, B.; Frandsen, H.; Jacobsen, N. R.; Larsen, E. H.; Binderup, M., 
Genotoxicity of unmodified and organo-modified montmorillonite. Mutation Research/Genetic 
Toxicology and Environmental Mutagenesis 2010, 700, 18-25. 
62 
36.  Souza, P. M. S.; Morales, A. R.; Marin-Morales, M. A.; Mei, L. H. I., PLA and 
Montmorillonite Nanocoposites: Properties, Biodegradation, and Potential Toxicity. Journal of 
Polymers and the Environment 2013, 21, 738-759. 
37.  Roes, L.; Patel, M. K.; Worrell, E.; Ludwig, C., Preliminary evaluation of risks related to 
waste incineration of polymer nanocomposites. Science of the Total Environment 2012, 417-418, 
76-86. 
38.  Lighty, J. S.; Veranth, J. M.; Sarofim, A. F., Combustion aerosols: factors governing their 
size and composition and implication to human health. Journal of the Air & Waste Management 
Association 2000, 50 (9), 1565-1618. 
39.  Knirsch, J. M.; Pulskamp, K.; Krug, H. F., Oops they did it again! Carbon nanotubes hoax 
scientists in viability assays. Nano Letters 2006, 6, 1261-1268. 
40.  Monteiro-Riviere, N. A.; Inman, A. O.; Zhang, L. W., Limitations and relative utility of 
screening assays to assess engineering nanoparticle toxicity in a human cell line. Toxicology and 
Applied Pharmacology 2009, 234, 222-235. 
41.  Casey, A.; Herzog, E.; Davoren, M.; Lyng, F. M.; Byrne, H. J.; Chambers, G., 
Spectroscopics analysis confirms the interactions between single walled carbon nanotubes and 
various dyes commonly used to assess cytotoxicity. Carbon 2007, 45, 1425-1432. 
42.  Hoet, P. H.; Brüske-Hohlfeld, I.; Salata, O. V., Nanoparticles-known and unknown health 
risks. Journal of Nanobiotechnology 2004, 2 (12). 
43.  Wang, L.; Zhu, J.; Deng, C.; Xing, W.; Cheng, J., An automatic and quantitative on-chip 
cell migration assay using self-assembled monolayers combined with real-time cellular impedance 
sensing. Lab Chip 2008, 8, 872-878. 
44.  Xi, B.; Yu, N.; Wang, X.; Xu, X.; Abassi, Y. A., The application of cell-based label-free 
technology in drug discovery. Biotechnology Journal 2008, 3, 484-495. 
45.  Xiao, C.; Lachance, B.; Sunahara, G.; Luong, J. H. T., Assessment of Cytotoxicity Using 
Electric Cell-Substrate Impedance Sensing: Concentration and Time Response Function 
Approach. Analytical Chemistry 2002, 74, 5748-5753. 
46.  Wegener, J.; Keese, C. R.; Giaever, I., Electric Cell-Substrate Impedance Sensing (ECIS) 
as a Noninvasive Means to Monitor the Kinetics of Cell Spreading to Artificial Surfaces. 
Experimental Cell Research 2000, 259 (1), 158-166. 
63 
47.  Erdely, A.; Dahm, M.; Chen, B. T.; Zeidler-Erdely, P. C.; Fernback, J. E.; Birch, M. E.; 
Evans, D. E.; Kashon, M. L.; Deddens, J. A.; Hulderman, T.; Bilgesu, S. A.; Battelli, L.; 
Schwegler-Berry, D. E.; Leonard, H. D.; McKinney, W.; Frazer, D. G.; Antonini, J. M.; Porter, D. 
W.; Castranova, V.; Schubauer-Berigan, M. K., Carbon nanotube dosimetry: from workplace 
exposure assessment to inhalation toxicology. Particle and Fibre Toxicology 2013, 10. 
48.  Hubbs, A.; Greskevitch, M.; Kuempel, E.; Fernando, S.; Toraason, M., Abrasive blasting 
agents: designing studies to evaluate relative risk. . Journal of Toxicology and Environmental 
Health, Part A 2005, 68, 999-1016. 
49.  Eldawud, R.; Stueckle, T. A.; Manivanna, S.; Elbaz, H.; Chen, M.; Rojanasakul, Y.; Dinu, 
C. Z., Real-time analysis of the effects of toxic, therapeutic and sub-therapeutic concentrations of 
digitoxin on lung cancer cells. Biosensors and Bioelectronics 2014, 59, 192-199. 
50.  Yin, L. M.; Wei, Y.; Wang, Y.; Xu, Y. D.; Yang, Y. Q., Long term and standard 
incubations of WST-1 reagent reflect the same inhibitory trend of cell viability in rat airway 
smooth muscle cells. International Journal of Medical Sciences 2013, 10 (1), 68-72. 
51.  Giaever, I.; Keese, C. R., Micromotion of mammalian cells measured electrically. 
Proceedings of the National Academy of Science 1991, 88, 7896-7900. 
52.  Zhang, X.; Rongjing, X.; Zenggang, W.; Zhou, C., The synthesis and characterization of 
polyurethane/clay nanocomposites. Polymer International 2003, 52, 790-794. 
53.  Saikia, B. J.; Parthasarathy, G., Fourier Transform Infrared Spectroscopic 
Characterization of Kaolinite from Assam and Meghalay, Northeastern India. Journal of Modern 
Physics 2010, 1, 206-210. 
54.  Bishop, J.; Madejova, J.; Komadel, P.; Froschl, H., The influence of structural, Fe, Al, and 
Mg on the infrared OH bands in spectra dioctahedral smectites. Clay Minerals 2001, 37, 607-616. 
55.  Shameli, K.; Ahmad, M. B.; Zargar, M.; Yunus, W.; Ibrahim, N. A.; Shabanzadeh, P.; 
Moghaddam, M. G., Synthesis and characterization of silver/montmorillonite/chitosan 
bionanocomposites by chemical reduction method and their antibacterial activity. . International 
Journal of Nanomedicine 2011, 6, 271-284. 
56.  Xie, W.; Gao, Z.; Pan, W.; Hunter, D.; Singh, A.; Vata, R., Thermal degradation chemistry 
of alkyl quaternary ammonium montmorillonite. Chemistry of Materials 2001, 13, 2979-2990. 
64 
57.  Rahimi-Razin, S.; Salami-Kalajahi, M.; Haddadi-Asl, V.; Roghani-Mamaqani, H., Effect 
of different modified nanoclays on the kinetics of preparation and properties of polymer-based 
nanocomposites. Journal of Polymer Research 2012, 19, 1-16. 
58.  Ribeiro, S. P. S.; Estevao, L. R. M.; Nascimento, R. S. V., Effect of clays on the fire-
retardant properties of a polyethlenic copolymer containing intumescent formulation. Science and 
Technology of Advanced Materials 2008, 9, 1-7. 
59.  Kendall, M.; Hodges, N. J.; Whitwell, H.; Tyrrell, J.; Cangul, H., Nanoparticle growth and 
surface chemistry changes in cell-conditioned culture medium. Philosophical Transactions of the 
Royal Society B: Biological Sciences 2015, 370 (1661). 
60.  Lordan, S.; Higginbotham, C. L., Effect of serum concentration on the cytotoxicity of clay 
particles. Cell Biology International 2012, 36, 57-61. 
61.  Kuhlbusch, T. A. J.; Asbach, C.; Fissan, H.; Göhler, D.; Stintz, M., Nanoparticle exposure 
at nanotechnology workplaces: A review. Particle and Fibre Toxicology 2011, 8 (22). 
62.  Jensen, K. A.; Koponen, I. K.; Clausen, P. A.; Schneider, T., Dustiness behaviour of loose 
and compacted Bentonite and organoclay powders: What is the difference in exposure risk? 
Journal of Nanoparticle Research 2009, 11, 133-146. 
63.  Tsai, C.; Huang, C.; Chen, S.; Ho, C.; Huang, C.; Chen, C.; Chang, C.; Tsai, S.; 
Ellenbecker, M. J., Exposure assessment of nano-sized and respirable particles at different 
workplaces. Journal of Nanoparticle Research 2011, 13, 4161-4172. 
64.  Kim, W.; Lee, D. W.; Lee, S., Size Characterization of Incinerator Fly Ash Using 
Sedimentation/Steric Field-Flow Fractionation. Analytical Chemistry 2002, 74 (848-855). 
65.  Chang, F.; Wey, M., Comparison of the characteristics of bottom and fly ashes generated 
from various incineration processes. Journal of Hazardous Materials 2006, B138, 594-603. 
66.  Siegrist, K. J.; Reynolds, S. H.; Kashon, M. L.; Lowry, D. T.; Dong, C.; Hubbs, A. F.; 
Young, S.; Salisbury, J. L.; Porter, D. W.; Benkovic, S. A.; McCawley, M.; Keane, M. J.; 
Mastovich, J. T.; Bunker, K. L.; Gena, L. G.; Sparrow, M. C.; Sturgeon, J. L.; Dinu, C. Z.; Sargent, 
L. M., Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses. Particle 
and Fibre Toxicology 2014, 11 (6). 
67.  Schinwald, A.; Murphy, F. A.; Jones, A.; MacNee, W.; Donaldson, K., Graphene-Based 
Nanoplatelets: A New Risk to the Respiratory System as a Consequence of Their Unusual 
Aerodynamic Properties. ACS Nano 2012, 6, 736-746. 
65 
68.  Gangwal, S.; Brown, J. S.; Wang, A.; Houck, K. A.; Dix, D. J.; Kavlock, R. J.; Cohen 
Hubal, E. A., Informing selection of nanomaterial concentration for ToxCast in vitro testing based 
on occupational exposure potential. Environmental Health Perspectives 2011, 119, 1539-1546. 
69.  Benson, K.; Cramer, S.; Galla, H., Impedance-based cell monitoring: barrier properties 
and beyond. Fluids and Barriers of the CNS 2013, 10 (5), 1-11. 
70.  Arndt, S.; Seebach, J.; Psathaki, K.; Galla, H.; Wegener, J., Bioelectrical impedance assay 
to monitor changes in cell shape during apoptosis. Biosensors and Bioelectronics 2004, 19, 583-
594. 
71.  Xiao, C.; Luong, J. H. T., Assessment of cytotoxicity by emerging impedance 
spectroscopy. Toxicology and Applied Pharmacology 2005, 206, 102-112. 
72.  Male, K. B.; Lachance, B.; Hrapovic, S.; Sunahara, G.; Luong, J. H. T., Assessment of 
Cytotoxicity of Quantum Dots and Gold Nanoparticles Using Cell-Based Impedance 
Spectroscopy. Analytical Chemistry 2008, 80, 5487-5493. 
73.  Lo, C.; Keese, C. R.; Giaever, I., Impedance Analysis of MDCK Cells Measured by 
Electric Cell-Substrate Impedance Sensing. Biophysical Journal 1995, 69, 2800-2807. 
74.  Driscoll, K. E.; Carter, J. M.; Howard, B. W.; Hassenbein, D. G.; Pepelko, W.; Baggs, R. 
B.; G., O., Pulmonary Inflammatory, Chemokine, and Mutagenic Responses in Rats after 
subchronic inhalation of carbon black. Toxicology and Applied Pharmacology 
 1996, 136, 372-380. 
75.  Frisch, S. M.; Francis, H., Disruption of Epithelial Cell-Matrix Interactions Induces 
Apoptosis. The Journal of Cell Biology 1994, 124 (4), 619-626. 
76.  Re, F.; Zanetti, A.; Sironi, M.; Polentarutti, N.; Lanfrancone, L.; Dejana, E.; Colotta, F., 
Inhibition of Anchorage-dependent Cell Spreading Triggers Apoptosis in Cultured Human 
Endothelial Cells. The Journal of Cell Biology 1994, 127, 537-546. 
77.  Dong, C.; Kashon, M. L.; Lowry, D. T.; Dordick, J. S.; Reynolds, S. H.; Rojanasakul, Y.; 
Sargent, L. M.; Dinu, C. Z., Exposure to Carbon Nanotubes Leads to Changes in the Cellular 
Biomechanics. Advanced Healthcare Materials 2013, 2, 1-7. 
78.  Shen, Y.; Leng, M.; Yu, H.; Zhang, Q.; Luo, X.; Gregersen, H.; Wang, G.; Liu, X., Effect 
of Amphiphilic PCL-PEG Nano-Micelles on HEpG2 Cell Migration. Macromolecular Bioscience 
2015, 15, 372-384. 
66 
79.  Zou, J.; Wang, X.; Zhang, L.; Wang, J., Iron Nanoparticles Significantly Affect the In 
Vitro and In Vivo Expression of Id Genes. Chemical Research in Toxicology 2015, 28, 373-383. 
80.  Zhou, X.; Wang, B.; Chen, Y.; Mao, Z.; Gao, C., Uptake of Cerium Oxide nanoparticles 
and their influences on functions of A549 cells. Journal of Nanoscience and Nanotechnology 2013, 
13, 204-215. 
81.  Hussain, S.; Thomassen, L. C. J.; Ferecatu, I.; Borot, M.; Andreau, K.; Martens, J. A.; 
Fleury, J.; Baeza-Squiban, A.; Marano, F.; Boland, S., Carbon black and titanium dioxide 
nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells. Particle and Fibre 
Toxicology 2010, 7 (10). 
82.  Janer, G.; Fernández-Rosas, E.; Mas del Molino, E.; González-Gáalvez, D.; Vilar, G.; 
López-Iglesias, C.; Ermini, V.; Vázquez-Campos, S., In vitro toxicity of functionalised nanoclays 
is mainly driven by the presence of organic modifier. Nanotoxicology 2014, 8, 279-294. 
83.  Yoshida, T.; Yoshioka, Y.; Matsuyama, K.; Nakazato, Y.; Tochigi, S.; Hirai, T.; Kondoh, 
S.; Nagano, K.; Abe, Y.; Kamada, H.; Tsunoda, S.; Nabeshi, H.; Yoshikawa, T.; Tsutsumi, Y., 
Surface modification of amorphous nanosilica particles suppresses nanosilica-induced 
cytotoxicity, ROS generation, and DNA damage in various mammalian cells. Biochemical and 


















Early Assessment and Correlations of Nanoclay’s Toxicity to their Physical 
and Chemical Properties 
 
Abstract 
Nanoclays’ functionalization with organic modifiers increases their individual barrier 
properties, thermal stability, and mechanical properties and allows for ease of implementation in 
food packaging materials or medical devices. Previous reports have showed that while organic 
modifiers integration between the layered mineral silicates leads to nanoclays with different 
degrees of hydrophobicity that become easily miscible in polymers, they could also pose possible 
effects at inhalation or ingestion routes of exposure. Through a systematic analysis of 3 organically 
modified and one pristine nanoclays, we aimed to relate for the first time the physical and chemical 
characteristics, determined via microscopical and spectroscopical techniques, with the potential of 
these nanoclays to induce deleterious effects in in vitro cellular systems, i.e. immortalized and 
primary human lung epithelial cell lines. In order to derive information on how functionalization 
could lead to toxicological profiles throughout nanoclays’ life cycle, both as-received and 
thermally degraded nanoclays were evaluated. Our analyses showed that the organic modifiers 
chemical composition influenced both the physical and chemical characteristics of the nanoclays, 
as well as their toxicity. Overall, nanoclays with organic modifiers containing bio-reactive groups 
displayed lower cellular numbers as well more elongated cellular morphologies relative to the 
pristine clay and the nanoclay containing a modifier with long carbon chains. Additionally, thermal 
degradation caused for loss of the organic modifiers, as well as changes in size and shape of the 
nanoclays, which led to changes in toxicity. Our study provides insight into the synergistic effects 
of chemical composition, size, and shape of the nanoclays and their toxicological profiles in 
conditions that mimic exposure in manufacturing and disposal environments respectively, and can 
help aid in safe-by-design manufacturing of nanoclays with user-controlled functionalization and 





With an estimated growth rate of about 25% annually,1 nanocomposites or composites 
containing nanoclays incorporated into polymers, are expected to have wide implementation in 
commercial and industrial products,2 from food packaging materials3 to automotive4 and medical 
devices.5  In food packaging for instance, nanoclays are organically modified to allow for better 
exfoliation within the polymer matrix4 at a low silicate weight percent,6 leading to commercial 
applications of almost 70% of the market volume.7 The organic modification generally occurs via 
an ion exchange reaction with the positively-charged ions present between the nanoclay platelets4  
and directly impacts  the type of polymer the clay can be exfoliated in, as well as the properties of 
the resulting nanocomposite. The increased implementation of nanoclays is a result of the 
improved mechanical strength,8 barrier properties,8 UV dispersion,9 and fire resistance,10 that they 
inflict to the polymeric packaging materials thus reducing gas and moisture permeability,11 
allowing for a longer shelf life4 while still producing a lightweight,12 transparent13 material capable 
of withstanding physical manipulation12 and other environmental elements, such as light and 
heat.12  
Some of the most common nanoclays used in food packaging are Nanomer I.31PS, 
Nanomer I.34TCN, and Nanomer I.44P respectively. These nanoclays, belonging to the 
montmorillonite (MMT) clay ”family”, are made up of 2:1 phyllosilicates consisting of 2 silicate-
oxygen tetrahedral sheets bounding an aluminum octahedral sheet,14 with each of the clays 
containing a different organic modifier that tailors its name as well as its exfoliation ability in the 
specific types of polymer matrices.12 Specifically, Nanomer I.31PS is modified with 
aminopropyltriethoxysilane and octadecylamine, while Nanomer I.34TCN and Nanomer I.44P are 
modified with methyl dihdroxyethyl hydrogenated tallow ammonium and dimethyl dialkyl amine 
respectively. Previous results showed that upon such modifications, Nanomer I.31PS and Nanomer 
I.44P can be exfoliated in polyethylene15 and polypropylene16 to result in composites with 
increased Young’s15,17 and storage moduli,15  thermal stability,17 and tensile strengths17 that 
ensures enhanced shelf life of food packaging products. Complementary, addition of Nanomer 
I.34TCN into polylactide acid18,13 has resulted in nanocomposites with increased barrier 
properties,18,13 thermal stability,18 and tensile modulus,18 along with high transparency13 thus 
making Nanomer I.34TCN a good candidate for the green food packaging area, i.e., using 
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biodegradable polymers from renewable resources to allow for a more environmental friendly food 
packaging material formation.  
Previous reports showed that manufacturing and disposal of nanocomposites used in food 
packaging applications could possibly lead to nanoclays being released from their polymer 
matrix,19,20 which can pose health concerns if the exposure is via inhalation or ingestion routes. 
General in vitro assessment has found that both pristine and organically modified nanoclays cause 
decreased cellular proliferation,21 mitochondrial damage,22 reactive oxygen species (ROS) 
generation,22 membrane22 and DNA damage,23 micronuclei induction,24 and changes in mRNA 
expression,24 in lung epithelial cells,21,25 liver cells,22 colon cells,23 or skin cells,25 with the degree 
of toxicity dependent on the cell type, dosage, and the organic modifier itself. Complementary, in 
vivo results revealed significant toxic effects through alteration of protein expressions after 
organically modified nanoclay was administered orally to rats,26 as well as robust inflammatory 
responses characterized by transient neutrophilia for instance.27 
However, while such reports hint at varying degrees of toxicity, minimal information is 
available to compare and contrast the effects of the unique physico-chemical properties of the 
nanoclays across their lifecycle and their effects on biological responses which may differ in 
degree and mechanism of toxicity due to each clay’s unique properties and organic 
functionalization. During their as-received usages in free forms in manufacturing environments, 
workers could potentially be exposed to elevated levels of the airborne nanoclays.28, 29 In addition, 
high temperatures and the oxidative environment present during the incineration process 
associated with their disposal19 can lead to changes in both chemical composition and surface 
morphology of nanoclays,20,30 that could potentially change their toxicological effect. Establishing 
life cycle toxicity assessment profiles are essential to prevent deleterious effects associated with 
inhalation of such particles by workers in both manufacturing and disposal environments. 
Specifically, Yuwen et al, observed DNA damage in blood cells for workers exposed to high levels 
of bentonite particles in factories producing such particles.29 
We designed a systematic study to help determine the potential for inhalation toxicity of 
the three organically modified Nanomer nanoclays currently used for food packaging applications. 
Our study uses human immortalized bronchial epithelial cells (BEAS-2B),  and  primary small 
airway epithelial cells (SAECs), as established cell lines for assessing toxicity induced via 
inhalation since they have previously helped assess toxicity of graphene nanoparticles,31 asbestos32 
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and carbon nanotubes.33 The SAECs model expands the impact of our study to a more human-
related biological platform as primary cells more closely mimic their tissue of origin and further, 
reduce misidentification, contamination,34 general genetic instability,35 or lack of functions and 
markers often encountered with immortalized cellular systems. Additionally through the use of 
two epithelial lung cell lines we will be able to further assess the potential toxicity of nanoclays 
when they deposit in both the bronchioles and distal airways near the terminal bronchiole and 
alveolar duct. Our systematic assessment will map and correlate the physical and chemical 
properties of nanoclays at two points in their life cycle (i.e. production/manufacturing or the end 
of their life cycle) with their potential to induce toxicity for a better understanding of how 
nanoclays’ deleterious interactions with the cellular systems can be reduced so safe, yet effective 
materials can be produced and implemented in commercial sectors.  
 
Materials and Methods 
Nanoclay Preparation 
Four types of commercially available, raw (as-received), montmorillonite (MMT) clays, 
were obtained from Sigma-Aldrich. Per the manufacturer specifications, Nanomer PGV (PGV) is 
an unmodified, hydrophilic bentonite, Nanomer I.31PS (I.31PS) is surface modified with 
aminopropyltriethoxysilane at 0.5-5 wt. % and octadecylamine at 15-35 wt. %, Nanomer I.34TCN 
(I.34TCN) is surface modified with methyl dihdroxyethyl hydrogenated tallow ammonium at 25-
30 wt. % and, Nanomer I.44P (I.44P) is surface modified with dimethyl dialkyl amine at 35-45 wt. 
%.  All the modifications were done at the manufacturing site.  
Thermal Degradation 
Samples of PGV, I.31PS, I.34TCN, and I.44P were thermally degraded using a TGA701 
Thermogravimetric Analyzer from LECO; degradation was used to mimic the disposal generation 
in municipal solid waste plants.19 Differences in mass from unheated samples were monitored as 
a function of temperature and used to calculate % content change. Moisture content of the samples 
(around 0.5 g each) was determined in the 25 ºC to 105 ºC range, in nitrogen, at a rate of 6 ºC/min, 
while high temperature volatile content was determined in the 105 ºC to 950 ºC range, in nitrogen, 
at a rate of 43 ºC/min. Finally, ash content was determined in the 550 ºC to 900 ºC range, in oxygen, 
at a rate of 15 ºC/min (Table S1). The resulting individual byproduct was collected to serve as the 
end of life cycle sample assessment, i.e., thermally degraded Nanomer PGV (PGV900), thermally 
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degraded Nanomer I.31PS (I.31PS900), thermally degraded Nanomer I.34TCN (I.34TCN900), 
and thermally degraded Nanomer I.44P (I.44P900) respectively. 
Material Characterization 
Molecular composition of the samples and their thermally degraded byproducts in dry, 
powder forms, was determined via Fourier Transform Infrared Spectroscopy (FTIR, Digilab FTS 
7000) equipped with diamond Attenuated Total Reflection (ATR). For each of the samples, a total 
of 100 scans in the range of 4000-400 cm-1 at a resolution of 4 cm-1 were co-added/ averaged to 
form the final spectrum.  
Surface morphology and elemental composition of the samples were investigated using a 
Hitachi S-4700 Field Emission Scanning Electron Microscope (SEM, Hitachi High-Technologies 
Corporation) equipped with an energy dispersive X-ray spectroscopy (EDX) unit. For the analyses, 
dry individual powders were mounted on carbon tape and their surface morphology was examined 
at 5.0 kV, while their elemental composition was evaluated at 20.0 kV. For surface morphology, 
samples were also sputter coated for 10 s in vacuum injected with argon using a gold/palladium 
target. The argon atoms were ionized and collided with the gold/palladium target, causing the 
metal ions to deposit on the sample in a thin conductive layer of about 3 nm as calculated using 
the equation d=KIVt, where d is thickness, k is a constant value of 0.17, I is plasma current, V is 
voltage, and t is the time.  
The size distribution of the nanoclays and thermally degraded byproducts was determined 
by dynamic light scattering (DLS) via the Mastersizer 2000 with a Hydro 2000S accessory 
(Malvern Instruments). For this, samples of PGV, I31PS, I.3TCN, I.44P, PGV900, I.31PS900, 
I.34TCN900, or I.44P900 were dispersed either in Dulbecco’s Modified Eagle Medium (DMEM, 
Life Technologies) containing 5% fetal bovine serum (FBS), or in Small Airway Growth Medium 
(SAGM, Lonza) with SingleQuots Kit (Lonza) containing bovine pituitary extract, hydrocortisone, 
human Epidermal Growth Factor, epinephrine, transferrin, insulin, retinoic acid, triiodothyronine, 
gentamicin/amphotericin-B, and 1 % bovine serum albumin (BSA). Also, the nanoclays and 
byproducts were dispersed in a control, phosphate buffered saline (PBS, Lonza) and in distilled 
water containing 0.15 mg/ml Survanta®, a pulmonary surfactant.36 The solutions were then bath 
sonicated and dropped into the Hydro 2000S until laser obscuration was within 10-20%. The size 
analysis was performed 3 consecutive times with a stirrer speed of 1750 rpm and under continuous 
sonication in the Hydro 2000S accessory.  
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Cell Culture 
Immortalized human bronchial epithelial cells (BEAS-2B) from American Type Culture 
Collection (ATCC) were cultured in 100 mm dishes (Corning, Inc.) in DMEM containing 5% FBS, 
1 % L-glutamine, and 1 % penicillin-streptomycin (all reagents were purchased from Life 
Technologies). The cells were incubated at 37 ⁰C, 5 % CO2, and in an 80 % relative humidity; 
consistent sub-culturing took place using 0.05 or 0.25 % trypsin (Invitrogen). Before each 
experiment, cells were grown to a monolayer of 90-100% confluency and cells in the 3rd-6th 
passage were used. 
Additionally, small airway epithelial cells (SAECs) were cultured in SAGM with 
SingleQuots Kit and 1 % penicillin-streptomycin (Life Technologies). Cells were seeded into T-
25 flasks (Corning, Inc.), grown to 75-80% confluency and subsequently split (5 passages total). 
All experiments completed with SAECs were performed using the same passage number. 
Half Maximal Inhibitory Concentration (IC50) 
BEAS-2B cells and SAECs were seeded into 12 well plates (Thermo Scientific) at densities 
of approximately 1.5x105 and 2.0x105 cells/ml, respectively. After 24 h, the cells were treated with 
PGV, I.31PS, I.34TCN, I.44P or their thermally degraded byproducts at various doses ranging 
from 0 to 197 µg/cm2 (i.e. 0, 0.03, 0.3, 13, 26, 66, 132, and 197 µg/cm2). To ensure an effective 
dose metric and uniform dosage distribution per well, the dose is reported in µg/cm2 with the 
analysis considering the area of the specific well into which the cells were seeded and the initial 
dilution of nanoclays to form µg/ml solutions. Before addition to the respective wells, each 
nanoclay or byproduct sample was sonicated for 10 min in a bath sonicator (2510 Branson; 100 
W) with the concentrations used for exposure being serial dilutions from the original stock; cells 
in only media served as controls. After 24 h of exposure to individual treatment, the treated cells 
(as well as the controls) were washed to remove the nanoclays and byproducts, trypsinized, and 
stained with 0.4% trypan blue solution (Invitrogen). Subsequently, 10 µl of the sample containing 
the stained cells was added to a hemocytometer, and the number of cells in the 4 outer grids was 
counted through the use of the Leica DM IL optical microscope (Leica Microsystems) and a 10X 
objective. Analyses of the cellular proliferation post-exposure were used to extrapolate IC50 values 
that would also be used in the remaining cellular assays. At least 6 replicates were performed for 




To evaluate changes in cell morphology, BEAS-2B cells and SAECs were seeded at 
densities of 1.5x105 and 2.5x105 cells/ml, respectively, in 24 well plates. After 24 h the cells were 
treated with the as-received nanoclays and thermally degraded byproducts, dispersed in media via 
a bath sonicator, at their respective, determined IC50 dose. After 24 h of treatment the cells were 
imaged through use of a Leica DM IL optical microscope (Leica Microsystems) with a 10X 
objective. Two replicates were performed with 10 images, per replicate, taken at random spots 
within the well for each control and treatment. 
Extracellular Reactive Oxygen Species (ROS) 
BEAS-2B cells were seeded into 24 well plates at a density of approximately 1.5x105 
cells/ml. After 24 h, the cells were treated with nanoclays and byproducts dispersed in media 
through use of a bath sonicator at their respective, determined IC50 value; cells exposed to only 
media served as control samples. After 24, 48, and 72 h of treatment, 50 µl of the media was 
transferred from the 24 well plate to its respective well in a black-bottomed 96 well plate (Corning, 
Inc.). Subsequently, 50 µl of PBS was added to each well in the 96 well plate. Fifty µl of the 
extracellular reactive oxygen species (ROS) assay reagent, Lumigen ECL Plus (Lumigen, Inc.), 
was also added to each well. The samples were subsequently incubated at room temperature for 5 
min, in the dark before luminescence was evaluated using a FLUOstar OPTIMA plate reader 
(BMG LABTECH) at 600 nm. Media and treated media containing nanoclays or byproducts 
suspended in solution served as blanks. Respective cellular measurements of the samples were 
evaluated after subtracting the blanks in order to determine the effect treatment had on extracellular 
ROS. It has been determined that Lumigen reagent assays generate chemiluminescent responses 
specific to extracellular ROS.37 Four replicates were performed for each treatment. 
Statistical Analyses 
The cellular experiments were repeated at least 4 times for each one of the samples (with 
the exception of cellular imaging). All tables are presented as the average value (+/-) standard 
deviation (SD) values. All graphs are presented as the mean value of the number of indicated 
replicates with (+/-) standard error (SE) bars. Excel and Origin (OriginLab) were used to determine 
the IC50 value for each of the nanoclays and thermally degraded byproducts, through use of a best-
fit line (either logistic, exponential, or logarithmic) for each individual replicate with each 
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nanoclay or byproduct treatment containing at least 4 replicates. Significance was determined by 
one-way analysis of variance ANOVA with p<0.05* indicating significance.  
 
Results and Discussion 
We aimed to provide insights into the toxicity 
mechanisms associated with human exposure to nanoclays in both manufacturing and disposal 
areas.  For this, we first selected a regiment of four nanoclays, namely one pristine (PGV) and 
three organically modified nanoclays, (I.31PS, I.34TCN, and I.44P), with different physico-
chemical properties and with relevant implementation in current food packaging applications.7 
Specifically, the modifier for I.31PS consists of a long alkyl tail and a silane coupling agent (Figure 
1a).17 I.34TCN’s modifier consists of a long alkyl chain and 2 hydroxyl molecules,17 while, the 
modifier for I.44P consists of 2 long alkyl chains.17  Secondly, we thermally degraded these 
nanoclays in conditions aimed to mimic their disposal at the end of their individual life cycles and 
created resulting byproducts. To assess possible deleterious pulmonary effects, two in vitro cellular 
models were exposed to as-received nanoclays and their incinerated byproducts. Immortalized 
human bronchial epithelial cells (BEAS-2B) and small airway epithelial cells (SAECs), previously 
used for pulmonary toxicity in occupational studies, provide sensitive models for known nanoclay 
deposition areas in the lung38 and serve as validation tool, as toxicity of nanoclays has shown to 
differ based on cell line. The results are included below.   
Materials Preparation and Characterization 
To help evaluate the physico-chemical characteristics of the samples being assessed, we 
compared nanoclays and their byproducts. Specifically, the thermally degraded byproducts of the 
pristine (PGV) and the three organically modified nanoclays (I.31PS, I.34TCN, and I.44P) were 
obtained at temperatures up to 950 °C, in three different temperature regimes known to mimic 
incineration conditions at the end of food packaging product lifecycle19 (Figure 1b).  The moisture, 
high temperature volatiles, and ash contents of the resulting byproducts were determined in the 
range of 25 °C to 105 °C and 105 °C to 950 °C in nitrogen for moisture and volatile contents, while 
ash content was assessed in the range of 550 ⁰C to 900 °C in oxygen respectively. 
Analyses showed that all the modified nanoclays had significantly lower amount of 
moisture relative to the pristine nanoclay (Table 1), presumably a result of their greater 
hydrophobicity resulted from individual chemical functionalization with an organic modifier 
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known to replace adsorbed water normally found in pristine clays,39 therefore minimizing the 
overall amount of free water to be released.40,41 The modified nanoclays also showed a 
significantly higher amount of high temperature volatile content and a significantly lower amount 
of ash content relative to the pristine nanoclay. This is also presumably due to the degradation of 
the organic modifier which has previously been shown to be released within the 200-500 °C 
temperature range.40,41 Further, out of the modified nanoclays themselves, I.44P seemed to have 
the highest amount of high temperature volatile content of around 39 %, along with the lowest 
amount of ash content of around 59 % respectively, presumably due to the chemical structure of 
its organic modifier which is made up of 2 long alkyl chains which differs from the one of I.31PS 
and I.34TCN, each only having one long alkyl chain.17  
 
Table 1: The percent amount of moisture, high temperature volatiles, ash, and fixed carbon present 
in the Nanomer nanoclays as determined by TGA. The symbol * indicates a significant difference 
between PGV and the organically modified nanoclays (n=2). 
  Moisture High Temperature Volatiles Ash Fixed Carbon 
PGV 13.51 +/- 0.71 6.41 +/- 0.06 79.78 +/- 0.67 0.31 +/- 0.10 
I.31PS 0.66 +/- 0.05* 30.53 +/- 0.01* 68.50 +/- 0.05* 0.32 +/- 0.08 
I.34TCN 2.25 +/- 0.27* 26.50 +/- 0.08* 70.69 +/- 0.18* 0.58 +/- 0.16 
I.44P 1.48 +/- 0.13* 39.23 +/- 0.12* 59.20 +/- 0.06* 0.10 +/- 0.06 
 
 
The modified nanoclays also experienced a greater weight loss when compared to pristine 
PGV, all within the temperature range of 400-800 °C (Figure 1b), with I.31PS and I.34TCN 
experiencing similar amounts of weight loss of about 32 and 30 % respectively, while I.44P 
experienced a greater weight loss of around 40 %. The observed differences are presumably due 
to the weight percentages (wt. %) and chemical composition of the individual organic modifiers 
used during functionalization, as well as their roles in the individual nanoclay’s degradation 
profile,41 with I.44P’s organic modifier being added at 45 wt. %, while the organic modifiers of 
I.31PS and I.34TCN were reported to be added up to 40 and 30 wt. %, respectively, via 
manufacturer specifications. Our analyses are supported by Xie et al. that showed that the amount 
of organic modifier released in degradation studies is dependent on the interlayer spacing and 
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architecture of the modifier and its integration during nanoclay functionalization.42 Lastly, PGV 
seemed to have a more gradual weight loss in the 400-800 °C range when compared to the 
functionalized nanoclays, which is probably associated with the MMT structure breakdown in 
which hydroxyl groups incorporated within the crystal lattice are being dehydrated within the 
temperature range of 500-800 ºC.41   
Physico-chemical characterization of the nanoclays and their thermally degraded 
byproducts was performed via Fourier Transform Infrared Spectroscopy (FTIR), scanning electron 
microscopy (SEM) and elemental composition via energy dispersive X-ray spectroscopy (EDX). 
Results of the thermally degraded byproducts are reported relative to the representative non-
degraded form of the respective nanoclay being investigated. Specifically, FTIR analysis of the 
characteristic peak of montmorillonite (MMT) at 1000 cm-1, indicative of Si-O-Si stretching 
vibration of silicates,22,40 was observed for all the nanoclays.  However, the peak was shifted to a 
higher wavelength for the thermally degraded byproducts (Figure 1c,d,e) when compared to their 
as-received counterparts. Further, all of the as-received nanoclays also displayed a peak at 900 cm-
1 indicative of Al-OH-Al deformation of aluminates,22,40,43 while the organically modified as-
received nanoclays displayed a peak at 840 cm-1 presumably resulted from the deformation of OH 
linked to Al3- and Mg2- respectively.43 Previous analysis showed that peaks at 790 and 630 cm-1 
are associated with Si-O groups43 and out of the plane vibration of Al-O group,44 respectively.  
Additionally, the three, as-received, organically modified nanoclays also had peaks at 2920, 
2850, and 720 cm-1 respectively, presumably resulting from the asymmetric and symmetric 
stretching of their C-H groups included in methylene or alkane rock of CH2 for alkanes with 7 or 
more carbons, respectively,22,40,43  and indicative of the incorporation of their respective organic 
modifiers. The 3 peaks were however no longer present in the spectra of the thermally degraded 
byproducts of these nanoclays, confirming their organic modifiers degradation.40 Additionally, the 
peak around 3600 cm-1 with small repeated peaks moving out towards 3800 cm-1 for the as-received 
clays, indicative of silanol groups on the SiO2 tetrahedral sheets,
45 was no longer present for the 
thermally degraded byproducts. Along with the shift recorded for 1000 cm-1 peak, the only other 
peaks remaining for the thermally degraded byproducts were at 780 and 640 cm-1 respectively, and 
are presumably associated with Si-O groups43 and Si-O-Si bending.43 Moreover, the peaks associated 
with Al-OH-Al deformation and OH linked to Al3- and Mg2- were no longer present for any of the 
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Figure 1: (a) Chemical structures of the organic modifiers present in I.31PS, I.34TCN, and I.44P 
(b) Thermal degradation profile of PGV and the 3 organically modified nanoclays (n=2). FTIR 
spectrum for (c) I.31PS, (d) I.34TCN, and (e) I.44P along with their thermally degraded 
byproducts, all relative to PGV and PGV900 (n=2).  
 
SEM surface morphology analyses revealed layered platelet surfaces (Figure 2a-d) for all 
the nanoclays being investigated, with I.44P appearing to have a sharper, more defined platelet-
like geometry when compared to the other nanoclays being investigated. PGV and I.34TCN 
displayed similar morphologies in that their platelet edges seemed smoother, i.e., more rounded, 
relative to I.31PS and I.44P. Also, while I.31PS had a similar morphology to I.44P. It did not seem 




The observed SEM differences are attributed to the presence of the organic modifiers and 
their individual integration since previous analyses have showed that functionalization of pristine 
nanoclays could influence their basal spacing.46 In particular, basal spacing was shown to increase 
with increasing cation exchange capacity of a modifier46 or with increasing its alkyl length.42 Such 
increases are presumably due to lowering of the surface energy of the platelets upon introduction 
of the modifier, thus allowing for their easier separation and better mixing within polymer matrices 
during manufacturing of composites.12 The easier dispersion also was shown to allow for better 
exfoliation within such polymer matrices,4 thus resulting in nanocomposites with enhanced 
properties, such as increased mechanical strength8 and barrier properties,8 when compared to the 
neat polymer.8 Further, previous analysis showed that structure of the nanoclay is influenced by 
the lateral layer arrangements of the modifiers,46 and is also dependent on the concentration of the 
modifier used as well as the degree into which the organic molecules are able to fit/adsorb into the 
nanoclay individual platelet surface.46 
 Thermal degradation caused for a loss in the platelet morphology for all the byproducts 
but I.44P900 which seemed to display platelets with smoother edges, relative to its non-degraded 
form (Figure 2e-h). PGV900 also displayed a smoother surface, while both I.31PS900 and 
I.34TCN900 displayed a fragmented surface, with platelets jutting out, potentially due to slower 
degradation due to the organic modifier. The loss in platelet structure recorded upon thermal 
degradation was most likely caused by the high temperatures encountered which could cause their 
breakdown likely by dehydroxylation of their aluminosilicates’ lattice.42,46 This is supported by 
previous study by Ounoughene et al., who also observed a change in morphology of halloysite 
nanotubes (HNTs) after their exposure to high temperatures (beyond 1000 ºC).20  
Elemental composition analyses (EDX) showed that the as-received organically modified 
nanoclays had significantly higher amount of carbon, relative to their pristine counterparts (Figure 
3a). Additionally, they also had significantly lower amounts of oxygen, sodium, magnesium, 
silicon, and calcium, relative to PGV. These changes in elemental composition further confirmed 
the individual organic modifier functionalization.39 Moreover, EDX analyses showed that 
I.34TCN had a lower amount of carbon and higher amount of oxygen relative to I.44P and I.31PS, 
again, indicative of the presence of the 2 hydroxyl moieties associated with the functionalizing 
modifier.17  Additionally, I.31PS had a higher amount of oxygen relative to I.44P, likely due to the 
presence of the silane coupling agent which contains carbon and oxygen.17  
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After thermal degradation, all of the nanoclays experienced decreases in their respective 
carbon contents (up to 40-60 % loss) and increases of their oxygen (up to 40-85% increase), 
magnesium, aluminum, and silicon contents respectively (Figure 3b). These changes were only 
significant for the organically modified nanoclays, most likely due to the loss of their individual 
organic modifiers. Lastly, the organically modified clays had around 40% decrease in their iron 
contents after thermal degradation. The general trends in elemental composition between PGV and 
the modified nanoclays also persisted after thermal degradation, relative to the as-received forms 
(Table S2). Further, the only significant difference between PGV and PGV900 was an increase in 
magnesium, showing that the organic modifiers played a large role in the changes observed in 
elemental composition due to thermal degradation. 
 
 
Figure 2: Surface morphology of (a) PGV, (b) I.31PS, (c) I.34TCN, and (d) I.44P and thermally 
degraded (e) PGV900, (f) I.31PS900, (g) I.34TCN900, and (h) I.44P900 as determined by SEM. 
 
Dispersity Analysis of Nanoclays and Byproducts 
 Considering that particle size and distribution have been demonstrated to influence the 
toxicity of materials,47 as well as internalization into exposed cells,47 we first assessed nanoclays 
and byproducts dispersion in cellular media. Such analyses were also expected to provide insights 
into any sedimentation and/or possible diffusion of the materials thus helping ensure that there are 
no-mass transfer limitations when exposure to cells is attempted thus limiting an uneven exposure 
and localized toxicological effects.  
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Size distributions of the nanoclays and byproducts were assessed by dynamic light 
scattering (DLS); for this, samples were dispersed in their cell-specific media. A pulmonary 
surfactant (Survanta) of 90 % lipid and 10 % protein was also used, to provide a model of similar 
consistency to the pulmonary surfactant environment of humans.48 How a particle interacts with a 
pulmonary surfactant will affect its deposition on and interaction with lung cells, its clearance, and 
overall alveolar surface tension.49 Analyses are reported relative to control buffer solution 
(phosphate buffered saline: PBS) normally used for cellular studies.  
Overall, the organically modified nanoclays (with the exception of I.44P) had smaller sizes 
in PBS and DMEM, whereas larger sizes were observed when the modified nanoclays were placed 
in SAGM and Survanta respectively, all relative to the pristine nanoclay (PGV; Table S3). 
Specifically, analyses showed that 90 % of the I.44P dispersed in either PBS, DMEM, SAGM, or 
Survanta all had similar sizes and were smaller than 8 µm (Figure 3c). Moreover, 90 % of the 
I.31PS and I.34TCN clays dispersed in either control PBS, DMEM, or SAGM were smaller than 
0.9 µm. Both I.31PS and I.34TCN displayed an increase in size when in Survanta, with 90 % of 
these nanoclays being under 8 µm. Lastly, 90% of the PGV dispersed in either SAGM or Survanta 
were smaller than 0.15 µm. Particle size increased when the nanoclay was placed in PBS and 
DMEM, with 90 % of it ranging under 9 µm for both solutions respectively. The specific 
distribution ranges are summarized in Tables S4-7.  
The observed differences are likely due to the complex interactions of nanoclays with 
proteins and lipids in the media they were dispersed in,50,51 formations of protein corneas,50 or/and 
particle repulsion.52 Specifically, particles that contain long hydrophobic chains, such as I.44P, 
have been previously shown to have increased protein-binding sites53 relative to their more 
hydrophilic counterparts, likely leading to an increased agglomeration via inter-particle-protein 
bridges.54 Additionally, the hydrophobic portions of the proteins may associate with the more 
hydrophobic nanoclays like the I.44P, to further cause for agglomeration.51  
In the case of PGV, the hydrophilic portions of the proteins may also bind strongly to the 
nanoclay’s hydrophilic surface,51 also causing for particle agglomeration as seen in DMEM.50 
However, PGV, had a large decrease in size when placed in SAGM (relative to DMEM), signifying 
the influence of media composition.55 Specifically, since SAGM has a greater variety of proteins 
and growth factors present relative to the DMEM, it could possibly allow for a more varied protein 
adsorption profile to this nanoclay and thus an increase in its dispersity. Similarly, I.34TCN and 
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I.31PS likely had less agglomeration in both DMEM and SAGM due to their relative intermediate 
hydrophobicity relative to PGV, resultant from their organic modifiers functionalization which 
could presumably cause for heterogeneous51 or less protein adsorption55 and thus a better 
dispersion.55 Additionally, their organic modifiers containing hydroxyl (I.34TCN) and amine 
(I.31PS) groups could be more prone to interaction with proteins via hydrogen bonding, van der 
Waals forces, and electrostatic interactions respectively, causing for clay repulsion52 to be recorded 
as an increase in their individual dispersity.  
Overall, solution type did not appear to largely influence the size distributions of the 
dispersed byproducts however it did cause for an increase in the individual particle size 
distributions (Figure 3d). For instance, 90 % of the I.44P900 dispersed in DMEM, SAGM, 
Survanta and PBS were smaller than 9, 10, 11, and 11 µm, respectively. I.31PS900 displayed 
similar size distributions in all 4 solutions, with 90 % of its particles smaller than 9 µm in PBS, 
DMEM, and Survanta and 90 % of its particles smaller than 7 µm in SAGM only. Ninety % of the 
I.34TCN900 dispersed in DMEM, SAGM, or Survanta were smaller than 10, 9, and 11 µm, 
respectively; 90 % of the particles in PBS were smaller than 10 µm. Finally, 90 % of the PGV900 
dispersed in DMEM, SAGM, or Survanta were smaller than 12, 9, and 8 µm, respectively. 
Additionally there was no longer any differences between the organically modified nanoclays (i.e. 
difference in size for I.31PS and I.34TCN relative to I.44P in DMEM, SAGM, and PBS) after 
thermal degradation, further confirming that once the organic modifier was removed and the 
platelet structure was melted and fused, no platelet exfoliation or breakup of loose agglomerates 
might have taken place, thus, the surface chemistry and resulting molecular interactions might 
have changed. In particular, since the byproducts no longer have their organic modifiers present, 
this would likely decrease the amount of adsorbed protein and, dependent on the modifier, the 
variety of proteins being adsorbed, thus in turn decreasing the stability of the suspensions56 and 






   







Figure 3: Elemental composition of (a) as-received nanoclay and (b) their thermally degraded 
byproducts as determined by EDX at 1 µm (n=10). The symbol * indicates significant differences 
between the unmodified clay (PGV/PGV900) and the organically modified clays. Average size of 
<90% of (c) the as-received nanoclays in solutions of PBS, DMEM, SAGM, or Survanta (d) as 
well as their byproducts (n=3).  
 
Lastly, the different size distributions observed for nanoclays or byproducts in Survanta 
could be a result of Survanta’s high content of phospholipids,49 which could largely change the 
agglomeration states of the dispersed materials. Specially, the increased hydrophobicity of the 
modified nanoclays relative to PGV, likely caused for an increased agglomeration and higher 
interactions with the hydrophobic tails of the phospholipids.48 Sauer et al. found similar results for 
hydrophobic nanoparticles that generally seemed to agglomerate more when in the presence of 
lipids and proteins relative to their more hydrophilic counterparts.57  
Toxicity Screening Based on Nanoclays’ Physico-chemical Properties 
Upon dispersity analysis, nanoclays and byproducts dispersed in the complementary media 
were used in different concentrations (i.e., 0-197 µg/cm2) and exposed to human bronchial 
epithelial (BEAS-2B) cells and small airway epithelial cells (SAECs) respectively, for 24 h. The 
dose range was chosen to mimic exposure in manufacturing and disposal condition areas, with 
light exposure being defined as minimal concentration that could lead to inhalation in a 
manufacturing or disposal environment and acute exposure being defined as a 45-year working 
lifetime exposure based on 8 h/day and 50 weeks/year taking into account particle and lung 
characteristics.58 The resulting IC50 values (concentration of the nanoclays or byproducts that 
(d) 
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inhibit cell growth by 50%) were extrapolated from the dose response trend lines derived from raw 
data (Table S8). IC50 is an acceptable mean for early measure and comparison of particle 
cytotoxicity,59 and could help identify early deleterious mechanisms associated with nanoclays 
exposure to cellular systems.  
Overall, the as-received nanoclays, with the exception of I.44P in SAECs, displayed a 
greater cytotoxicity relative to their thermally degraded byproducts when exposed to both BEAS-
2B cells and SAECs respectively (Figure 4a). In addition, organically modified nanoclays showed 
higher toxicity than their pristine counterpart (PGV), again, with the exception of I.44P in SAECs. 
The byproducts showed similar toxicity with the PGV900 for the BEAS-2B cells (with PGV900 
being the least toxic), while all the byproducts had a similar toxicity to each other for the SAECs. 
The highest degree of toxicity was observed for I.34TCN (which has a long alkyl chain and 2 
hydroxyl molecules),17 followed by lower degrees of toxicity for I.31PS (which has a long alkyl 
tail and a silane coupling agent), and finally I.44P (which has 2 long alkyl chains), in both cell 
lines being investigated. Lastly, SAECs showed a greater sensitivity relative to BEAS-2B cells for 
all the nanoclays and byproducts, with the exception of I.44P.  
We hypothesize that the cytotoxicity differences are based on the different interactions of 
the organic modifiers-functionalized nanoclays that could influence particle’s degree of 
hydrophobicity. Previous studies have showed that such chains could interact with the cell 
membrane lipids to cause for changes in membrane integrity.60  For instance, Farcal et al.  showed 
that TiO2 nanomaterials with a hydrophobic coating were more toxic than their hydrophilic 
counterpart in murine alveolar macrophages.60 Additionally, the increased toxicity of I.34TCN 
relative to I.31PS and I.44P was likely due to the presence of bio-reactive groups, such as hydroxyl 
present in its organic modifier.  Previous studies on particles containing bio-reactive groups have 
showed similar results,61,62 with analysis showing that such particles could interact with biological 
macromolecules61 such as phospholipids and proteins62,63 via hydrogen bonding and electrostatic 
interactions,63 disrupt the cell membranes62,63 and initiate apoptosis.63 For instance, Zhang et al. 
showed a decrease in BEAS-2B cell viability upon their exposure to amorphous silica 
nanoparticles with increased hydroxyl contents.62 Das et al. found that graphene sheets containing 
reactive hydroxyl functional groups were more toxic than sheets without these groups and of the 
same sizes,61 while Zhang et al. showed that hydroxyl groups can generate reactive oxygen species 
(ROS)62 to be responsible for damage to macromolecules, such as nucleic acids, proteins, and 
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lipids, and for deregulation of cellular signaling pathways associated with cell proliferation, 
survival, and mitochondrial oxidative stress.64  
While I.31PS did not contain hydroxyl groups, it did contain a silane coupling agent 17 and 
an amine group which were shown to also be capable of binding to both organic and inorganic 
compounds,65 to allow for interactions with biological molecules containing hydroxyl groups66 as 
well as the negatively charged cell membrane.67 Positively charged particles such as the silane 
terminated amine groups in I.31PS will also have a better cell internalization68 which could further 
contribute to its observed increased toxicity.63 While the interchange of bio-reactive groups with 
long alkyl chains has showed a decrease in toxicity, as observed by the reduction in toxicity of 
I.44P relative to the other two organically modified nanoclays and by previous studies,68 their 
presence on particles still caused toxicity most likely because of disturbances of hydrophobic 
interactions between the lipids and proteins and possibly induced changes in cell signaling.69  
The byproducts were less toxic relative to their as-received counterparts in both cell lines 
(except for I.44P/I.44P900 in SAECs). This is presumably due to the recorded loss of their organic 
modifiers,25,23,22 reduction of their iron contents, and changes in their platelets morphology21 as 
demonstrated by the SEM and EDX analyses or to the loss of the silanol groups on the SiO2 
tetrahedral sheets of the nanoclays45 as demonstrated by the FTIR analysis. Specifically, our EDX 
analysis confirmed that iron decreased by around 40% in the byproducts thus causing for lower 
toxicity as supported by previous analysis that showed that high levels of iron promote cell death,70 
and decrease ATP production.71 Complementary, silanol groups (especially the disorganized 
silanols) have been previously hypothesized to contribute to SiO2 toxicity.
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Along with the presence of the organic modifiers, the size and general solubility of the 
nanoclays and byproducts may also be contributing to the observed differences in cytotoxicity. As 
seen by the DLS measurements, smaller sized nanoclays (I.34TCN and I.31PS) seemed to show 
an increase in cytotoxicity relative to the larger as-received nanoclays (PGV and I.44P) as well as 
their byproducts presumably due to a resultant higher surface area73 or higher degree of uptake.74,75 
Results are consistent with previous analysis;74 specifically, Napierska et al. found that smaller 
sized particles (14-16 nm diameter) were more toxic relative to their larger sized counterparts (19-
335 nm), as well as were internalized by human endothelial cells at a faster rate.74 Additionally, 
Lin et al. found that smaller Stöber silica nanoparticles had higher hemolytic activity than larger 
counterparts, most likely resulting from a larger surface area of such particles.75 However, PGV 
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displayed the smallest size distribution in SAGM (media for SAECs), yet still had a lower degree 
of toxicity relative to I.34TCN and I.31PS, showing that the chemical composition of the organic 
modifiers also plays a large role in the toxicity profiles of these nanoclays, as detailed above. The 
resultant smaller size of PGV could have attributed to it having a higher degree of toxicity relative 
to I.44P though in SAECs, which was not observed in the BEAS-2B cells when I.44P and PGV 
had a similar size distribution.  
Overall, SAECs showed a greater sensitivity (of about 4 to 5 times) for all the clays (except 
I.44P), while the sensitivity of the primary cells exposed to byproducts was only about 2 to 4 times 
higher relative to BEAS-2B cells. This is presumably due to the fact that primary cells more closely 
mimic their tissue of human origin; contrary, their immortalized counterparts can undergo 
mutations as well as contain viral genes to influence their overall stability thus reducing their 
susceptibility to external agents used for toxicity analysis.34 Further, immortalized cell lines 
generally are not as genetically stable as primary cells and lack function and markers often seen in 
vivo.35 Our results confirm previous experiments in which primary cells displayed a higher degree 
of toxicity when compared to immortalized cell lines upon exposure to nanoparticles with similar 
aspect ratios.38 Moreover, the general trends in our experiments remained the same between the 2 
cell lines showing validation of the obtained results and overall confirming that such cell-based 
systems are suitable models for assessing inhalation toxicity in vitro.  
Changes in IC50 were complemented by the changes in cell morphology (Figure 4b) which 
is known to be an indicator of overall cell health.76,77 Specifically, treatment with the nanoclays 
and byproducts caused for changes in the cellular shape of both cell types relative to the control, 
more so for the BEAS-2B. These cells were more stretched, thin-like structures relative to the more 
oval shapes displayed by the controls (especially in regards to their exposure to the byproducts). 
When comparing BEAS-2B with the primary cells, there was observed that the immortalized cells 
had a more stretched profile. Generally, treatment with PGV produced more circular cells than any 
of the other treatments, in both cell lines and also a lower cell confluence especially in primary 
cells, likely serving as a signal of cell death and thus complementing our IC50 values as well as 
possibly indicating a different mechanistic-based cytotoxic effect.77 A difference in cytotoxic 
mechanism is also supported by different slopes of the dose response curves for PGV compared to 
organically modified nanoclays. For SAECs, exposure seemed to also cause changes in the cell 
membrane, which could then influence cell-cell and cell-substrate interactions.76 Additionally, 
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there were changes in the cell monolayer with all of the treatments causing for a loss of monolayer 
integrity relative to controls for both cell lines being investigated and over 72 h time period 
(Figures S1 and S2). Such changes can further provide insights into the integrity of the tight 
junctions of the epithelial cells and mechanisms of toxicity since it is known that in the lung, the 
epithelial cells serve as a barrier to prevent the entrance of inhaled particles and pathogens.78  
Our results overall hint that treatment with nanoclays or byproducts may cause 
cytoskeleton alterations76 which may eventually lead to changes in cell mechanics,79 
differentiation, and organization.80 Similarly, Snyder et al. showed changes in cellular morphology 
of primary human bronchial epithelial cells, from a cuboidal shape to a spindle-shaped, 
fibroblastoid appearance upon treatment with multi-walled carbon nanotubes.78 Further, our 
systematic analysis showed that the observed differences in cytotoxicity are most likely due to 
synergistic effects resulting from (1) the presence of the organic modifiers and their surface 
chemistry, and/or (2) the individual nanoclay or byproduct particle size and surface area and 
general dispersibility. Synergism has been previously reported for other materials where the 
combined effects of size, shape, solubility, and/or surface functionalization all contributed to the 
toxicity profile of the material.81,82 For instance, Tarantola et al. found that cetyl-trimethyl-
ammonium bromide (CTAB)-coated spherical particles were more toxic than rod-shaped ones, due 
not only due to the shape, but also due to the way such shape influenced cluster formation and 
release of the CTAB.81 Xia et al. found that the composition of metal oxide nanoparticles 
influenced toxicity; however, the degree of toxicity of the metal oxide was also dependent on its 
solubility in the media.82 Based on our results, it is likely that the chemical composition of the 
organic modifier is influencing the degree of toxicity both directly and indirectly due to such 
modifier composition and effect on the size and dispersibility of the nanoclays. Such toxic effects 
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Figure 4: (a) IC50 values (µg/cm
2) for BEAS-2B cells and SAECs treated with as-received 
nanoclays and byproducts. The symbol * and ~ indicate significant differences between the 
unmodified nanoclay (PGV/PGV900) and the organically modified nanoclays and between the as-
received nanoclay and its thermally degraded byproduct, respectively (n≥4 for each treatment). (b) 
(c) 
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Representative optical images of BEAS-2B cells and SAECs treated with as-received nanoclays 
and byproducts at their respective IC50 dose after 24 h of exposure. (c) Extracellular ROS 
production by BEAS-2B cells after treatment with as-received nanoclays and byproducts at their 
respective IC50 dose over 72 h (n=4). 
 
The observed synergism also implies that setting up rather simplistic platforms for toxicity 
evaluation will not provide a realistic or viable assessment strategy. Extracellular quantitative 
luminescence reactive oxygen species (ROS) assays,62 were previously shown to be reliable and 
help provide information on oxidative stress and cellular metabolism64 or damage to 
macromolecules.64 Indeed, our control analysis showed that when using the extracellular ROS 
assay our results were inconclusive (Figure 4c). In particular, there was no significant trend 
observed in the cell response with treatment and moreover, there was a large variability in the 
extracellular ROS production. A similar response was also observed for doses above and below 
the IC50 value for each clay and byproduct (Figure S3). This could be due to the interaction of the 
nanoclays with the reagent. Our study accentuates the controversy of using such reagent for 
toxicity screening, and adds to the bases of other studies that showed22 or did not show83 ROS 
generation for cells exposed to nanoclays. In particular, Maisanaba et al. did not observe any ROS 
generation for Cloisite Na+ and Cloisite 30B in HepG2 cells up to a dose of 88 µg/ml;83 however, 
Lordan et al. found that Cloisite Na+ did cause ROS generation in HepG2 cells at doses 50 µg/ml 
higher.22  
Our study is the first to show that if one is to implement a platform for toxicity screening 
of nanoclays during their lifecycle, the overall functionality of the material needs to be tested, with 
functionality encompassing not only physico-chemical characteristics of the ‘as-produced’ 
material, but also its changes in a variety of conditions that reflect product implementation and 
disposal. Further, our study shows that cellular systems complexity needs to be accounted for, as 
differences in toxicity may be observed between cell lines and could be due to the different cell 
lines sensitivity as well as any related cellular changes upon cell line transformation. Only through 
such a dynamic interplay that could affect both the product “personality” as well as its shelf-life 





 Our study showed that the chemical composition of individual organic modifiers used for 
nanoclays functionalization played large roles in their interactions with cellular systems. 
Specifically, differences in organic modifiers caused differential size distributions in dispersion 
cellular media and differential degrees of toxicity upon their or thermally degraded byproducts 
exposure to lung epithelial cells. The organically modified nanoclays I.34TCN and I.31PS 
displayed the highest degree of toxicity, followed by I.44P, all relative to the pristine PGV. Based 
on the chemical structure of their modifiers, it can be determined that modifiers containing bio-
reactive groups, such as hydroxyl, are more toxic, relative to the modifiers containing long alkyl 
chains, likely due to increased interaction with biological macromolecules. Further, the 
composition of the bio-reactive group was shown to influence toxicity, as the modifier containing 
hydroxyl (I.34TCN) was more toxic relative to the one containing amine and silane (I.31PS). 
Finally, the byproducts displayed a loss in toxicity, likely due to the loss of their organic modifier, 
changes in size, shape, and elemental composition. Such changes in toxicity profiles of the as-
received nanoclays relative to their byproducts emphasize the importance of examining such 
materials at all stages in their life cycle where human exposure might occur. Understanding how 
the physical and chemical properties of such materials influences toxicity can aid in safer design 
functionalities, while still maintaining beneficial properties to make them miscible with polymer 
matrices for food packaging applications.  
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Chapter 3: Early Assessment and Correlations of Nanoclay’s Toxicity to their Physical and 
Chemical Properties 
 
Materials and Methods 
Dispersion analysis 
The size distribution of the nanoclays and thermally degraded byproducts was determined 
by dynamic light scattering (DLS) via the Mastersizer 2000 with a Hydro 2000S accessory 
(Malvern Instruments). For this, samples of Nanomer PGV (PGV), an unmodified, hydrophilic 
bentonite, Nanomer I.31PS (I.31PS), a nanoclay surface modified with 
aminopropyltriethoxysilane at 0.5-5 wt. % and octadecylamine at 15-35 wt. %, Nanomer I.34TCN 
(I.34TCN), a nanoclay surface modified with methyl dihdroxyethyl hydrogenated tallow 
ammonium at 25-30 wt. % and, Nanomer I.44P (I.44P), a nanoclay surface modified with dimethyl 
dialkyl amine at 35-45 wt. %, as well as their thermally degraded byproducts (PGV900, I.31PS900, 
I.34TCN900, or I.44P900 respectively) were dispersed either in Dulbecco’s Modified Eagle 
Medium (DMEM, Life Technologies) containing 5% fetal bovine serum (FBS), or in Small 
Airway Growth Medium (SAGM, Lonza) with SingleQuots Kit (Lonza) containing bovine 
pituitary extract, hydrocortisone, human Epidermal Growth Factor, epinephrine, transferrin, 
insulin, retinoic acid, triiodothyronine, gentamicin/amphotericin-B, and 1 % bovine serum 
albumin (BSA). Also, the nanoclays and byproducts were dispersed in a control, phosphate 
buffered saline (PBS, Lonza) and in distilled water containing 0.15 mg/ml Survanta®, a pulmonary 
surfactant. The solutions were then bath sonicated and dropped into the Hydro 2000S until laser 
obscuration was within 10-20%. The size analysis was performed 3 consecutive times with a stirrer 
speed of 1750 rpm and under continuous sonication in the Hydro 2000S accessory. 
Cell Culture 
Immortalized human bronchial epithelial cells (BEAS-2B) from American Type Culture 
Collection (ATCC) were cultured in 100 mm dishes (Corning, Inc.) in DMEM, containing 5% 
FBS, 1 % L-glutamine, and 1 % penicillin-streptomycin. The cells were incubated at 37 ⁰C, 5 % 
CO2, and in an 80 % relative humidity; consistent sub-culturing took place using 0.05 or 0.25 % 
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trypsin (Invitrogen). Before each experiment, cells were grown to a monolayer of 90-100% 
confluency and cells in the 3rd-6th passage were used. 
Additionally, small airway epithelial cells (SAECs) were cultured in SAGM with 
SingleQuots Kit and 1 % penicillin-streptomycin (Life Technologies). Cells were seeded into T-
25 flasks (Corning, Inc.), grown to 75-80% confluency and subsequently split (5 passages total). 
All experiments completed with SAECs were performed using the same passage number. 
Half Maximal Inhibitory Concentration (IC50) 
BEAS-2B cells and SAECs were seeded into 12 well plates (Thermo Scientific) at densities 
of approximately 1.5x105 and 2.0x105 cells/ml, respectively. After 24 h, the cells were treated with 
PGV, I.31PS, I.34TCN, I.44P, or their thermally degraded byproducts at various doses ranging 
from 0 to 197 µg/cm2. Before addition to the respective wells, each nanoclay or byproduct sample 
was sonicated for 10 min in a bath sonicator (2510 Branson; 100 W) with the concentrations used 
for exposure being serial dilutions from the original stock; cells in only media served as controls. 
After 24 h of exposure to individual treatment, the treated cells (as well as the controls) were 
washed to remove the nanoclays and byproducts, trypsinized, and stained with 0.4% trypan blue 
solution (Invitrogen). Subsequently, 10 µl of the sample containing the stained cells was added to 
a hemocytometer, and the number of cells in the 4 outer grids was counted through the use of the 
Leica DM IL optical microscope (Leica Microsystems) and a 10X objective. Analyses of the 
cellular proliferation post-exposure were used to extrapolate IC50 values that would also be used 
in the remaining cellular assays. 
Cellular Imaging 
 BEAS-2B cells and SAECs were seeded at densities of 1.5x105 and 2.5x105 cells/ml, 
respectively, in 24 well plates. After 24 h the cells were treated with the as-received nanoclays and 
thermally degraded byproducts, dispersed in media via a bath sonicator, at their respective, 
determined IC50 dose. After 24, 48, and 72 h of treatment the cells were imaged through use of a 
Leica DM IL optical microscope (Leica Microsystems) with a 10X objective. Two replicates were 
performed with 10 images, per replicate, taken at random spots within the well for each control 
and treatment.  
Extracellular Reactive Oxygen Species (ROS) 
 BEAS-2B cells were seeded into 24 well plates at a density of approximately 1.5x105 
cells/ml. After 24 h, the cells were treated with nanoclays and byproducts dispersed in media 
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through use of a bath sonicator at doses above and below their respective, determined IC50 value; 
cells exposed to only media served as control samples. After 24, 48, and 72 h of treatment, 50 µl 
of the media was transferred from the 24 well plate to its respective well in a black-bottomed 96 
well plate (Corning, Inc.). Subsequently, 50 µl of PBS was added to each well in the 96 well plate. 
Fifty µl of the extracellular reactive oxygen species (ROS) assay reagent, Lumigen ECL Plus 
(Lumigen, Inc.), was also added to each well. The samples were subsequently incubated at room 
temperature for 5 min, in the dark before luminescence was evaluated using a FLUOstar OPTIMA 
plate reader (BMG LABTECH) at 600 nm. Media and treated media containing nanoclays or 
byproducts suspended in solution served as blanks. Respective cellular measurements of the 
samples were evaluated after subtracting the blanks in order to determine the effect treatment had 















Table S1: Equations used to determine the percent moisture, volatile, and ash present in the 4 
Nanomer nanoclays upon thermal degradation via the TGA701 Thermogravimetric Analyzer. 
Content Equation 
Moisture (([Initial Mass]-[Moisture Mass])/[Initial Mass])*100 
Volatile (([Moisture Mass]-[Volatile Mass])/([Initial Mass])*100 
Ash ([Ash Mass]/[Initial Mass])*100 
 
 
Table S2: Elemental composition of as-received nanoclay and their thermally degraded 
byproducts as determined by EDX at 1 µm (n=10). The symbol * and ~ indicate significant 
differences between the unmodified nanoclay (PGV/PGV900) and the organically modified 
nanoclays and between the as-received nanoclay and its thermally degraded byproduct, 
respectively. 










































































































































































Table S3: Average particle size (µm) of <90 % of the four as-received nanoclays and their 
thermally degraded byproducts in solutions of PBS, DMEM, SAGM, or Survanta with +/- standard 
deviation (n=3). The symbol * and ~ indicate significant differences between the unmodified 
nanoclay (PGV/PGV900) and the organically modified nanoclays and between the as-received 





Table S4: Average particle size (µm) distributions of the 4 as-received nanoclays and their 
thermally degraded byproducts in PBS with +/- standard deviation (n=3). The symbol * and ~ 
indicate significant differences between the unmodified nanoclay (PGV/PGV900) and the 






PGV I.31PS I.34TCN I.44P PGV900 I.31PS900 I.34TCN900 I.44P900 





















































































































Table S5: Average particle size (µm) distributions of the 4 as-received nanoclays and their 
thermally degraded byproducts in DMEM with +/- standard deviation (n=3). The symbol * and ~ 
indicate significant differences between the unmodified nanoclay (PGV/PGV900) and the 





Table S6: Average particle size (µm) distributions of the 4 as-received nanoclays and their 
thermally degraded byproducts in SAGM with +/- standard deviation (n=3). The symbol * and ~ 
indicate significant differences between the unmodified nanoclay (PGV/PGV900) and the 

















































































































Table S7: Average particle size (µm) distributions of the 4 as-received nanoclays and their 
thermally degraded byproducts in Survanta with +/- standard deviation (n=3). The symbol * and 
~ indicate significant differences between the unmodified nanoclay (PGV/PGV900) and the 




Table S8: IC50 values (µg/cm
2
) of BEAS-2B cells and SAECs treated with as-received nanoclays 
and thermally degraded byproducts. 
  BEAS-2B SAECs 
PGV 60.3 13.2 
I.31PS 4.5 1.3 
I.34TCN 2.1 0.5 
I.44P 13.7 14.2 
PGV900 96.3 26.3 
I.31PS900 43.2 21.8 
I.34MN900 51.1 21.6 

































































(a) 24 h  (b) 48 h  (c) 72 h  
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Figure S1: Representative optical images of BEAS-2B cells treated with as-received Nanomer 
nanoclays and thermally degraded byproducts at their respective IC50 doses at  (a) 24 h, (b) 48 h, and 
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Figure S2: Representative optical images of SAECs treated with as-received Nanomer nanoclays 
and thermally degraded byproducts at their respective IC50 doses at (a) 24 h, (b) 48 h, and (c) 72 h 











Figure S3: Extracellular ROS production by BEAS-2B cells after treatment with (a) as-received 
nanoclays above and below their respective IC50 dose and (b) thermally degraded byproducts above 
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Toxicity Assessment of Byproducts Resulted from Nanoclay Composite 
Disposal by Incineration 
 
Abstract 
Addition of nanoclays into a biodegradable polymer matrix leads to nanocomposites with 
increased mechanical strength, barrier properties, UV dispersion, and thermal stability to be used 
in plastics for food packaging applications. Because of the plastics’ relatively high stored energy 
values, such nanocomposites make good candidates for disposal via municipal solid waste plants, 
with the plastics being combusted to allow for the recovery of energy and reduction of waste 
volume of up to 90 %. However, upon nanocomposite disposal at the end of their lifecycle, 
increased concerns related to their potential toxicity arise, especially considering that byproducts 
resulting from nanocomposite incineration could escape disposal filters to cause worker inhalation 
hazards. Herein, we investigated the deleterious effects that a biodegradable polymer polylactic 
acid (PLA)-based nanocomposite containing methyl, tallow, bis-2-hydroxyethyl, quaternary 
ammonium functionalized montmorillonite nanoclay could pose to human lung epithelial cells, 
used as a model for inhalation exposure, at the end of its lifecycle. Chemical (elemental and 
molecular compositions) and physical (morphology, mechanical and optical properties, 
crystallinity and degree of exfoliation of nanoclay in PLA, and hydrodynamic diffusion versus 
projected area of byproducts, respectively) properties were assessed and correlated with the 
toxicological profiles of the end of lifecycle byproduct at different exposure doses. The byproducts 
induced toxic responses, including reductions in cellular viability and proliferation, changes in 
cellular morphology, and cytoskeletal alterations, but only at high doses. Further, the degree of 
dispersion of nanoclays in the polymer matrix appeared to influence both the physical and 
chemical characteristics, thermal degradation, as well as the toxicity. With toxicity of the 
byproduct occurring at high doses, safety protocols should be considered, along with further 
investigation into how the material characteristics of such nanocomposites and their disposal 





Biodegradable polymers such as linear aliphatic thermoplastic polyester1 polylactic acid 
(PLA),2-4 made from renewable resources,2,3,5 have shown good biocompatibility6-8 and 
applicability in food packaging2 and medical areas.7,8 Biodegradable polymers allow for the 
reduction of environmental risks resulting from high greenhouse gas emissions and fossil fuel 
energy usage5 otherwise encountered at the implementation of conventional petrochemical 
polymers such as polyethylene (PE), polyethylene terephthalate (PET), polyvinylchloride (PVC), 
polypropylene (PP), or polystyrene (PS).5,6,9 Additionally, since biodegradable polymers require 
25-55 % less power at their production when compared to the power used to generate petroleum-
based polymers,5 and because of their relatively low production cost resulting from 
implementation of new processing techniques,6 it is expected that biodegradable polymers’ usage 
will increase in the future especially when considering the amount of plastics being needed and/or 
consumed daily.10,11 However, such biodegradable polymers, including PLA, are still brittle6,12,13 
and lack the barrier,4,12 thermal,4,12 and impact resistance properties13 displayed by the 
conventional petroleum-based polymers,6 thus limiting their consumer application.  
Recent studies have showed that incorporation of nanoclays, i.e., layered mineral 
silicates14,15  with a platelet thickness of about 1 nm and lengths and widths in the micron range,16,17 
could enhance polymers’ mechanical strength,18-20  barrier,21,22 and thermal properties6,18,23 when 
mixed at a low weight percent.16,18 When such incorporation is attempted, the nanoclays need to 
be fully exfoliated within the polymer matrix6 to allow for increased interactions with the polymer, 
thus minimizing chain mobility and creating reinforcement effects.18  For the increased 
interactions, such nanoclays need to be functionalized with organic modifiers to allow for the 
required miscibility within the polymer,24,25 as well as a better incorporation/exfoliation.19 One 
example of a nanoclay isolated from the clay fraction of soil14,15 is montmorillonite (MMT) which 
can be easily modified with methyl, tallow, bis-2-hydroxyethyl, quaternary ammonium (to form 
Cloisite 30B (CC)) for facile incorporation within PLA.1,19,26,27 The good miscibility observed 
upon such nanoclay incorporation is presumably due to interactions of the C=O moieties present 
in PLA with its modified hydroxyl groups.1 Due to the resulting increased barrier properties,20,28,29 
UV dispersion,21,30 transparency,31 mechanical strength,28,32 and a longer shelf life,17 polymer-
based nanoclay nanocomposites have shown increased implementation in food packaging with the 
ability to withstand physical stresses associated with transportation and handling.33 Further, PLA-
116 
CC nanocomposites were shown to provide a ”green” packaging material that has a lower 
environmental impact and increased sustainability relative to conventional polymers.1,12,17 Upon 
the end of their use, such nanocomposites are known to either be disposed in the landfills, 
incinerated, or recycled.34,35 However, due to plastics relatively high stored energy values,11 the 
PLA-based nanocomposites make good candidates for disposal via municipal solid waste (MSW) 
plants, with the waste being combusted to allow for the recovery of energy and reduction of volume 
of waste of up to 90 %.11  
Considering the large implementation that is envisioned for such nanocomposites, recent 
research is focused on determining whether they have toxicological profiles. The need to identify 
possible deleterious pathways is driven by the minimal studies on their toxicity in both 
manufacturing and disposal areas, with the available toxicity studies only considering the 
migration extracts from such nanocomposites,36,37 and other numerous results showing that 
nanoclays by themselves can induce toxic effects upon exposure to lung cells38-41 in such areas.42-
44  Specifically, Maisanaba et al. examined the toxicity of migration extracts from a PLA-Clay 1 
(a nanoclay modified with hexadecyltrimethyl-ammonium bromide (HDTA)) and PLA-Clay 2 (a 
nanoclay modified with HDTA and acetylcholine chloride) nanocomposite on Caco-2 and HepG2 
cells and found no significant toxic effects.36 Similarly, Maisanaba et al. examined the toxicity of 
a PLA-Clay 1 migration extract on Wistar rats and found no significant toxic effects.37 However, 
Zia et al. examined the toxicity of nanocomposite films via investigation of cell attachment and 
spreading of L-929 cells on a chitin based polyurethane-bentonite nanocomposite and found that 
nanocomposites with increasing amounts of bentonite had adverse effects on the samples’ 
biocompatibility with less adhesion and dissimilar morphology of the cells relative to control 
cells.45 Complementary, we and others showed that nanoclays by themselves decrease cellular 
proliferation,38,40 cause mitochondrial46 and membrane damage,46,47 induce reactive oxygen 
species (ROS) generation,46 and genotoxic effects, such as micronuclei induction48,49 and changes 
in mRNA expression.48 
Considering that ultrafine and fine-sized particles could result from disposal of 
nanocomposites via MSW plants to potentially escape exhaust filters,42 and that the high 
temperatures encountered in the MSW disposal42 could cause property changes of the incinerated 
material50,51 and could potentially create a byproduct with its own toxicological profile,52,40 we 
aimed to determine the toxicity of incinerated PLA-CC nanocomposites through the use of a model 
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in vitro cell line, human bronchial epithelial cells (BEAS-2B).53 The toxicity of such thermally 
degraded nanocomposites (i.e., herein called byproducts) is expected to allow for correlation 
studies between the consumption/usage and disposal stages during the nanocomposite’s life cycle, 
while also allowing the individual toxicological impacts and material characteristics of the 
components themselves, i.e. PLA and nanoclay, as well as their associated byproducts, to be 
explored. Such a study could potentially lead to mitigation strategies for worker protection and 
controlled land field disposal of byproducts.  
 
Materials and Methods 
Nanocomposite and Incinerated Byproducts Preparation 
Cloisite 30B (CC) was obtained from Southern Clay Products (Gonzales, TX) and, per the 
manufacturer specifications, organically modified via an ion-exchange reaction with methyl, 
tallow, bis-2-hydroxyethyl, quaternary ammonium (Scheme S1). Polylactic acid 6752 (PLA; 
NatureWorks) was melt-mixed with CC loaded at a 5 wt. %, in a Thermo-Haake internal mixer 
operating at 200 ºC and 80 rpm for 5 min. Thin films were then molded at 200 ºC using a 
compression press to form PLA-CC nanocomposites (PLACC), as well as PLA films to be used 
as controls.  
Samples of PLA and PLACC (1 g per sample) were thermally degraded using a TGA701 
Thermogravimetric Analyzer (LECO) to mimic their disposal. To determine the moisture content, 
the samples were heated in nitrogen at a rate of 6 ºC/min and in a range of temperatures from 25 
ºC to 105 ºC. To determine the volatile content, the samples were heated from 105 ºC to 950 ºC, 
also in nitrogen and at a rate of 43 ºC/min. Finally, to determine the ash content, the samples were 
heated from 550 ºC to 900 ºC in oxygen, at a rate of 15 ºC/min. The resulting ash was collected to 
serve as a model of the byproducts resulted from incineration i.e., thermally degraded PLA-CC 
nanocomposite (PLACC900).  
Materials Characterization  
Elemental composition and surface morphology of PLA, PLACC, and PLACC900 were 
investigated using a Hitachi S-4700 Field Emission Scanning Electron Microscope (SEM, Hitachi 
High-Technologies Corporation) equipped with energy dispersive X-ray (EDX) spectroscopy. 
Surface morphology was examined at 5.0 kV while elemental composition was determined at 20.0 
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kV. For the analyses, dry films or powder samples were mounted onto a carbon tape and then 
sputter coated with gold/palladium for 10 s in vacuum injected with argon.  
Molecular composition of the samples was determined using Fourier Transform Infrared 
Spectroscopy (FTIR, Digilab FTS 7000) equipped with diamond Attenuated Total Reflection 
(ATR). Scans were collected in the range of 4000-400 cm-1 at a resolution of 4 cm-1; a total of 100 
scans were co-added to form the final spectrum for each of the samples.  
The crystallinity of PLA and PLACC and the degree of exfoliation of CC in PLACC was 
determined via X-ray diffraction (XRD): PANalytical X’Pert Pro XRD for crystallinity via a Cu-
kα1 8047.2 eV source at 45 kV and 40 mA with a 10 sec/step in a 5-80 º 2θ range and Bruker D8 
Discovery XRD for determination of the degree of exfoliation. For the Bruker XRD, thin films 
were mounted on the sample holder and diffraction was obtained in the 2θ range of 1-10 º at an 
increment of 0.02 º and scan speed of 10 sec/step via a Cu-kα1 8047.2 eV source at 40 kV and 40 
mA. Basal spacing was determined by Bragg’s equation 
nλ=2dsinθ,  
where n is an integer, λ is the wavelength of the X-ray radiation (0.1546 nm), d is the spacing 
between lattice planes, and θ is the measured diffraction angle. 
The absorption spectra for PLA and PLACC was determined in the range of 200-800 nm 
via the Shimadzu UV-Vis spectrophotometer (Shimadzu Scientific Instruments). UV barrier 
properties of the film were determined by measuring transmission at 280 nm, and transparency of 
the films was determined by measuring transmission at 660 nm, also via the Shimadzu UV-Vis 
spectrophotometer.  
The tensile strength, Young’s Modulus, and elongation at break for films of PLA and 
PLACC were evaluated via the Instron E1000 (Instron Corporation) under a 2 kN load cell and 
using the Bluehill 3 software. For this, rectangular films of PLA and PLACC, 5 mm in width x 32 
mm in length x 0.3 mm in thickness, were placed in the Instron grips, and the experiments were 
performed with a crosshead speed set at 5 mm/min. A specimen gauge length of about 25 mm was 
used for each sample upon gripping in the crosshead. 
The size distribution of PLACC900 was determined by dynamic light scattering (DLS) via 
the Mastersizer 2000 with a Hydro 2000S accessory (Malvern Instruments). For this, solutions of 
PLACC900 dispersed and bath sonicated in cell culture media (Dulbecco’s Modified Eagle 
Medium: DMEM) containing 5% fetal bovine serum (FBS) or in phosphate buffered saline (PBS) 
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were dropped into the Hydro 2000S until laser obscuration was within 10-20 %. The size analysis 
was performed 3 consecutive times with a stirrer speed of 1750 rpm and under continuous 
sonication.  
Cell Culture 
Immortalized human bronchial epithelial cells (BEAS-2B) were cultured in DMEM media 
containing 5% FBS, 1 % L-glutamine, and 1 % penicillin-streptomycin (all reagents were 
purchased from Life Technologies). The cells were passaged regularly using 0.25 % trypsin 
(Invitrogen) and incubated at 37 ºC, 5 % CO2, and 80 % relative humidity. Before each experiment 
cells were grown to a confluent monolayer.  
Dose Response Curve (IC50)/ Cell Viability 
BEAS-2B were seeded in a 12 well plate (Falcon) at a density of 2.0x105 cells/ml. After 
24 h, the cells were exposed to PLACC900 from 0-750 µg/ml, with the doses obtained by serial 
dilutions. For this, samples were first sonicated for 8-10 min in media by using a bath sonicator 
(Branson). After 24 h of exposure to PLACC900, the cells were trypsinized and stained with 0.4% 
trypan blue solution (Invitrogen). Subsequently, 10 µl of the sample containing the stained cells 
was added to a hemocytometer (Hausser Scientific), and the number of cells in the 4 outer grids 
was counted through use of the Leica DM IL optical microscope (Leica Microsystems) using a 
10X objective. OriginPro (OriginLab Corporation) software was used to determine the IC50 value 
via fit with a sigmoidal curve. 
In another assay, BEAS-2B were seeded in a 96 well plate (CellTreat Scientific Products) 
at a density of 2.0x105 cells/ml. After 24 h, the cells were exposed to PLACC900 at 100, 300, and 
500 µg/ml dispersed in media following 8-10 min sonication. Cells in only media served as 
controls. The 4-[3-(4-Idophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate 
known as WST-1 assay (Roche, USA) was used to determine cellular metabolic activity since it is 
known that changes in color of such reagent are produced when cellular dehydrogenases of 
metabolically active cells reduce it to formazan.54 Twenty four, 48, and 72 h post exposure to 
PLACC900, 10 µl of WST was added to the wells. Cells (exposed and control) were incubated for 
2 h and absorbance was read at 485 nm using a FLUOstar OPTIMA plate reader (BMG 
LABTECH). Media and PLACC900 byproduct dispersed in media served as blanks with their 
absorbance values being subtracted from the cellular measurements counterparts.  
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Extracellular Reactive Oxygen Species (ROS)   
BEAS-2B were seeded in a 12 well plate at a density of 1.5x105 cells/ml. After 24 h, the 
cells were exposed to 100 or 300 µg/ml of PLACC900 dispersed in media as previously described. 
After 24, 48, and 72 h of exposure, 50 µl of media from each treatment was transferred to a black-
bottomed 96 well plate (Corning, Inc.). Subsequently, 50 µl of PBS and 50 µl of Lumigen ECL 
Plus (Lumigen, Inc.) were added to each well, and the samples were incubated for 5 min in the 
dark. Luminescence was read at 600 nm via the FLUOstar OPTIMA plate reader. Media as well 
as PLACC900 dispersed in media, at each dose, served as blanks. Extracellular reactive oxygen 
species (ROS) was calculated by subtracting PLACC900 luminescence (determined via 
subtraction of media from the PLACC900+media blanks) from the respective cellular 
measurements.  
Cellular Imaging 
BEAS-2B were seeded on glass coverslips (15 mm diameter; Fisher Scientific) in a 12 well 
plate at a density of 1.5x105 cells/ml overnight. The cells were subsequently exposed to 100, 300, 
or 500 µg/ml PLACC900 dispersed in media as previously described. After 24 h, the media was 
removed and the cells were washed two times with Hank’s Balanced Salt Solution (HBSS) 
(Corning, Inc.), fixed with 4% formaldehyde (Sigma-Aldrich) for 15 min and at 37 ºC, and 
subsequently washed 3 more times with HBSS to remove any remaining formaldehyde. The cells’ 
plasma membranes and nuclei were then stained with 3 µg/ml Alexa Fluor 594 wheat germ 
agglutinin (WGA) and 2 µM Hoechst 33342 (Image-iT LIVE Plasma Membrane and Nuclear 
Labeling Kit, Life Technologies), respectively, both dispersed in HBSS, for 10 min and at 4 ºC. 
After incubation, cells were washed 2 times with HBSS, the cover slides were mounted on glass 
coverslips, and imaged under a Nikon Inverted Microscope Eclipse Ti Series (Nikon) and a 40X 
objective. The NIS-Elements BR 3.1 software was used to analyze the size and morphology of the 
cells.  
Electrical Cell-substrate Impedance Testing 
Real-time measurements of BEAS-2B cellular resistance during and after exposure with 
PLACC900 were performed using an electrical cell-substrate impedance sensing instrument 
(ECIS-ZΘ, Applied Biophysics, NY). For such cellular studies, a 96 well plate (96W10idf) that 
contained inter-digitated finger connection electrodes covering an area of about 4 mm2 of each 
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well were used. Before addition of the cells, the electrodes were stabilized for 2 h with 200 µl of 
media to minimize any drift during the experiment.  
For exposure, BEAS-2B were seeded on the ECIS electrodes at a density of 2.0x105 
cells/ml in a volume of 150 µl/well. After 24 h, the cells were exposed to 100, 300, or 500 µg/ml 
of PLACC900, dispersed in media; cells in media served as controls. The resistance of the cells 
was monitored continuously for 72 h. The recovery of the cells was also monitored for 72 h. For 
this, parallel experiments were performed in which, after 24, 48, and 72 h of exposure, the cells 
were trypsinized and counted so that 1.0x105 cells/ml could be added to its respective ECIS well 
at a volume of 150 µl/well.  
Cell Cycle 
BEAS-2B were seeded in a 6 well plate (Corning, Inc.) at a density of 2.5x105 cells/ml; 
cells in media served as controls. After 24 h, the cells were exposed to 1-100 µg/ml (1, 10, 25, 50, 
and 100 µg/ml) of PLACC900 dispersed in media as previously described. After 24 h, the cells 
were washed 2 times with PBS, trypsinized, pelleted, and washed again. The cells were then 
resuspended and fixed with 70 % ethanol overnight at -20 ºC. Subsequently, the cells were pelleted 
and the ethanol decanted. The cells were once again washed and resuspended in 0.2% Tween 20 
(Fisher Scientific) for 15 min at 37 ºC. In another step, PBS was added and the cells were pelleted 
and resuspended in 180 µg/ml Ribonuclease A-PBS (Sigma-Aldrich) for 15 min at room 
temperature. Finally, the DNA of the cells was stained via a 15 min incubation with 75 µg/ml 
propidium iodide solution (Sigma-Aldrich) at room temperature. After incubation, the volume was 
brought up with 300 µl of PBS. The cells’ DNA content was then analyzed via the BD LSRFortessa 
(BD Biosciences) and BDFACSDiva 8.0 software and knowing that the amount of DNA will 
double in the G2 phase when compared with S phase of the cell cycle. There were 20,000 events 
contained in the gated area of the live cell population per sample (formed via forward scatter and 
side scatter) used for analysis.  
Statistical Analyses 
All cellular experiments were repeated at least 4 times for all samples, with the exception 
of cellular imaging which was repeated 3 times. All tables are presented as the average value with 
(+/-) SD values. All graphs are presented as the mean value of the number of indicated replicates 
with (+/-) SE bars. Significance was determined by one- or two-way analysis of variance ANOVA 
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with p<0.05* indicating significance. OriginPro software was used for determination of the IC50 
value for PLACC900 by using a sigmoidal dose response fit on the average of the 5 replicates.  
 
Results and Discussion 
 Considering that nanocomposites (or nanoclay melt-mixed within polymers) have seen 
increased implementation in food packaging,55,56 with such products being disposed by 
incineration because of their energetic costs reduction and cost recovery,11,57 we aimed to design 
a platform for meaningful assessment of possible toxicity profiles. The need for toxicity studies is 
driven by the recent reports that show that nanoparticles resulted from incineration have the 
potential to escape filters in disposal areas42,58 and induce toxic effects on lung cells40,41 of the 
workers present in such environments. However, no reports assess human exposures in such areas.  
To demonstrate the feasibility of the designed platform, we used a model polylactic acid 
(PLA)-based nanocomposite since PLA has seen a high consumer implementation in the food 
packaging industry59,60 due to its known “green polymer” characteristics  and granted approval by 
the Food and Drug Administration.32,61 In the first part of the assessment strategy, we evaluated 
the materials’ and byproduct resulting from incineration characteristics, while in the second we 
assessed  any induced deleterious effects of such byproducts on model human lung cells and 
correlated any  toxicological mechanistic profiles with the starting material or resulting byproducts 
physico-chemical characteristics.  
Materials Characterization 
We first created the PLA-based nanocomposite (PLACC) by melt mixing Cloisite 30B 
(CC) into PLA.62-65 Films formed from solely PLA  served as controls. Consideration was given 
to CC as a model nanoclay because of its good miscibility in PLA,4 large consumer 
implementation,66,67 and the available reports on its toxicity on systems such as liver,68 colon,69 
and lung,40 where it has shown both reductions in proliferation and viability,40,68,69 as well as 
cellular membrane damages,68 changes in cellular morphology,40 and increased reactive oxygen 
species (ROS) generation.70 
We then aimed to mimic the route of disposal by incineration of such nanocomposites using 
conditions encountered in MSW plants.42 Specifically for this, we thermally degraded both 
PLACC and the PLA control films under temperatures ranging from 25 to 950 ºC and then 
evaluated the resulting moisture, volatile, and ash contents. As expected, no ash was obtained upon 
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PLA films incineration, indicating complete degradation of the polymer (Table S1). However, 
PLACC had around 4 % of its weight remaining as ash, likely due to CC, which was added at 5 
wt. %. Additionally, PLACC had a significantly lower amount of volatile content relative to PLA, 
again, presumably due to the presence of such nanoclay. Such results are supported by Koh et al. 
who also showed byproduct formation after degradation at up to 700 ºC of PLA containing either 
Cloisite 15A or Cloisite 20A respectively.71 However, the ash content identified in our study was 
larger when compared to the previous one, most likely because of a more prominent char resistance 
of the CC relative to the other nanoclays71 as dictated by their different thermal stability as resulting 
from their respective organic modifier composition (i.e. amount of volatile compounds present) 
and the wt. % in which the organic modifier was added to them.41 Specifically the organic 
modifiers for Cloisite 15A or 20A respectively are made up of 2 tallow groups when compared to 
CC which is made up of only one tallow group (Scheme S1).71 
Based on our analysis, both PLA and PLACC lost the majority of their weight in the range 
of 300-600 ºC, with PLACC showing a slightly slower degradation rate relative to control PLA 
(Figure 1a). Overall, the differences in degradation rate and onset degradation temperature were 
fairly minimal between PLA and PLACC, showing that the addition of CC did not appear to 
significantly influence PLA’s thermal stability. It is known that thermal stability of 
nanocomposites is generally dependent on the degree of dispersion and wt. % of the nanoclays, 
with a well exfoliated nanocomposite displaying increased stability.72,73 This is presumably due to 
the thermal stability of inorganic materials,71 their interactions with the polymer substrate that 
allow for the formation of char by hindering the release of volatile products,71,73,74 or/and to the 
nanoclays themselves which could potentially be creating a protective barrier when on the surface 
of the nanocomposite.72  
The nanocomposites, control films, and their byproducts resulting from incineration were 
subsequently investigated for their chemical (elemental and molecular compositions) and physical 
(morphology, mechanical and optical properties, crystallinity and degree of exfoliation of CC in 
PLA, and hydrodynamic diffusion versus projected area of byproducts, respectively) 
characteristics.  
For chemical characteristics specifically, the elemental composition of PLA, PLACC, and 
PLACC900 was determined by energy dispersive X-ray (EDX) spectroscopy. Analysis confirmed 
the presence of carbon and oxygen as the majority of the elements for PLA (Figure 1b), as well as 
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a significant decrease in carbon content and increase in oxygen and silicon contents respectively 
in the PLACC nanocomposite presumably resulting from the incorporation of the CC.14 Upon 
thermal degradation, the amount of carbon was significantly decreased, confirming the loss of 
PLA.75 Additionally, PLACC900 had a significantly higher amount of oxygen, magnesium, 
aluminum, silicon, and iron, all relative to PLACC with such elements being associated with the 
presence of the nanoclay itself,14,76 thus signifying that the ash content was made up mostly of the 










Figure 1: (a) Thermal degradation profile of PLA and PLACC as determined by TGA (n=2). 
Chemical characteristics analysis. (b) Elemental composition of PLA, PLACC, and PLACC900 as 
determined by EDX (n=5). The symbol * and ~ indicate significant differences between PLA and 
PLACC and between PLACC and its incinerated byproduct, PLACC900, respectively. (c) FTIR 
spectra for PLA, PLACC, and PLACC900 (n=2).  
 
Molecular composition of the nanocomposites, PLA control films, and PLACC900 was 
determined by Fourier Transform Infrared Spectroscopy (FTIR). PLA and PLACC both displayed 
similar spectra (Figure 1c), as previously reported for PLA itself.21,77-79 Specifically, both PLA and 
PLACC displayed peaks at 1267, 1181, 1090, and 1045 cm-1, indicative of  -C-O- stretching77,78 
and at 1454, 1384, and 1362 cm-1, indicative of symmetric and asymmetric deformational 
vibrations of C-H present in the CH3 groups of the PLA respectively.
21,77-79  Additionally, the peaks 
present at 2995 and 2944 cm-1 and 1747 cm-1 were indicative of -CH- 77-79 and C=O 
stretching,21,78,79 respectively. Finally, the peak at 871 cm-1 was presumably due to -C-C bond 
formation.77,78 Peaks specific for CC did not show up in PLACC likely due to the low concentration 
at which this nanoclay was added when the nanocomposite was formed. Similar results were 
obtained by Moo-Espinosa et al., when CC was exfoliated into segmented polyurethanes at 
concentrations of 2, 6, or 10 wt. %.80  
All of the peaks associated with PLA were no longer present for the byproduct, 




only 2 peaks remaining for PLACC900 were associated with Si-O-Si stretching vibration of 
silicate as indicated by the peak around 1000 cm-1,46,81  and Si-O indicated by the peak observed 
around 780 cm-1.82 Along with the loss of polymer, the nanoclay itself also lost its organic modifier 
as confirmed by the absence of peaks at 2920, 2850, and 720 cm-1.46,81-83 Further, the loss of the 
alumino-silicate lattice normally displayed by MMT was confirmed by the loss of peaks associated 
with Al-OH-Al deformation (900 cm-1)46,81  and OH respectively which was previously linked to 
Al3- and Mg2- (840 cm-1) (Figure S1a).82 
For physical characteristics we considered that thermal degradation led to an ash 
byproduct, as such we only investigated the crystallinity of PLA and PLACC, as well as the degree 
of exfoliation of CC within the polymer, by using X-ray diffraction (XRD) in the 2θ ranges of 5-
80 º and 1-10 º, respectively. In the context of our goal to design a platform for meaningful 
assessment of toxicity, crystallinity was to be evaluated since it has been previously shown to 
influence toxicity,84-86 with crystalline materials being known to produce more oxidant species 
with pronounced deleterious cellular effects.84,86 Also, exfoliation of nanoparticles has previously 
shown to influence toxicity, with studies showing that toxicity generally decreased when 
nanoparticles were properly exfoliated versus when they were in agglomerate forms.87,88 Further, 
both crystallinity and exfoliation have been shown to influence degradation of materials,65,88,89 
which in itself could potentially cause for a differential influence in deleterious effects.90  
Our analysis showed that in the 2θ range of 5-80 º, both PLA and PLACC displayed broad 
peaks around 15.4 and 18.1 º, respectively (Figure S2a), which are characteristic of neat PLA91 
thus confirming the amorphous structure and low crystallinity of the samples80,92 likely induced 
by the high cooling rates used during the molding process of the polymer.93  
No peaks were observed for PLA in the 1 to 10 º 2θ range which was in contrast with CC 
and PLACC which both displayed peaks within that range (Figure S2b). Specifically, CC displayed 
a peak at around 4.8 º, presumably indicating a basal spacing of 1.85 nm.94 This peak was also 
present for PLACC, however at a lower intensity, presumably demonstrating that a small amount 
of the nanoclays were likely agglomerated within the polymer matrix.12 Additionally, PLACC 
displayed peaks at smaller angles, i.e., around 1.8 º (basal spacing of 4.92 nm) and 2.5 º (basal 
spacing of 3.54 nm) respectively, presumably due to the penetration of the polymer chains between 
the nanoclay platelets and thus resulting in increased basal spacing to confirm intercalation or 
exfoliation of the nanoclay within the PLA.12,95-97  
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The CC did not seem to be completely surface exfoliated within PLA,97 as confirmed by 
surface morphology analysis performed by scanning electron microscopy (SEM). Specifically, 
results showed that PLACC displayed a slightly rougher morphology relative to PLA used as 
control (Figure 2a,b). Complementary, upon nanocomposites degradation, the PLACC900 
displayed generally two types of morphologies, namely one with a fragmented surface with 
platelets jutting out, and a second one with a porous conformation (Figure 2c,d). Such different 
morphologies may be due to differential distribution and degrading of the nanoclay within the 
polymer matrix, interactions of the nanoclay with the polymer, and/or the different exfoliation 
noted. Degree of dispersion can be controlled in the future by manufacturing parameters, such as, 
temperature,98 time,22 and feed rate.99 Previous results by Stueckle et al., showed a porous 
morphology if only CC was degraded, with the degraded CC’s (CC900) morphological changes 
being attributed to the interactions of the organic modifier with Si-O and Al-O bonds in the pristine 
clay and an increase in basal spacing of the nanoclay.52 The porous morphology of the degraded 
nanocomposite, PLACC900, could also be attributed to the polymer increasing the basal spacing 
between CC, with the fragmented morphology potentially due to agglomerated CC. Indeed, our 
control experiments of thermally degraded CC (CC900) showed that the main difference between 
the thermally degraded nanocomposite (PLACC900) and CC900 respectively, appeared to be 
related to the physical properties and not changes in the elemental or molecular properties of the 
two samples (Figure S1).  
Additional physical characterizations of transparency and UV dispersion of PLA and 
PLACC provided further insights into the exfoliation of CC into PLA. Both means of 
characterizations have previously been shown to be contributing to overall samples’ physical 
characterization and implementation as they allow for a consumer “to see the product” and for the 
blocking of light/UV transmission to increase product’s shelf life100 by reduction in the UV driven 
lipid oxidation and discoloration.101 Analysis showed that PLA and PLACC displayed similar 
absorbance spectra with peaks around 245 and 270 nm, respectively (Figure S3a). PLACC also 
had a significantly higher transparency than PLA (Table S2) which could indicate a better 
orientation of the PLA upon addition of CC in the nanocomposite volume12,102 since previous 
analysis showed that cast control films typically have a low degree of crystallinity and transparent 
appearance due to the rapid cooling.75 Complementary, both PLA and PLACC generally displayed 
good UV dispersion properties with around 4 and 3 % transmittance, respectively. The slight 
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decrease in PLACC’s UV dispersion relative to PLA was most likely due to the presence of the 
nanoclays which are known to enhance the scattering of the UV light.103 Additionally, upon 
incorporation of CC, PLACC displayed a color change (to a brown color, Figure S3b,c), further 
known to be preferable for preventing UV transmission in food packaging.104 
 
 
Figure 2: Surface morphology of (a) PLA, (b) PLACC, and (c), (d) the two morphologies 
displayed by PLACC900 as determined by SEM. 
 
Mechanical properties analysis of the nanocomposite showed that PLACC had a 
significantly higher Young’s Modulus relative to PLA films, thus indicating that CC interacted 
with the polymer within the volume of the nanocomposite (Table S3).72 However, both elongation 
and tensile strength were lower for the nanocomposites when compared to control, presumably 
due to an uneven dispersion of CC105 and resulting reduction in strength.106 Further, such 
agglomerated nanoclays cause poor interfacial bonding, leading to the formation of 
microcracks,105,107 as well as lower plasticity.108 
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Lastly, the hydrodynamic diffusion versus projected area of byproducts was evaluated via 
dynamic light scattering (DLS) since previous analysis have showed that the size of a particle 
could influence its toxicity109 and internalization profiles.109 Specifically, spherical particles less 
than 10 µm can be inhaled110,111 with particles smaller than 2.5 µm potentially reaching the 
alveoli.110 Further, particles of up to 25 µm in diameter were shown to be deposited in ciliated 
airways if they had a platelet like morphology and a thickness of less than 0.1 µm.112 Our analysis 
showed that PLACC900 displayed size distributions in the micrometer range in both media and 
control buffer, PBS (Figure S4). Specifically, 90 % of the particles were under 13 µm, with 50 % 
of such particles being under 5 µm (Table S4) presumably due to the recorded loss of the organic 
modifier from CC and the majority of the polymer matrix.41  
Toxicity Evaluation 
Thermally degraded PLACC byproduct (i.e., PLACC900) was exposed to model human 
bronchial epithelial cells (BEAS-2B). BEAS-2B were chosen for inhalation toxicity assessment 
due to their ease of handling and previous feasibility studies.113-116  
A dose response curve was initially performed to identify the PLACC900 concentrations 
that would create a differential effect on the cell viability. Specifically, cells were exposed to doses 
of 0.1, 1, 50, 100, 250, 300, 500, and 750 µg/ml for 24 h (Figure 3a). The large number of doses 
was chosen to mimic what a worker might inhale in areas of disposal, where it is known that 
concentrations could vary based on the point of emission, time of day, the amount and 
incorporation of the nanoparticle in the material being disposed, and the amount of the material 
being disposed, respectively.43,117,118 Additionally, such doses represent different working 
lifetimes by taking into account total work hours, and particle and lung characteristics of the 
worker.119  
Analysis showed that the IC50 value (i.e., concentration of PLACC900 required to inhibit 
cell growth by 50%) of PLACC900 was 435 µg/ml. No significant decrease in cell viability was 
observed for cells exposed to 100 µg/ml (below IC50) over the 72 h (Figure 3b). However, after 24 
h of exposure a significant decrease in cellular viability (around 20 and 50 %) was observed for 
cells exposed to PLACC900 at 300 and 500 µg/ml, respectively. This effect continued for BEAS-
2B exposed to 500 µg/ml PLACC900 throughout the 72 h of exposure. When examining the effect 
of doses under the IC50 value of PLACC900 over time on cellular proliferation, there were not any 
significant decreases even after 72 h of exposure (Figure S5).  
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Figure 3: (a) Dose response curve (based on live cell counts) for BEAS-2B cells exposed to 
PLACC900 from 0-750 µg/ml (n=5). (b) Cellular viability (based on WST assay) for cells exposed 
to PLACC900 (n=6). The symbol * indicates a significant difference between the control cells and 
exposed cells. The values are normalized relative to the controls. (c) Extracellular ROS of cells 
exposed to varying doses of PLACC900 (n=4). The symbol * indicates a significant difference 





The decrease in cellular viability could be due to the accumulation of reactive oxygen 
species (ROS) and the effects that such accumulation could induce on the cells.120 In particular, 
previous studies have showed that CC by itself could induce internal ROS70 to lead to cellular 
membrane damage and cell morphology changes from an oval to a more circular profile.121,122 Our 
results showed that the cells exposed to 300 µg/ml PLACC900 had a significant decrease in 
external ROS after 72 h of exposure, indicating that ROS may be building up within individual 
cells,120 to potentially cause damage to internal organelles or cell membrane and shape46 (Figure 
3c). The observed error bars are attributed to the byproducts interaction with the reagent123 or to 
the variability in the surface morphology of the byproduct (Figure S6).38  
Cellular imaging complemented the above results showing a dose-dependent behavior for 
cells exposed to PLACC900 at 100, 300, and 500 µg/ml over a 24 h period (Figure 4a-d). Analysis 
showed that at 24 h of exposure, the control and cells exposed to 100 µg/ml displayed a confluent 
monolayer with oval cells. However, the cells were no longer confluent upon exposure to doses of 
300 µg/ml and higher. Further, the cells seemed to assume irregular shapes, with stretched or 
circular profiles being noted. Cells exposed to 500 µg/ml PLACC900 displayed the greatest loss 
in cell monolayer.  
The observed change in shape as well as the loss of the cellular monolayer and buildup of 
ROS could indicate that cells may have begun to lose their ability to attach to substrates, as well 
as to other cells, two mechanisms hinting at deleterious effects and potential toxicity121,122,124,125 of 
the byproducts. Indeed, our electrical cell-substrate impedance sensing (ECIS) analysis indicated 
that cells exposed to PLACC900 at 100, 300, and 500 µg/ml and subsequently monitored for 72 h 
(Figure 5a) had changes in their resistance pathways which were both time and dose dependent. 
ECIS is known to monitor changes in cell-cell and cell-substrate interactions, cell morphology, 
and coverage in real time,126,127 with such changes being quantitatively analyzed, at a nanoscale 
resolution, and in a non-invasive,123,128 and high-throughput manner.126,127,129,130 Specifically, 
while cells exposed to 100 µg/ml had very similar resistance values relative to the control over the 
whole exposure time, cells exposed to 300 and 500 µg/ml of the byproducts displayed an initial 
increase in resistance, with the increase being more dramatic and longer for the 500 µg/ml dose. 
However, after 24 h, the resistances lowered with such drops in resistance complementing the 




                      
Figure 4: Fluorescent images of the cell membrane (red) and nucleus (blue) for (a) control cells 
and cells exposed to PLACC900 at (b) 100 µg/ml, (c) 300 µg/ml, and (d) 500 µg/ml after 24 h.  
 
The recovery of cells exposed to PLACC900 was also non-invasively monitored with only 
100 and 300 µg/ml doses being used in order to allow for an adequate number of cells to be added 
to the electrodes. Overall, the cells ability to recover was dose dependent. Specifically, analysis 
showed that after 24 h of exposure to 100 and 300 µg/ml of PLACC900, the cells showed lower 
resistance relative to the control (Figure 5b). However, cells exposed to 100 µg/ml PLACC900 
had similar resistances to the control within 48 h of recovery, while cells exposed to 300 µg/ml 
had similar resistances to the control within 60 h of recovery. After a 48 h exposure to PLACC900, 
cells exposed to 100 µg/ml also had slightly lower resistance values relative to the control again 
over the first 48 h of recovery, but eventually had the similar resistances to the control cells by 40 
h of recovery (Figure 5c). Cells exposed to 300 µg/ml of PLACC900 had slightly lower resistances 
relative to the control cells over the full 72 h of recovery. Finally, after 72 h of exposure to the 
byproduct, cells exposed to 100 µg/ml had higher resistances relative to the control for the first 40 
133 
h of recovery, while cells exposed to 300 µg/ml had lower resistances relative to the control over 
the full 72 h of recovery (Figure 5d). Similarly, AshaRani et al. noted that cells exposed to 400 
µg/ml of silver nanoparticles took a month to recover when compared to cells exposed to 100 or 
200 µg/ml which were able to recover within 5 or 15 days, respectively.131  
The ability of the cells to recover was also confirmed by cell cycle analysis (Figure 5e) 
with analysis showing that there were no significant differences in cell cycle phases for G1, G2, 
or S after exposure to any of the doses, all relative to the control cells. While previous studies have 
shown genotoxic effects of nanoclays, ranging from DNA strand breaks68 to condensed 
chromatin132 and micronuclei,133 as well as, changes in gene expression,133 the lack of cell cycle 
arrest and normal progression through the cell cycle for cells exposed to PLACC900 hints at DNA 







    




Figure 5: (a) Representative real-time measurements of normalized resistance for BEAS-2B cells 





measurements of normalized resistance for the recovery of BEAS-2B cells over 72 h after exposure 
to PLACC900 for (b) 24 h, (c) 48 h, and (d) 72 h. (e) Percentage of cells in the G1, G2, or S phase 
of the cell cycle after exposure to 1-100 µg/ml PLACC900 (n=4). 
 
The observed recovery after removal of the exposure could be attributed to a volume-based 
dilution of the internalized byproducts and/or lower toxicity that such byproducts have. First, 
previous analysis showed that internalized gold nanoparticles were devised between the surviving 
cells to lead to a cell recovery profile dependent on the cell growth/division.136 However, in such 
studies, the nanoparticles were around 45 and 13 nm.136  For the second, PLACC900 seems to be 
following a similar toxicity profile to thermally degraded nanoclays which have previously been 
shown to be less toxic relative to their as-received counterparts.40,41 Previous results showed wide 
ranges in toxicity of nanoclays with IC50 values as low as around 1 µg/ml
39 to more than 1000 
µg/ml,137 generally with the organic modifier being the variant.39,68-70 In particular, thermally 
degraded byproducts of one pristine and three organically modified nanoclays had higher IC50s 
relative to their as-received counterparts.41 Such lower toxicity was attributed to loss of the organic 
modifier, along with changes in morphology, size, and molecular and elemental composition of 
the byproduct itself.  Additional changes may exist herein most likely due to morphology, size, or 
potential entrapment of polymer species within the byproduct. For instance, while some of the 
smaller PLACC900 particles may be internalized,138,139 larger particles could disrupt the 
membrane and potentially cause damage88 due to their uneven, jagged profile (SEM),87,88 however 
with such damage to be recovering in a time-dependent manner (real-time analysis). Additionally, 
the variability observed in toxic effects may be due to the different surface morphologies and sizes 
of the byproducts. Finally, PLACC900 itself may have effects similar to that of crystalline silica, 
i.e., inflammation and collagen deposition, since it contains similar CC900 properties previously 
shown to produce a low, persistent inflammation profile in mice.52  
Our results indicate that while more information is required to determine mechanisms for 
nanocomposites degradation and ultimately toxicity of its end of life cycle byproduct, proper 
engineering control and protocols for workers in areas of disposal should be implemented to help 
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Chapter 4: Toxicity Assessment of Byproducts Resulted from Nanoclay Composite 
Disposal by Incineration 
 
Material and Methods 
Nanocomposite Preparation 
Polylactic acid 6752 (PLA) was melt-mixed with Cloisite 30B (CC) loaded at a 5 wt. %, 
in a Thermo-Haake internal mixer operating at 200 ºC and 80 rpm for 5 min. Thin films were then 
molded at 200 ºC using a compression press to form PLA-CC nanocomposites (PLACC), as well 
as PLA films to be used as controls. Cloisite 30B was obtained from Southern Clay Products 
(Gonzales, TX) and, per the manufacturer specifications, organically modified via an ion-exchange 
reaction with methyl, tallow, bis-2-hydroxyethyl, quaternary ammonium at a concentration of 90 
meq/100 g clay. 
Thermal Degradation of PLACC and CC 
PLACC (1 g per sample) and CC (0.5 g per sample) were thermally degraded using a 
TGA701 Thermogravimetric Analyzer (LECO). To determine the moisture content, the samples 
were heated in nitrogen at a rate of 6 ºC/min and in a range of temperatures from 25 ºC to 105 ºC. 
To determine the volatile content, the samples were heated from 105 ºC to 950 ºC also in nitrogen 
and at a rate of 43 ºC/min. Finally, to determine the ash content, the samples were heated from 550 
ºC to 900 ºC in oxygen, at a rate of 15 ºC/min. 
Material Characterization of PLA, PLACC, and Associated Nanoclays or Byproducts 
Molecular composition of CC, thermally degraded CC (CC900), and thermally degraded 
PLACC (PLACC900) was determined using Fourier Transform Infrared Spectroscopy (FTIR, 
Digilab FTS 7000) equipped with diamond Attenuated Total Reflection (ATR). Scans were 
collected in the range of 4000-400 cm-1 at a resolution of 4 cm-1; a total of 100 scans were co-
added to form the final spectrum for each of the samples. Elemental composition of PLACC900  
and CC900 was investigated using a Hitachi S-4700 Field Emission Scanning Electron Microscope 
(SEM, Hitachi High-Technologies Corporation) equipped with energy dispersive X-ray (EDX) 
spectroscopy at 20.0 kV. 
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The crystallinity of PLA and PLACC and the degree of exfoliation of CC in PLACC was 
determined via X-ray diffraction (XRD). The PANalytical X’Pert Pro XRD was used to determine 
crystallinity via a Cu-kα1 8047.2 eV source at 45 kV and 40 mA with a 10 sec/step in a 5-80 º 2θ 
range. The Bruker D8 Discovery XRD was used to determine the degree of exfoliation; thin films 
were mounted on the sample holder and diffraction was obtained in the 2θ range of 1-10 º at an 
increment of 0.02 º and scan speed of 10 sec/step via a Cu-kα1 8047.2 eV source at 40 kV and 40 
mA. Basal spacing was determined by Bragg’s equation 
nλ=2dsinθ, 
where n is an integer, λ is the wavelength of the X-ray radiation (0.1546 nm), d is the spacing 
between lattice planes, and θ is the measured diffraction angle. 
 The absorption spectra for PLA and PLACC was determined in the range of 200-800 nm 
via the Shimadzu UV-vis spectrophotometer (Shimadzu Scientific Instruments). UV barrier 
properties of the film were determined by measuring transmission at 280 nm, and transparency of 
the films was determined by measuring transmission at 660 nm, also via the Shimadzu UV-Vis 
spectrophotometer.  
The tensile strength, Young’s Modulus, and elongation at break for films of PLA and 
PLACC were evaluated via the Instron E1000 (Instron Corporation) under a 2 kN load cell and 
using the Bluehill 3 software. For this, rectangular films of PLA and PLACC, 5 mm in width x 32 
mm in length x 0.3 mm in thickness, were placed in the Instron grips, and the experiments were 
performed with a crosshead speed set at 5 mm/min. A specimen gauge length of about 25 mm was 
used for each sample upon gripping in the crosshead. 
 The size distribution of PLACC900 was determined by dynamic light scattering (DLS) 
via the Mastersizer 2000 with a Hydro 2000S accessory (Malvern Instruments). For this, solutions 
of PLACC900 dispersed and bath sonicated in cell culture media (Dulbecco’s Modified Eagle 
Medium: DMEM) containing 5% fetal bovine serum (FBS) or in phosphate buffered saline (PBS), 
were dropped into the Hydro 2000S until laser obscuration was within 10-20 %. The size analysis 
was performed 3 consecutive times with a stirrer speed of 1750 rpm and under continuous 
sonication.  
Cell Culture 
Immortalized human bronchial epithelial cells (BEAS-2B) were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) containing 5% FBS, 1 % L-glutamine, and 1 % penicillin-
139 
streptomycin (all reagents were purchased from Life Technologies). The cells were passaged 
regularly using 0.25 % trypsin (Invitrogen) and incubated at 37 ºC, 5 % CO2, and 80 % relative 
humidity. Before each experiment cells were grown to a confluent monolayer.  
Live Cell Count 
BEAS-2B were seeded in a 12 well plate (Falcon) at a density of 2.0x105 cells/ml. After 
24 h, the cells were exposed to PLACC900 at 100 and 300 µg/ml, which were first sonicated for 
8-10 min in media via a bath sonicator (Branson). Cells in only media served as controls.  Twenty 
four, 48, and 72 h post exposure to PLACC900 the cells were trypsinized and stained with 0.4% 
trypan blue solution. Subsequently, 10 µl of the sample containing the stained cells was added to 
a hemocytometer, and the number of cells in the 4 outer grids were counted through use of the 
Leica DM IL optical microscope using a 10X objective.  
Reactive Oxygen Species (ROS) Generation of PLACC900  
PLACC900 was dispersed in media via a bath sonicator at doses of 100 and 300 µg/ml. 
The solutions were then placed in a 12 well plate with media only serving as the control. After 24, 
48, and 72 h of incubation at 37 ºC, 5 % CO2, and 80 % relative humidity, 50 µl of the 
PLACC900+media from each dose (and media only as control) was transferred to a black-
bottomed 96 well plate. Subsequently, 50 µl of PBS and 50 µl of Lumigen ECL Plus (Lumigen, 
Inc.) were added to each well, and the samples were incubated for 5 min in the dark. Luminescence 











Table S1: The amount of moisture, volatile, and ash present in PLA and PLACC as determined 
by TGA. The symbol * indicates a significant difference between PLA and PLACC (n=4). 
  Moisture Volatile Ash 
PLA 0.49 +/- 0.18 99.70 +/- 0.27 0 +/- 0 
PLACC 0.60 +/- 0.17 95.37 +/- 0.43* 3.92 +/- 0.10* 
 
 
Table S2: UV dispersion (determined by Transmittance at 280 nm (T280nm)) and Transparency 
(determined by Transmittance at 660 nm (T660nm)) of PLA and PLACC. The symbol * indicates a 
significant difference between PLA and PLACC (n=5). 
  T280nm T660nm 
PLA 3.85 +/- 0.12 4.88 +/- 0.08 
PLACC 3.35 +/- 0.21* 7.11 +/- 0.20* 
 
 
Table S3: Mechanical properties of PLA and PLACC as determined via the Instron. The symbol 
* indicates a significant difference between PLA and PLACC (n=5). 
  Tensile Strength (MPa)  Elongation at Break (mm) Young's Modulus (MPa) 
PLA  81.2 +/- 19.0 0.436 +/- 0.093 9291.3 +/- 850.9 
PLACC 66.8 +/- 22.3 0.270 +/- 0.053* 11055.8 +/- 1517.6* 
 
 
Table S4: Average particle size distributions (µm) of PLACC900 in cellular media and control 







  PBS Media 
<10% 3.00 +/- 0.01 3.12 +/- 0.08 
<50% 4.57 +/- 0.01 4.84 +/- 0.29 
<90% 12.67 +/- 0.03 12.14 +/- 1.14 
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Figure S1: (a) FTIR spectra for CC, CC900, and PLACC900 (n=2). (b) Elemental composition of 













Figure S2: Physical characteristics analysis. (a) Crystallinity of PLA and PLACC as determined 














Figure S3:  (a) Absorbance spectra for PLA and PLACC from 200-800 nm (n=3). Representative 





Figure S4: Average particle diameter size distribution of PLACC900 in cellular media or control 










Figure S6: ROS generation of PLACC900 at varying doses in DMEM (n=6). The symbol * 
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The analysis performed in this thesis showed that nanoclays, throughout their life cycle, 
induced toxic responses upon exposure to lung epithelial cell lines, with such analysis hinting at 
nanoclay’s potential to induce toxicity when inhaled. The effects were more pronounced on small 
airway epithelial cells (SAECs) than on immortalized human bronchial epithelial (BEAS-2B) cells 
since the primary cell lines more closely mimic their tissue of origin. Moreover, our analysis 
showed that a model nanocomposite formed upon incorporation of the nanoclays into a 
biodegradable polymer, polylactic acid, influenced material’s properties throughout its life cycle, 
its degradation, and ultimately toxicity.  In such studies, general toxicological profiles included 
decreases in viability and proliferation of the exposed cells, as well as changes in cellular 
morphology, mitochondrial activity, cellular attachment, and membrane integrity. The differences 
in toxicity were correlated to the physical and chemical properties of the nanoclays or 
nanocomposites and how such changes were influenced by the life cycle. Such differences were 
analyzed and validated through both single point as well as real-time assays. 
 More specifically, our studies were the first to show that thermally degraded nanoclays, 
used to mimic the end of life cycle or the disposal stage of nanoclay systems, had different 
toxicological profiles relative to their as-received counterparts, used to mimic the manufacturing 
stage of the nanoclay systems’ life cycle. Specifically, the thermally degraded nanoclays generally 
showed a lower degree of toxicity relative to their as-received counterparts; this was presumably 
due to changes in their physical and chemical properties upon degradation.  
Moreover, our studies also showed that organically modified nanoclays generally induced 
higher degrees of toxicity in lung cells relative to pristine (non-modified) nanoclays. Further, the 
degree of toxicity of organically modified nanoclays was dependent not only on the presence of 
the organic modifier, but also on the composition of the modifier, with the organic modifier 
directly and indirectly contributing to toxicity via its composition. Briefly, organic modifiers with 
bio-reactive groups (i.e. hydroxyls and amines) showed a greater degree of toxicity relative to 
organic modifiers with long carbon chains. No large differences in toxicity (or chemical properties) 
were however displayed by the organically modified nanoclays’ thermally degraded byproducts, 
further verifying the large role the organic modifier plays towards contributing to physical and 
chemical properties and ultimately toxicity of nanoclays. 
161 
 Complementary, the thermally degraded nanoclays showed lower degrees of toxicity due 
to the loss of their aluminosilicate lattice and platelet-like morphology.  Further, the thermally 
degraded nanoclays no longer had silanol groups present presumably leading to lower membrane 
disruptions and reactive oxygen species generation when compared with as-received samples.  
 Based on our results, detection and mitigation strategies should be implemented in 
nanoclay/nanocomposite manufacturing and disposal areas to minimize worker inhalation hazards. 
Specifically, further investigations into the amount and sizes of particles workers are being 
exposed to should be performed and used to help set up proper occupational exposure limits and 
protection equipment that allows for the filtering of nanoparticles of certain sizes.  Further, 
engineering controls such as better ventilation and encasing appropriate release areas of process 
equipment used in nanocomposite manufacturing should be implemented. Finally, with such 
toxicity information, safe-by-design manufacturing can be implemented. For instance, nanoclays 
functionalized with modifiers containing long carbon chains instead of bio-reactive groups can be 
used in the manufacturing of nanocomposites to help make safe, yet still effective products. Also, 
further investigations into the manufacturing parameters that influence nanoclay exfoliation within 
a polymer, such as temperature, processing time, and processing conditions can be performed to 
help decrease the toxicity of nanocomposites in addition to building a more effective product.  
With a combinatorial approach of lessening nanoclay exposure and designing safer products with 
an understanding of both material properties along with toxicity, the effects of these systems 
throughout their life cycle can be minimized.  
 
 
 
 
 
 
 
 
 
